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PREFACE 
This study was conceived m 1976 during a three months stay m Prof. Hommes 
laboratory. At that time it was clear to both of us that the method m use 
for measuring epilepsy induced by heat lesion and folic acid in rats showed 
some shortcomings. We received a grant from TNO (CLEO A28 ) in order to 
investigate the practical applicability of the "folic acid focus". In august 1978 
we started the project. From the beginning we tr ied to answer two questions: 
1. How could we "validate" the method used until then ? 
2. Could we f ind "any useful application" of this method apart from the 
elucidation of the mechanism of action of folic acid ? 
Furthermore we tr ied to reduce the burden imposed on our experimental 
animals because the method hitherto in use was considered to be rather pain-
ful l and causing to much stress. 
So from august 1978 until december 1980 we (M L.F. Schoofs, T .J .A .M. 
van der Velden and the author ) did a number of experiments, which we were 
able to work out last year thanks to a sabbatical period of six months, 
offered by the Medical Faculty of this University. Most of the work was done 
in the Central Animal Laboratory in Nijmegen, which served as a very stimu-
lating environment. 
We wondered, why most investigations with regard to anticonvulsants 
merely evaluated seizure suppression. Therefore we tr ied to assess the inf lu-
ence of these drugs on some phenomena preceding these seizures. This issue 
gradually became the central part of our experiments. 
For the wr i t ing of this thesis all results from the articles, published in 
the course of this investigation, were recalculated and new outcomes were 
added (some ECoG experiments and the "O-deoxyglucose and ^C-ant ipyrme 
results). Because our articles showed a lack of coherence and clar i ty, the 
text was entirely rewritten too. This was done by using a text editor (Words-
tar®) and a spreadsheet (Supercalc©) on an Osborne® microcomputer. The 
final manuscript was sent to the IBM® computer of the Catholic University of 
Nijmegen*, re-edited and pr inted. 
We hope, that our efforts will have some influence on our knowledge 
concerning epilepsy and the action of anticonvulsants. 
With special thanks to Mr. T. Adriaansen. 
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SUMMARY 
In this thesis we describe the development and application of a model of par-
tial motor epilepsy in the rat Starting from the principle of acute heat lesion 
at the sensorimotor cortex, followed by iv. injection of an epileptogenic agent 
(folic acid or penicillin) 24 hours later, all aspects of this method, which was 
already in use in our laboratory for some years, were re-evaluated. Some 
properties of the focus were re-examined and finally the effects of six major 
anticonvulsants systematically studied. 
In chapter 1 a review of the l i terature is given. From this some aspects 
become clear. The interactions between neuronal populations, leading to 
organized forms of epileptic act iv i ty, are not well known, m contrast to the 
sequence of cellular events. The abundancy of models, available for the 
study of epilepsy, illustrates the complicated nature of this disease. The val-
ue of animal models is underscored by the fact, that f ive out of the six major 
anticonvulsants were discovered through animal experiments. Finally some 
general aspects concerning the EEG, contr ibuting factors and the two epilep-
togenic substances are reviewed 
In chapter 2 the re-evaluation of the method is discussed. The following 
aspects were studied: 
• Construction of the stereotaxic heat-lesion probe. 
• Thermal effects. 
• Toxicity and body concentrations of folic acid. 
• Preliminary electrocorticographic features. 
• Preliminary observation results. 
• Definition of a standard lesion. 
• Choice of the variables. 
• Selection of the animals. 
• Statistical design. 
Due to the presence of censored observations, an estimation procedure 
was developed for the variables duration of epilepsy and number of jerks. 
The latter was subdivided into short, medium and long interval jerks. Other 
variables, chosen for fur ther testing, were: spread and intensity of jerks, (type 1 and 2) seizures and the jerk-mterval mode (Jl-mode). 
In chapter 3 reference values are described after folic acid or penicillin 
injection. The two types of epilepsy differed with respect to spread and num-
ber of jerks, both being greater m penicillin epilepsy. It is concluded, that 
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activation of the lesion by means of penicillin causes a more generalized form 
of epilepsy. The sequence of jerk intervals (often regular and then referred 
to as "rhythm"), as measured by the Jl-modes, was not different for both 
agents. However the greater number of jerks m penicillin epilepsy might indi­
cate, that the epileptic rhythm is more stable in this form of the disease. 
From our own data, supported by scarce l i terature, a relation between several 
aspects of epilepsy was expected, which might have consequences for the way 
drugs interfere with focal seizures and spread. An important association 
indeed was present between the occurrence of type 2 seizures (afterdischarge 
type) and the rhythm of the long interval ("mterictal") jerks, as well as for 
the spread of jerks and this rhythm. 
In order to get additional information about some general aspects of our 
epileptic focus, we describe a number of electrocorticographic features in 
chapter 4. This analysis included the development of a method of automatic 
spike recognition, some details of which can be found m the appendix. The 
development of epilepsy was studied more closely and the correspondence 
between the electrocorticographic features and the observations is shown. The 
complementary value of both methods is stressed. 
In chapter 5 the cerebral metabolism and vascular volume were studied. 
The glucose utilization of the epileptic tissue did not consistently increase, 
but occasionally an enhanced uptake of ( "Odeoxyglucose was seen m and 
around the focus and m the ipsilateral thalamus and n. caudatus. This f i n d ­
ing however was not due to epilepsy alone. 1 he difference between our 
results and those found in the l iterature іь mainly explained by the fact, that 
folate induced partial epilepsy was much less severe, m terms of frequency 
and spread of seizures. The vascular compartment (measured through 
injection of (1*C )antipyrme) diminished; in the lesioned cortex a 16 % lower 
volume was seen, in the underlying thalamus and striatum 4-6 %. These 
changes were ascribed to increased local intracranial pressure. Finally the 
relation between some anatomical features and functional properties was stud­
ied, yielding negative results. Only the primary spread of jerks to the limbs 
seemed to be caused and limited by the boundaries of the lesion. The secon­
dary spread to the face did not depend on lesion size. 
In chapter 6 one application of our method is presented. The influence 
of six major anticonvulsants on the form of partial epilepsy, presented here, 
was studied. The results from the foregoing chapters led to a number of 
hypotheses concerning the action of these drugs: 
• Apart from a separate influence on type 2 seizures the anticonvulsants 
appeared to be able to inhibit seizures by interfering with the basic 
rhythm of isolated long interval jerks (especially around 0.7 Hz.). This 
0.7 Hz. rhythm correlated with the occurrence of type 2 seizures. 
• The secondary spread of the discharges, outside the area, damaged dur­
ing the lesion, showed a similar correlation with the 0.7 Hz. rhythm. 
Therefore inhibition of it was also supposed to depend partly on the abil i­
ty of the drugs to change the 0.7 Hz. rhythm. 
• Furthermore it was expected, that both seizure types would not be equal­
ly sensitive to anticonvulsants. 
• Finally, induction of a more generalized form of epilepsy (after penicillin) 
apart from creating a more locali7ed one (with folic acid) might provide 
indications, to what extent the degree of generalization influences these 
drug effects. 
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After a long series of experiments the important role of the rhythm of 
the epileptic jerks was shown. Adjustments for drug effects on the jerk 
rhythm explained a great deal of the variabi l i ty m the drug effects on type 
2 seizures and spread to the face Type 1 seizures were more diFficult to 
suppress than type 2. The ability of drugs to prevent type 1 seizures was, 
m folate induced epilepsy, associated with their potency to interfere with the 
sequence of isolated jerks. In the penicillin groups the spread of the jerks 
was more easily inhibited, than m the folate groups. It was also found, that 
the greater resistance of long interval epileptic jerk rhythm m penicillin epi-
lepsy caused four drugs out of the six to be much less effective m this form 
of partial epilepsy. It is concluded, that interaction between epileptic phenom-
ena, such as the rhythm of isolated discharges and type 2 seizures, dist in-
guishes partial models of experimental epilepsy from generalized seizure mod-
els. 
In chapter 7 the validity of our test is discussed. Considering recent 
evidence concerning the chemical mode of action of the anticonvulsants, the 
suppression of the 1.3 sec. Jl-mode seems related to GABAergic mechanisms, 
while the antagonism of seizures type 2 and possibly spread of jerks seems to 
depend on the ability of the drugs to interfere with membrane phosphoryla-
t ion. Furthermore a classification of the anticonvulsant drugs is proposed, 
based on the l i terature and the experimental data from this investigation. 
Fthosuximide, valproate and clonazepam (in use for petit mal) are the f i rs t 
group and might be combined with carbamazepme or phenytom. Phénobarbital 
shows a mixed type of action, which makes this substance less useful for 
combinations of drugs. Finally, the choice of applying a heat lesion m order 
to evoke epilepsy might be a wrong one m view of some findings presented in 
this thesis. The use of techniques for local injection m freely moving animals 
is advised, with preservation of the method of analysis of partial motor epi-
lepsy, presented here. 
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SAMENVATTING 
In dit proefschrift wordt de ontwikkeling beschreven van een methode om bij 
proefdieren (ratten) epilepsie op te wekken die begint vanuit een haard 
(-focus) en zich dan gedeeltelijk (=partiëel) door de hersenen verspreidt. Het 
principe van de hier beschreven methode is reeds een aantal jaren in het 
laboratorium voor experimentele neurologie toegepast. Een soortgelijk onder-
zoek is bij mensen niet mogelijk, onder meer vanwege de grote individuele 
verschillen. Een aantal redenen maakten een nieuwe opzet nodig. In de eerste 
plaats was de bestaande methodiek niet voldoende betrouwbaar en te belastend 
voor de proefdieren. Bovendien wilden wij nagaan in hoeverre geneesmidde-
len tegen epilepsie ("anti-epileptica") bij partiele epilepsie anders werkzaam 
zijn dan bij gegeneraliseerde vormen, waarbij van de aanvang af de hersenen 
in hun geheel betrokken zijn bij de epileptische ontladingen. 
In hoofdstuk 1 worden enige achtergronden van epilepsie beschreven. 
Neurofysiologisch onderzoek heeft uitgewezen, dat de zenuwcellen tijdens epi-
leptische verschijnselen een verandering vertonen van de elektrische spanning 
over de celwand, waardoor zij t i jdelijk heftig kunnen gaan ontladen. Dit wordt 
waarschijnlijk veroorzaakt door een combinatie van een overvloed aan pr ikkel-
ing vanuit naburige zenuwcellen en een afwijkend funktioneren van de cel-
wand. Op welke wijze groepen zenuwcellen geli jkt i jdig gaan ontladen en hoe 
epileptische aanvallen ontstaan, is nog onbekend. 
Er bestaat een grote verscheidenheid aan diermodellen waarin epilepsie 
en de werking van anti-epileptica onderzocht kan worden. Dit grote aantal 
geeft een indruk van de complexiteit van het begrip epilepsie. In ieder geval 
staat vast, dat vi j f van de zes meest gebruikte anti-epileptica zijn ontwikkeld 
via experimenteel onderzoek bij dieren. 
In hoofdstuk 2 wordt de ontwikkeling van de methode beschreven. Bij 
onze proefnemingen zijn naast een weefselbeschadiging door warmte twee ver-
schillende stoffen gebruikt om epilepsie op te wekken, foliumzuur en penicil-
line. In dit proefschrift worden de volgende fasen beschreven: 
• Aanpassing van de soldeerinstallatie voor stereotaktisch gebruik (dwz. in 
een toestel, waarmee nauwkeurige hersenoperaties kunnen worden ver-
r icht ) . 
• Meting van de temperatuurseffecten. 
• Bestudering van de nevenverschijnselen en lichaamsconcentraties van fol i -
umzuur. 
• Voorlopige observaties van de epilepsie. 
• EEG-metingen. 
• De ontwikkeling van een standaardlesie en standaardprocedure. 
• Selectiecriteria voor de proefdieren. 
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De definitieve keuze van de variabelen. 
• Statistische verantwoording. 
Aangezien de epilepsie ontstaat m de motorische hersenschors zijn de epilep-
tische ontladingen te zien als t rekkingen, die zich soms vanuit de ledematen 
uitbreiden naar het gelaat. Wanneer deze trekkingen m reeksen achter elkaar 
komen, spreken we van aanvallen. 
In hoofdstuk 3 worden een aantal resultaten beschreven die het verloop 
van de epilepsie weergeven na mjektie van foliumzuur en penicilline. De epi-
lepsie die ontstaat na toediening van penicill ine, toont een grotere tendens tol 
uitbreiding en een groter aantal t rekkingen. De verdeling van de meest voor-
komende intervallen tussen de trekkingen is voor beide groepen hetzelfde. 
Aan de hand van onze resultaten en schaarse literatuurgegevens wordt veron-
dersteld, dat diverse aspekten van epilepsie elkaar beïnvloeden. Zo l i jkt het 
aannemelijk, dat sommige plaatselijke aanvallen vaker voorkomen, wanneer de 
langzamere, geïsoleerde, epileptische verschijnselen m hetzelfde dier een 
bepaald ritme vertonen. Hetzelfde geldt voor de uitbreiding van epilepsie naar 
naburige gedeelten van de hersenen. Een belangrijke bevinding is, dat er 
twee verschillende soorten lokale aanvallen bestaan. Dit is tot op heden m de 
l iteratuur onvoldoende onderkend. 
Om beter geïnformeerd te zijn over de achtergronden van het epilep-
tische focus, worden in hoofdstuk 4 een aantal experimenten beschreven, 
waarin het EEG van de proefdieren is geanalyseerd. Fr werd een methode 
ontwikkeld voor automatische herkenning van epileptische pieken in het EEG 
Nadere details kunt U vinden m de appendix. Met behulp hiervan wordt het 
beloop van de epilepsie nader beschreven. Tevens wordt de overeenkomst 
tussen de gegevens uit het EEG en de observaties besproken. Beide metho-
den bl i jken, ook bij deze vorm van experimentele epilepsie, elkaar aan te vu l -
len. 
In hoofdstuk 5 wordt beschreven, hoe de horsen-stofwisseling en het 
plaatselijke vaatvolume zich gedragen onder invloed van de lesie en epilepsie. 
In tegenstelling tot andere l i teratuur, waarin overigens heftiger vormen van 
epilepsie worden beschreven, heeft de gematigde epilepsie bij onze proefdieren 
geen duidelijke invloed op beide. De stofwisseling is m en rondom het focus 
incidenteel verhoogd, alsook m de naburige hersenkernen, het striatum en de 
thalamus. Het vaatvolume daarentegen is alléén door de lesie duidelijk vermin-
derd m een groot deel van de hersenschors (gemiddeld afnemend met 16 Oo) en 
eveneens m het striatum en thalamus (4-6 o). Dit l i jkt een gevolg van ae 
plaatselijke drukverhogmg tengevolge van hersenoedecm. Tenslotte is het ver-
band tussen de anatomie van de lesie en enige kenmerken van de epilepsie 
nagegaan. De afmetingen van de lesie blijken van weinig belang. 
In hoofdstuk 6 tenslotte wordt een belangrijke toepassing beschreven van 
onze methode, namelijk het testen van de invloed van de zes meestgebruikte 
anti-epileptica op partiele motorische epilepsie. Dit gebeurde met een aantal 
hypothesen m gedachte, die waren opgesteld op grond van de resultaten uit 
de voorgaande hoofdstukken: 
• Hoewel stoffen tegen epilepsie een rechtstreeksemvloed op locale aanvallen 
kunnen uitoefenen, zouden sommige m staat zijn tot een efficiëntere rem-
ming van het tweede type locale aanvallen door het ritme van de 
geïsoleerde trekkingen tussen de aanvallen te verstoren. 
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• Eenzelfde verstoring van het 0.7 Hz. ritme van de trekkingen zou kunnen 
leiden tot een betere onderdrukking van de uitbreiding buiten het primair 
beschadigde gebied. 
• De twee typen aanvallen zouden in verschillende mate gevoelig zijn voor 
de gebruikte stoffen. 
• Tenslotte zou de meer gegeneraliseerde vorm van epilepsie na toediening 
van penicilline, vergeleken met de meer plaatselijke vorm na foliumzuur, 
aanwijzingen kunnen verschaffen, m welke mate dit verschil zijn weerslag 
kan hebben op het effect van deze geneesmiddelen. 
Na een lange reeks proeven konden WIJ inderdaad aannemelijk maken, dat 
het ritme van de epileptische verschijnselen belangrijk is, omdat correcties 
hiervoor een groot deel van de verscheidenheid aan geneesmiddel-effecten kon 
verklaren. Type 1 aanvallen waren moeilijker te onderdrukken dan type 2. 
Het onderdrukken van type 1 aanvallen, welke ontstaan vanuit een geleidelijke 
verdichting van geïsoleerde verschijnselen was, m foliumzuur epilepsie, geas-
socieerd met het vermogen tot het tegengaan van deze geïsoleerde trekkingen 
zelf. Tijdens de meer gegeneraliseerde penicilline epilepsie was de uitbreiding 
zelf gemakkelijker te onderdrukken dan tijdens foliumzuur epilepsie. Aan de 
andere kant bleken vier van de zes geneesmiddelen duidelijk minder effektief 
op het aantal trekkingen en type 2 aanvallen na penicilline mjektie, omdat de 
langzamere epilepsieritmen dan met gevoelig zijn voor therapie. Dit model van 
partiele epilepsie verschilt essentieel van die proefopstellingen, waarbij wordt 
gekeken naar geïsoleerde aanvallen of totaal gegeneraliseerde epilepsie. Met 
name omdat de onderlinge samenhang tussen de diverse epileptische ver-
schijnselen bestudeerd kan worden. 
In hoofdstuk 7 wordt de geldigheid van onze methode nog eens 
geëvalueerd. Het effekt van de geteste stoffen op type 2 aan va en het domi-
nante epilepsientme van 0.7 Hz. is bekeken in het l icht van steeds duidelijker 
wordende gegevens over hun chemische werkingsmechanismen. Op grond van 
de verkregen gegevens uit de l i teratuur en het eigen onderzoek is een voor-
stel geformuleerd voor rationele combinaties van anti epiléptica. Hierbij 
vormen ethosuximide, valproaat en clonazepam (m gebruik voor petit mal) één 
groep, te combineren met carbamazepine of Phenytoine uit de andere. Phéno-
barbital heeft op zich reeds een gemengde werking en l i jkt geen goede kan-
didaat voor kombmatietherapie. 
Tenslotte wordt besproken, dat de keuze om epilepsie op te wekken met 
behulp van een hersenbeschadiging, misschien moet worden herzien op grond 
van enige resultaten uit dit proefschrif t . De methode, gebruikt om de par-
tiele motorische epilepsie te analyseren, l i jkt wel bruikbaar m de toekomst, m 
combinatie met lokale mjektie technieken bij v r i j bewegende proefdieren. 
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Chapter 1 
INTRODUCTION 
Epilepsy has long been an intriguing sign, attracting much attention because 
of its dramatic appearance. However scientific research m this field only 
started one century ago (Hughlmgs Jackson, in Taylor 1958). 
Since then there has been a steady growth in scientific papers, devoted 
to epilepsy. Nevertheless until now it is not known, why epilepsy appears m 
the organized forms it does. We will not give a review of the history of 
research m epilepsy. Only those fields that are of interest for our experi-
ments will be mentioned. These include the following: 
1. Neurophysiology of epilepsy. 
2. Experimental models m epilepsy. 
3. Anticonvulsant drugs. 
4. Folic acid and epilepsy. 
5. Penicillin and epilepsy. 
1.1 NEUROPHYSIOLOGY OF EPILEPSY 
The notion, that epilepsy is " an abnormal, excessive, elpctrical dis-
charge of neurons " CAjmone Marsan E, Gumnit 1972) appeared for the f i rs t 
time in the writ ings of Hughlmgs Jackson. This idea has since been worked 
out m more detail. Nowadays we have the paradoxical situation that more is 
known with regard to the individual cellular phenomena than concerning the 
modes of interactions between cells, which are responsible for the rhythmic 
events appearing as 'epilepsy'. We will summarize the state of knowledge 
according to the following items: 
1. Cellular level. 
2. Local circuits and local factors 
3. Surface EEG changes. 
4. Global factors. 
Before reviewing these issues, I would like to discuss the work of Fber-
sole (1977). In a series of very elegant experiments m feline visual cortex he 
was able to show the sequence of events leading from normal neuronal func-
tion to epilepsy by means of provoking epilepsy using local iontophoresis of 
penicil l in. Advances in the rate of iontophoresis were followed by a progres-
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sive increase m the number and frequency of spikes of individual neurons, 
indicating a so called enhancement of a physiological response (EPR). This 
enhancement was readily reversible and non-preferred stimuli ( i .e . not specif-
ic for the receptive field of that particular neuron) continued to elicit no cel-
lular responses under these conditions. At higher rates of iontophoresis addi-
tional cellular spikes with latencies longer than the EPR were elicited by a 
wide variety of previously non-preferred as well as preferred stimuli. These 
late responses (LR), unlike the EPR, were associated dur ing maximal ionto-
phoresis with cellular potentials, which increased significantly m amplitude, 
became recordable at the cortical surface, and were thouqht to represent 
"larval paroxysmal depolarization shifts (PDS, see below) ' , since at ful l 
development their properties were the same as those of PDS's. These late 
responses always had a longer latency than the EPR, so they were likely to 
be mediated by interference of neighbouring cells. This description of the 
process of epileptogenesis illustrates therefore a fundamental issue m the field 
of neurophysiology of epilepsy concerning the question, whether changes m 
the membranes of individual cells or the organization of the neuronal popula-
tions form the most important dr iv ing power for the generation of epilepsy. 
More details will follow now. 
1.1.1 CELLULAR LEVEL 
The state of knowledge is described in some recent reviews (Ajmone Marsan & 
Gummt 1972, Prince 1978). 
The f i rs t and most important cellular phenomenon, described after unit 
analysis became technically possible, was the paroxysmal depolarization shift (PDS) m the acute penicillin focus (Matsumoto 1964). Later several authors 
described the same phenomenon in a variety of other focus. The PDS is com-
posed of a slow depolarization with a steep rising phase on which multiple 
action potentials are superimposed; sometimes the plateau phase is followed by 
hyperpolanzation (see Figure 1). 
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Figure 1: Examples of paroxysmal depolarization shifts (PDS). Records are 
from a pyramidal (Α-C) and from an unidentified neuron (a-d) fo l­
lowing penicillin application on cat neocortex The PDS occurs 
spontaneously in f i g . l a , while it is ' tr iggered' by single pulse 
stimulation to the ipsilaleral thalamic nucleus ventrahs lateralis (Α-C) or to the cortical surface (b-d) Stimulation strength is 
constant m b-d and is progressively decreased in the order from 
A l , to A2, B, A3, C. Note how the stimulus may induce only an 
EPSP (C3), an EPSP followed by PDS (B3, С) or an EPSP with 
spike(s) followed at different delays by PDS. The lower tracing in 
each section of Α-C is from the cortical surface Calibrations: A-C 
10 msec. and 1 mV. (surface record), 50 mV (intracellular 
record); a-d 100c/sec. and 10 mV (Α-C modified from Matsumoto 
et al. 1969; a-d, Matsumoto 1964 ). Reprinted with permission from 
Ajmone Marsan ¿ Gumnit (1972). 
It is clear that considerable efforts have been made to show, whether 
the PDS is a giant synaptic potential, or an active neuronal response (for 
reviews see Prince 1978, Voskuyl 1978). Vve will not describe the arguments 
for and against both views here The general opinion is, that both may play 
a role m penicillin epileptogenesis, the synaptic part seeming more important (Gutmck et al 1982). 
Despite the fact that this PDS was found in several epileptogenic focus, 
this phenomenon is not as universal as previously thought. Dichter et al (1973) were able to record (in cat hippocampus) two additional f i r ing pat-
terns, suggestive of interneuron act iv i ty. These patterns were found in all 
layers of the hippocampus. The PDS and the two additional f i r ing patterns 
were seen to convert into each other dur ing ictal as well as mtenctal periods. 
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There was also a lack of correlation between mterictal and ictal f i r ing 
patterns of the individual cells The authors claimed, that other studies using 
intracellular analysis followed a highly selective procedure favouring predomi-
nantly the larger pyramidal cells for analysis (which more often show a PDS). 
They also concluded, that the use of intracellular analysis proved to be far 
from adequate in understanding the epileptic behavior of clusters of neurons. 
This also emerges from the study of E-bersole, mentioned above, who conclud 
ed· 
The initial and prerequisite abnormality of penicillin epilepto-
genesis appears to be one of individual neurons (the EPR). The 
LR and PDS, on the other hand are dependent on abnormal 
interactions within a cell population and appear to be a secon-
dary elaboration of the EPR's of many individual neurons through 
the aberrant utilization of mtracortical collateral and recurrent 
pathways. 
From this short review it will be clear that single cell analysis can not 
give a complete answer to the problem of epileptogenesis. Therefore we will 
tu rn our attention to the local circuits of neurons. 
1.1.2 LOCAL CIRCUITS AND LOCAL FACTORS 
The probably most important factor m epileptogenesis is formed by the inter-
actions of neuronal populations This became already apparent m the intro-
duction, where the epileptogenesis m visual cortex, as described by Ebersole, 
was mentioned. Neocortical slices for example show all characteristics of epi-
lepsy, without however spontaneous ictal and mterictal discharges or sponta-
neous PDS's (Gutmck et al 1982). For a more thorough understanding we 
f i rs t need a basic knowledge of some of the architectural features of the cere-
bral neocortex, especially the sensorimotor part . However not much is known 
about the exact architecture and even less about its significance for the func-
tion of the cortex. Despite the knowledge about pyramidal cells, their vertical 
cy lmdnc organization, the description of different sorts of mterripurons, the 
phylogenetic growing role of the neuropil and the preferential endings of tha-
lamocortical and other connections (Peters 1980, Marin-Padilla 19/5), the real 
significance and organization of local neuronal circuits remains vir tual ly 
unknown According to Rakic (1975) local neuronal circuits can be defined as 
any portion of neurons or neuron that, under given conditions, functions as 
an independent integrative unit Thus, they may have a wide range of mor-
phological and functional boundaries: simple or multisynaptic local units, inde-
pendent dendritic arborizations involving only a part of the dendritic tree, or 
they may involve one or many LCN's. An L CN is a 'local circuit neuron', for-
merly called interneuron. 
From neurophysiological studies and reviews (Ajmone Marsan & Gumnit 
1972, Prince & Wilder 1967, Dichter & Spencer 1969a and b. Lopes da Silva 
1980) it is known that within an penicillin epileptogenic focus three areas can 
be discerned during mterictal discharges, a central one, where excitation 
predominates, a peripheral one, generating largely inhibitory potentials and 
an intermediate one where both are present Intenctal ictal transition - a 
hitherto unexplained phenomenon - might be due to extreme depolarization of 
mterneurons through the activi ty of the pyramidal neurons; this extreme 
depolarization might stop the f i r ing of the inhibitory neurons (Dichter & 
Spencer 1969b). Other explanations for this transit ion remain open (Prince 
1978). 
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Studies by Petsche et al (1978) revealed that the discharges of a cortical 
penicillin focus arise from layers IV and V and spread from there to more 
superficial and deep structures. This was confirmed by Lockton and Holmes 
(1980) and Ebersole and Chatt (1980). 
Several nonsynaptic factors m epileptogenesis have been found, contr ib-
uting to the f i r ing of populations of neurons. The f i rs t of them is formed by 
the antidromic bursts, which are found to arise m cortical tissue at the end-
ings of thalamocortical relay cells and represent an important synchronizing 
mechanism for populations of neurons (Gabor & Scobey 1975). The second is a 
change in the ionic microenvironment (Lux 1980, Lopes da Silva 1980, Heme-
mann & Lux 1983). This has been well investigated for potassium and calcium. 
Despite the fact, that the extracellular K* concentration is increased during 
epileptogenesis until a peak of 10-12 mM (Prince 1973, Moody et al 1974 and 
others), its role seems to be limited. Superfusion of solutions with high 
extracellular K+ concentration can produce epileptiform discharges m hippo-
campus (Zuckermann & Glaser 1968), but according to Prince (1978): 
The normally resulting spatial distr ibution of ionic shifts in the 
epileptiform focus may offset the expected excitability increases 
which would occur from uniform exposure of a cellular population 
to increased extracellular K+ concentration alone. 
The accumulation of extracellular K+ is buffered by the glial tissue. 
Probably this buffering leads to shrinkage of the extracellular space, which 
prevents too large reductions m extracellular bia* and CI- levels (Hememann 
& Lux 1983). Changes m extracellular Ca + + concentrations also have been 
observed (review by Lux 1980, Hememann & Lux 1983), possibly increasing 
the efficacy of excitatory synaptic transmission. The reductions m extracel 
M a r Ca++ often precede the onset of spontaneous epileptiform activity and 
they may occur at atypical sites. Consequently intraccllularly an increase of 
Na4·, Ca + * and CI- and decrease of K+ are to be expected. This intracellular 
increase of Na+ can activate the Na'K-pump v\hich may cause a decrease of 
extracellular K+ during some minutos, thereby increasing seizure threshold 
and contributing to seizure termination. 
In conclusion we can say that ionic shifts only seem to play an important 
role in the development and termination of seizure act ivi ty. However reduc-
tions of extracellular Ca + + concentrations already occur before the onset of 
spontaneous epileptiform activity and seizures, and therefore might be impor-
tant during earlier episodes of epileptogenesis. 
1.1.3 SURFACE EEG CHANGES 
The electrical activity of the brain, discovered in animals by Fleisch von 
Marxow (1890) and registered for the f i rs t time in humans as the "elektren-
kephalogramm" by Berger (1929), is the reflection of a field potential or igi-
nating from the cerebral cortex. It represents the amplified summated activity 
of hundreds or thousands of cells (Cooper et al 1974). Ih is field potential is 
proportionate to the current flowing through the membrane, the summated 
surface of that current and the reverse of the distance between the site of 
origin and measurement (Lopes Da Silva 1978). Because of the small surface 
and the short duration from and during which action potentials are generated 
as compared to dendritic EPSP's and IPSP's, it is likely that the EEG only 
reflects the more massive dendritic field potentials, which are measurable 
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thanks to the columnar organization of the cerebral cortex. From the work of 
Ebersole (1977) and others it has become clear, that surface EEG changes 
become visible as soon as PDS's begin to develop. These PDS's, which are 
generated over a considerable neuronal surface, develop synchronously with 
the mtenctal spikes (see Figure 1). 
The role of the distance between the current generated at the cellular 
membrane and the field potential at the surface is an important one. To what 
extent differences in tissue conductance dependent on the direction of this 
conduction (= amsotropy, Petsche et al 1972 and 1975) and the passage of 
different anatomical structures are important, remains to be elucidated. This 
is especially true for the small lissencephalic rat brain. In chapter A we will 
discuss our own EEG f indings. 
1.1.4 GLOBAL FACTORS 
From clinical experience we know, that epilepsy m man can be easily inf lu-
enced by some factors, of which stress and sleep-wake rhythm, coupled to 
vigilance (Declerck 1983, Sterman et al 1982) are the most important ones. In 
man the epilepsies can be classified according to their preferential occurrence 
in the day-night cycle (Janz 1962) into waking, sleep and diffuse epilepsies. 
Despite the fact, that NREM stage 1 and 2 facilitate generalized epilepsy and 
REM promotes the partial seizures, localizing at the same time the focal abnor-
malities m the LEG, the exact situation is far more complex (Declerck 1983 p. 
13, Passouant 1982) Moreover the state dependency' of the different types 
of epilepsy is not the same, the partial forms being more independent. The 
influence of "arousal" mechanisms is poorly understood (Sterman et al 1982 p. 
187-90), but clearly a transitional state between wakefulness and sleep seems 
essential for the "state-dependent" epilepsies. To what extent stress influenc-
es epilepsy through these arousal mechanisms has not been extensively inves-
tigated. 
Another important element is the degree of maturation of the brain. In 
man this is il lustrated by the age related incidence of epilepsy, showing a 
peak in childhood In rats this maturation is completed at the age of 60 days (Vernadakis & Woodbury 1969). 
Other factors are important m the induction or propagation of epilepsy. 
They probably have only additional value, except for neurotransmission and 
hypoxia. We will not review them m detail here: 
1. Neurotransmitters (GABA, ammoacids) (Tower 1972, Siegel et al section 
I I I , 1981). 
2. Systemic hypoxia (Trojan 1978). 
3. Energy metabolism (Sokoloff 1981, Duffy & Plum 1981). 
4. Blood-brain barr ier damage (Katzman & Pappius 1973). 
5. Systemic ionic disturbances (Katzman & Pappius 1973, Katzman 1981). 
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1.2 EXPERIMENTAL MODELS IN EPILEPSY 
From the end of the 19th century it became known, that the overt manifesta-
tions of epilepsy could be replicated m laboratory animals by a variety of 
procedures (Swinyard 1980). There are many experimental models in epilepsy 
(Purpura et al 1972). Some of them are aimed to test anticonvulsant drugs, 
others serve as neurophysiological tools. The former use mostly primates, 
cats, rats or mice, while the latter also include many evertebrates, tissue 
slices and organ preparations. 
Epilepsy can be induced m mammals either chemically or electrically. 
Both have their advantages and disadvantages. In late years the development 
of the epileptic process has been simulated by means of 'k ind l ing ' , i.e. the 
daily electrical stimulation during some seconds leading to self-sustained epi-
leptic discharges after a variable period of time (for a review of cortical self 
sustained after-discharges m the rat see Mares et al 1981). Chronic applica-
tion of this principle has revealed some very interesting knowledge about the 
development of epilepsy (Wada 1976) Chemical induction of epilepsy, following 
a 'kindl ing' procedure has also been succesfull (e g . Clincke & Wauquier 
1982, Miller et al 1982), but is more di f f icul t 
Epileptogenic drugs can be administered systemically or locally. Micro-
lontophoretic techniques have been applied for special purposes (e .g . Eber-
sole 1977). Sometimes lesions and chemical induction of epilepsy are combined 
in order to establish a focus. Acute and chronic models can be created, the 
f i rs t having more versat i l i ty, the second in order to study the development of 
epilepsy; the latter are considered to simulate more closely human epilepsies (Woodbury 1972), although neurophysiologically no great differences exist (Dichter and Spencer 1968, Sherwm 1977). 
A comparison of some models and a description of other tools in the 
evaluation of anticonvulsant drugs will follow in chapter 6. As will become 
clear m the next section, the existence of good animal models has been of 
crucial importance for the development of anticonvulsant drugs, despite the 
fact that no complete analogy is present between human forms of epilepsy and 
those of other mammals. 
1 3 ANTICONVULSANT DRUGS 
The f i rs t effective antiepileptic agents were discovered from keen clinical 
observations on drugs being used for man for other purposes, bromide by 
Lolock in 1857 and phénobarbital by Hauptmann in 1912 (Swinyard 1980 and 
1982). Subsequently, 50 synthetic congeners of phénobarbital appeared in 
the next 25 years. In 1938 the clinical efficacy of phenytom was shown (Mer-
rit and Putnam 1938) after the drug had been discovered throLigh inhibition 
of electrically induced seizures in cats. In 1946 and 1947 the analogy between 
human and rodent responses to electrical stimuli of the brain was noted and 
also a similarity in response to anticonvulsant drugs (Toman et al 1954, 
Toman et al 1955). This led to test batteries for use m various laboratory 
animals (Purpura et al 1972, Swinyard & Woodhead 1982) from that time sev-
eral anticonvulsants have been discovered like trimethadione, marketed in USA 
m 1946, ethosuximide m 1960, diazepam m 1968, carbamazepme in 1974, clo-
nazepam m 1975 and valproate sodium m 1978 (Swinyard 1980 p. 4 ) . The 
application of experimental epilepsy m animals therefore considerably has con-
tr ibuted to the progress in antiepileptic therapy. 
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T h e d r u g s mentioned m t h e f o r e g o i n g , are now w i d e l y used m t h e t h e r ­
apy of ep i lepsy w i t h t h e e x c e p t i o n of b r o m i d e s . While i t is not d i f f i c u l t to 
make a d i s t i n c t i o n in t h e i r e f f i c a c y against p e t i t and g r a n d mal, which is s u p ­
posed to be analogous to a d i f f e r e n t in f luence on d i v e r s e animal models ( S w m -
y a r d 1982), i t has been e x c e e d i n g l y d i f f i c u l t u n t i l now t o f i n d a rat ional c las­
s i f i c a t i o n of t h e i r general c l in ical e f f i c a c y ( S h o r v o n 1983, Gram 1982, 
C e r e g h i n o 1982, White 1982) due to methodological p r o b l e m s . T h e r e f o r e t h e 
exact p r e f e r e n t i a l indicat ions of each d r u g s t i l l remain o b s c u r e . Th is even 
more holds f o r t h e choice between t reatment w i t h one d r u g o r more d r u g s m 
combinat ion and t h e quest ion of w h i c h d r u g s to combine, if necessary ( R e y ­
nolds 1980, P o r t e r 1984). T h e r e f o r e o u r goal was t o set up e x p e r i m e n t s , t h a t 
could g i v e good a n t i e p i l e p t i c p r o f i l e s of t h e a n t i c o n v u l s a n t s m p a r t i a l e p i l e p ­
s y . 
1.4 FOLIC A C I D AND EPILEPSY 
Folic acid ( p t e r o y l g l u t a m i c a c i d , see F i g u r e 2) is a w a t e r - s o l u b l e p t e r i d m e 
( M c G i l v e r y , 1970), t h a t does not enter the in tact b r a i n . 
•cooH 
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Figure 2: Structure of folic acid. In the organism the substance is reduced 
at the positions 6,7 and 5,8. Methyl groups may be added at the 
5 position; oxidation of this substituent causes additional binding 
to the N-10 atom (from Goodman and Gilman 1974, with permis­
sion) . 
However, m plexus chonoideus a facilitated transport mechanism is pres­
ent and a special folate binding protein exists, which carries methylated forms 
into, and oxidized folates and analogues out of, the brain (Spcctor & Lorenzo 
1975, Spector 19/9, Spector & Suleiman 1981). These processes in the CNS 
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help to maintain the levels of reduced folates there, which normally are 
higher than m plasma. This transport seem does not seem to be altered by 
massive intravenous doses of folates in rabbits (Spector 1979). 
Since 1960 (Noëll et al 1960) it has been known, that injection of minimal 
amounts of folic acid mtraventricularly m rats evokes epileptic seizures. Work 
done in our laboratory (Hommes Б Obbens 1972, Obbens 1973, Berge ten 
1975, Hommes et al 1979, Hommes 1981, Arends et al 1981 and 1982, Arends Б 
Hommes 1983), has confirmed this f inding and shown, that acute damage of 
the blood-brain barr ier by heat lesion and the subsequent intravenous injec­
tion of folic acid is an easy and safe way to induce epilepsy m rats 
A comparative study in rats (Obbens Ь Hommes 1973) showed, that the 
non-reduced form of folate is the most potent of all sodium salts with respect 
to epilepsy; the reduced and methylated forms are less active; glutamate, 
pterin and PABA (which are part of the folate molecule) are not epileptogen­
ic. The derivative methotrexate is about 4 times less active than folate itself. 
In a later study in guinea pig hippocampal slices (Cl i f ford & Ferrendelli 1983) 
the epileptogenicity of the not reduced form of folate was confirmed and the 
same pattern of epileptogenic action of its congeners was found, with slight 
differences, the pteroic acid part of the molecule being not epileptogenic too. 
These authors therefore argued, that not the glutamate moiety of folic acid 
was responsible for the epileptogenic effect, nor its oxidized or reduced 
state, but rather the structure of pteroylglutamic acid itself. Miller et al (1982) were able to 'kindle' epilepsy by repeated intraventricular injections of 
folic acid. Recently attention has been drawn by certain analogies and di f fer­
ences between the epileptogenic action of folates and kaimc acid, a more neu­
rotoxic epileptogenic substance (Mat Jais et al 1984, VIcGcer et al 1983, I rem-
Ыау et al 1983, Auker et al 1982, El-Lakany 1982, Evans et al 1982, De Sarro 
1982, Olney et al 1981, Roberts et al 1981, Ruck et al 1980). Folic acid and 
analogues seem to share the ability of other glutamates and related substances 
to inhibit synaptic act iv i ty, when nervous tissue is exposed to these subs­
tances for long periods, after an initial excitatory effect (Loots et al 1982). 
McLennan (1982) reported that folate and 5-methyltctrahydrofoldte were inac­
tive as excitants of spinal neurons. 
Reports on the clinical significance of folic acid appeared from 1945 
regarding its role m megaloblastic anemia and from 1965 concerning an associ­
ation between neuropsychiatrie disease and folate deficiency (Reynolds 1976 
and 1979) The evidence for the latter does not seem strong and perhaps it is 
only important in a small selected group of patients (Reynolds 1981, Turner 
1981). In fact the significance of the presence of folates and their function m 
the mature brain remain unknown (Turner 1981). 
In man the convulsive activity of folate derivatives has not been con­
vincingly demonstrated, although it has been suspected for a long time (Hommes 1980). Because the epileptogenic effect of folate in animals appears 
at high concentrations of about 10 -4 M, while normal concentrations are 
about 10 -6 M (Hommes 1981, ρ 643), and because the molecular structure 
rather than metabolism seems to be the epileptogenic factor, it is better to 
make a clear distinction between the epileptogenic action of folates in animals 
and the observed phenomena due to disturbances in folic acid metabolism m 
man 
Side-effects of massive intravenous doses of folates m rats have been 
described. Renal insufficiency have been observed (Schmidt and Dubach 
1976), as well as a small cardiogenic action (Spector 1973) 
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In summary, despite the fact that the epileptogenic action of folate is 
well documented, this substance has - until recently - not received the atten-
tion of investigators it deserves, especially because it is a substance with a 
physiological role in the body, which cannot be said of most of the other epi-
leptogenic substances, in use for inducing seizures (see Purpura et al 1972). 
The basic structure of folic acid seems responsible for its epileptogenic 
action, not its metabolism into reduced and methylated forms ( d i - , tetra- and 
b-methyltetrahydrofolate). The mechanism of this is not understood. 
1.5 PENICILLIN AND EPILEPSY 
Penicillins consist of a thiazolidme ring (A) connected to a beta-lactam ring 
(B ) , to which a side chain (R) is attached (Figure 3 ) . In this thesis only the 
derivative penicillin g is used, designated as 'penici l l in'. 
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Figure 3: Structure of penicill ins. The side-chain R for penicillin g consists 
of a benzyl group (from Goodman and Gilman 1974, with permis­
sion) . 
After its introduction as an antibacterial agent it soon became known, 
that penicillin was able to induce epilepsy (for review see Voskuyl 1978). In 
the clinical situation too, in cases of menmgo-encephalitis, where a damage in 
blood-brain barrier functions is present, intravenous application of penicillin 
sometimes provokes epilepsy. Since this discovery numerous articles have 
been published using penicillin as the epileptogenic agent (see REFERENCES). 
It has become a reference substance for almost all neurophysiologically orient­
ed papers. Therefore we included a number of tests with penicillin g as the 
epileptogenic agent instead of folic acid 
The mechanism of action of penicillin induced epilepsy is not known. 
There are structural requirements in order for penicillin and its analogues to 
be epileptogenic. For this the beta-lactam ring is necessary, as incubation 
with penicillinase destroys its epileptogenic properties (Gutnick Ь Prince 
ж I® 
fìC 
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1971). The structure common to all penicillin analogues, 6-APA, is relatively 
ineffective as a convulsant agent (Gutnick et al 1976). Modification by adding 
side chains to the beta-lactam ring greatly enhances its convulsive properties. 
The epileptogenic potency of these APA-substituents does not correlate with 
their l ipid solubility and kinetic behavior. 
In cats systemic application of penicillin induces an epileptic state resem-
bling petit mal, described as cortico-reticular epilepsy (Gloor 1979). In rats 
parenteral administration of penicillin is effective too, although a somewhat 
higher dose is required (Fanello 1976). The type of epilepsy observed con-
sists of a series of multifocal discharges, progressively more synchronized, 
giving the appearance of a pseudogeneralized pattern. In rats no exact dupl i -
cate of the human spike-and-wave epilepsy characteristics of petit mal can be 
induced by parenteral penicil l in. Side-effects of these large amounts of peni-
cillin were not mentioned in the articles, referred to here. 
Concluding this very short review we must say, that despite the huge 
efforts made in order to elucidate the mechanism of action of penicillin 
induced epilepsy, much remains unclear. To what extent this substance is 
representative for human forms of epilepsy remains to be determined more 
precisely. In the subsequent chapters we will compare and discuss the dis-
tinction between folate and penicillin induced epilepsy in our model and the 
different actions of antiepileptic drugs on both. 
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Chapter 2 
DESIGN OF THE METHOD 
A series of experiments was performed in order to f ind the best test. These 
included the following topics, which will be described in this chapter: 
1. Application of the heat lesion. 
2. First observations. 
3. Effects of iv. folic acid. 
4. Recording the ECoG. 
5. Subsequent observations. 
6. Anatomy of the lesion. 
7. Choice of the variables. 
8. Selection of the animals. 
9. Statistical procedures 
2.1 APPLICATION OF THE HEAT LESION 
The following aspects were investigated: 
1. Form and surface of the probe. 
2. Changes of temperature in the brain. 
3. Localization of the lesion. 
2.1.1 FORM AND SURFACE OF THE PROBE 
For the application of the heat lesion a stereotaxic frame was used * and a 
soldering iron set (Antex, type TCSU1©), thermostatically controlled, was 
adapted for stereotaxic use. Several loose soldering tips were made, with dif-
ferent diameters. Their top was made curvilinear in order to f i t the shape of 
the skul l . In the one chosen for the definit ive procedure, a copper-
constantane thermocouple was inserted at the t ip for registration of probe 
temperature during lesiomng. In Figure 4, the adapted soldering tip is 
* Constructed by the Department for Instrumental Service of our University 
(head: W.J. Nagelvoort). 
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shown. 
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Figure 4: Heat lesion probe. The adapted soldering iron probe is shown 
without distal thermocouple. 
2.1.2 CHANGES OF TEMPERATURE IN THE BRAIN 
In order to assess the effects of the heat applied to the animal's brain, the 
following conditions had to be met: 
1. The lesion should be reproducible with regard to its physical as well as 
biological effect. 
2. The optimal surface and depth of the lesion were to be determined; the 
minimal surface for the penicillin epileptogenic focus in the rat was 
found to be 0.5 mm2 (Reichenthal & Hocherman 1977). Furthermore an 
incomplete damage to all cortical layers was needed, especially the 
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pyramidal cell layer, responsible for the observable motor output (layer 
5) , at a depth of 1.6-2.0 mm. could not be allowed to become largely 
destructed. Besides, big lesions might increase intracranial pressure too 
much. In order to meet these requirements the probe surfaces were 
varied and the elevation of temperature in the target brain tissue 
during the application of the probe was measured. 
3. Other -mechanical- damage such as opening of skull and dura should be 
avoided, if possible. 
We set up an experiment in which the thermal effect of the application of 
the probe directly on the skull surface over the motor cortex was studied. 
For the theory of heat conduction we referred to Halhday & Resmck (1966). 
2 1.2.1 METHOD 
Because measurements m rats during anesthesia were not readily feasible due 
to the size of the necessary thermistors, we used dead animals (from other 
experiments) and measured the intracranial thermal effects with copper-
constantane thermocouples. 
Six dead rats (male Wistar, 250 300 g) were mounted m a stereotaxic 
frame. The soldering iron probe (see Figure 4) was installed and 3 loose tips 
were used with diameters of 2.38, 4.50 and 9.00 mm. These were connected to 
an electronic power supply (Delta E15-02®), from which current and potential 
could be read. Throughout the experiments 15 V was used, while the current 
strength was varied. The measurements of thermal effects were done with 
copper-constantane thermocouples, attached to a galvanometer (Kipp Microva 
AL-4®) with ice-waler serving as reference. The thermocouples were intro-
duced into the brain by means of burr holes at varying heights, one for each 
rat. At the site of the motor cortex the probe, covered with a heat conduc-
tive gel, was brought close to the skul l . The heating time of the probe before 
application to the skull was set at 10 mm. and the heating time during con-
tact with the skull surface was set at 2 mm. , according to earlier experi-
ments. Between two sessions m one rat minimal 30 mm. were allowed to 
pass. At varying distances from the cortical surface (for each rat one locali-
zation of the thermocouple) the maximal elevations of temperature for different 
probes and for current strengths were measured. The position ot the tip of 
the thermocouple was verified by brain sectioning m si tu. When the site of 
the tip could be located correctly, the experiment was considered to be val id. 
2.1.2 2 RESULTS 
For each rat and for each of the three probes the decrease of temperature 
per unit of heat energy as a function of the distance to the probe was plotted (see Figure 5). In rats 2 and 6 all probes were tested, m rat 1,3 and 5 two 
probes and m rat 4 only one. 
From these values we could calculate the estimated maximal elevation of 
temperature at the cortical surface for each probe (per unit of heal energy) (B) and the distance at which 50 % reduction of elevation of temperature (D1/2) can be observed. These results are shown m Table 1. 
From these results it was possible to calculate the current necessary to 
obtain a desired elevation of temperature at the cortical surface. 
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Figure 5: I n f l u e n c e of probe on b r a i n t e m p e r a t u r e . For each probe t h e 
decrease m elevat ion of t e m p e r a t u r e ( p e r u n i t of heat e n e r g y ) is 
p l o t t e d as a f u n c t i o n of d is tance f rom the c o r t i c a l s u r f a c e . 
Table 1: Measurements 
For e x p l a n a t i o n see t e x t . 
PROBE-DIAMETER 
nm 
2.38 
4.50 
9.50 
of t h erma e f f e c t 
В 
122 
182 
203 
of p r o b e s m t h e b r a i n 
Dl/2 
mm 
2.74 
2.69 
2.64 
2 . 1 . 2 . 3 DISCUSSION 
Because these measurements were p e r f o r m e d m dead r a t s , we could not 
account f o r t h e heat loss r e s u l t i n g f r o m heat c o n d u c t i o n due t o t h e c i r c u l a t i o n 
of b l o o d . T h e blood f low t e n d s t o spread t h e e levat ion of t e m p e r a t u r e , 
c h a n g i n g t h e conical f o r m of t h e lesion into a more f l a t t e n e d and broadened 
one. 
A second d r a w b a c k was formed b y the f a c t , t h a t n o t h i n g was known 
about t h e r e a c t i v i t y of the local blood vessels ( b a r b i t u r a t e a n e s t h e s i a ) , the 
p o s s i b i l i t y of local thrombosis and the in f luence of local in f lammatory response 
( b r a i n edema) t o t h e ul t imate shape and p r o p e r t i e s of t h e les ion. 
T h e r e f o r e we decided to t r y out an e x p e r i m e n t in l i v i n g rats in o r d e r t o 
establ ish t h e best i n t e n s i t y of t h e lesion (see section 2.2). 
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2.1.3 LOCALIZATION OF THE LESION 
In order to be easily observable, the epilepsy should include the motor cortex 
of the rat. Therefore coordinates were chosen, with bregma as a reference 
(Whislaw a .o . , 1977) after analysis of the results of Angel and Lemon (197b). 
From the bregma the region of the hmdlimb could be reached by going 2.0 
mm. to the r ight , the forehmb region by advancing the hallmark needle 1.0 
mm. and going 3.5 mm. to the r ight . The probe with the diameter of 2.38 
mm. seemed the most appropriate one, when aiming to avoid too much overlap 
between the different motor areas. By lesiomng such a distinct motor area, 
we expected, that the secondary spread of jerks outside the directly lesioned 
area would appear during the observations as spread to neighbouring limb or 
face. 
Considering, however, the results of Welker (1971), who found that the 
pyramidal cells in the albino rat had large receptive fields in superficial lay-
ers of the cortex, a more extensive lesion might be necessary in order to 
achieve a form of epilepsy involving the whole limb. Therefore the probe with 
a diameter of 4.50 mm. was also used. 
2.2 FIRST OBSERVATIONS 
A series of experiments was done to gain insight m the following problems: 
1. Which lesion size and intensity is the optimal one for chemical induction 
of epilepsy afterwards? Dawson and Holmes (1962) were not able to 
induce epilepsy after heat lesion alone; Hommes and Obbens (1972) used 
a probe, which caused a moderate elevation of temperature at the cort i -
cal surface (7-10 "C, according to our own experiments as shown in 
section 2.1.2) . 
2. What is the optimal period between the lesion and activation of it by 
means of injection of folic acid ? Earlier experiments had shown, that 
after 48 hours the probabil i ty of evoking epilepsy after an injection of 
folic acid decreased sharply (Hommes and Obbens 1972). 
3. What was the optimal amount of folic acid to be injected and the best 
way of administration ? 
2.2.1 METHOD 
Male albino Wistar rats (weight about 250 g , from TNO and the Central Animal 
Laboratory) with free access to food and water were used. Three animals 
were kept in each cage. A day-night cycle with daylight from 7.00 a.m. to 
19.00 p.m. was induced. These rats were, judged by weight (Spector 1956), 
to be 10-15 weeks old. At this age the animals can be considered adult in 
terms of development of epilepsy (Vernadakis & Woodbury 1969), skull growth (Moore 1966) and blood-brain barrier functions (Vernadakis & Woodbury, 
1969). Animals were accustomed to the experimental room and the workers in 
the week before the test by observing them at least twice. Before the appli-
cation of the lesion they were anesthetized (pentobarbital 45 mg/kg i p . . Nem-
butal®, and atropine 1 mg/kg s c ) . Lesions were made with different probes 
and dif ferent current strength with the apparatus described in 2 .1 .1 . The 
site of the lesion was the forelimb or hmdlimb area (see section 2.1.3). To 
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cause a homogeneous heating of the whole area, the probe was rotated to an 
angle of 8-12 in the frontal plane and a correction was made for the dis­
placement, resulting from this rotation. The periost was removed carefully 
and after the eventual bleeding had been stopped, the probe was left in con­
tact with the skull surface for two minutes, then the wound was closed. 
After surgery the animals were allowed to recover for at least 24 hours. At 
different intervals after surgery an intravenous injection (in the pemsvem, 
after roll ing the animal m a towel) was given, containing folic acid. For the 
higher dose of folic acid (90 mg/kg) a special solution was made every week: 
750 mg of folic acid (Sigma®) was dissolved m 25 ml aq. dist. under addition 
of NaOH. The solution was neutralized with HCl, the Na* concentration was 
measured (photometrically) and aqua dist. was added to get an isotonic solu­
t ion. Each rat received a volume of 0.7-0.9 ml. Before this injection a short 
observation of the animals behavior was made for the presence of spontaneous 
epilepsy. All observations took place in the same plexiglass cage (40 χ 80 
cm.). For the registration of all epileptic manifestations mechanical counters 
were used. The jerks, considered to be epileptic conform later ECoG experi­
ments (see section 2.4 and chapter 4 ) , were counted. These epileptic jerks 
will be referred to by calling them simply ' jerks' . 
In two animals a canulation of the a. femoralis was carried out under 
pentobarbital anesthesia * and by means of a method, designed for this 
experiment (Arends and Nagel voort 1981), chronic intra arterial infusion was 
made possible m the freely moving animal. The same solution of folic acid, as 
described above, was used at an infusion rate of 0.5 m l . / h r . , after a bolus 
injection of folic acid (90 mg/kg). 
2.2.2 RESULTS 
The results are summarized m Table 2. 
* By H.J.M. Janssen and P.B. Spaan. 
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Table 2: Results of f i rst heat lesions. 
AT = elevation of temperature at the cortical surface of dead animals. 
The rats in group VI were divided m two groups of three, that 
received a heat lesion at the hmdhmb resp. forehmb projection area. 
After three weeks only intenctal activity of short duration ( < 40 mm.) 
and low frequency (0.7-1.5/min. ) could be evoked. In group IV and V, 
the lesion caused complex activation (see below) and the area of tissue 
destruction extended into n. caudatus. In these groups spontaneous 
jerks of low frequency (0.7-1.5/min. ) were seen. In groups VI and VII 
a reproducibleform of epilepsy, associated with seizure act iv i ty, was 
present and tissue destruction never exceeded the cortex cerebri. 
EPILEPSY 
PROPORTION 
1/6 
4/12 
3/5 
3/5 
6/6 
2/2 
tOUP 
I 
II 
III 
I+II+III 
IV 
Ï 
VI 
VII 
NUHBER OF 
RATS 
3 
3 
6 
12 
5 
5 
6* 
2 
Δτ 
«с 
20 
20 
20 
20 
20 
30 
20 
20 
PROBE 
4.50 1 38 
• 
• 
•f 
+ 
•• 
• 
+ 
• 
TIME FOR RE­
COVERY 
72 hours 
72 boura 
48 hours 
3 veeke 
24 hours 
24 hours 
24 hours 
24 hours 90 
FA-DOSE 
-«/kg 
10 
30 
10 
90 
90 
90 
90 
+ lufusion 
2.2.3 DISCUSSION 
In some rats with large lesions complex activation was seen, accompanied by 
attacks of freezing and stereotyped behavior. Later on, the same phenomenon 
was seen m one rat during a ÉCoG registration. No epileptic spikes from the 
cortical surface were visible during these attacks. This does not mean, that 
the observed phenomena were not the consequence of subcortical or deep cor-
tical epileptic attacks. Before the folate injection in these rats spontaneous 
isolated jerks were seen, of low frequency. These lesions were considered to 
be too large and too complicated to be acceptable. Long delay (> 24 hours) 
after surgery, and low doses of folate (< 90 mg/kg) also did not produce 
reliable epilepsy. This is in agreement with the study of Hommes and Obbens (1972). 
The lesion of group VI was chosen for fur ther experiments. Before con-
t inu ing, we chose to investigate the (side-)effects of high doses of folates. 
These (renal) side-effects were also the reason that we did not continue our 
experiments with chronic infusion of folic acid. 
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2.3 EFFECTS OF INTRAVENOUS FOLIC ACID 
Side effects of massive intravenous doses of folates in rats have been 
described. A small cardiogenic effect (reversal of phenytom induced brady-
cardia was found by Spector (1973). More important was the f inding that 
acute renal failure could be produced by iv. folate (Schmidt and Dubach, 
1976). 
Therefore we tr ied to f ind out, whether or not changes m renal function 
and secondary disturbances of electrolytes and other parameters might be the 
result of our iv. folate injections. 
A second experiment was done in order to f ind out, how fast folic acid 
would disappear from the blood and the speed of its metabolic conversion to 
5-methyltetrahydrofolate. 
A th i rd -orientating- experiment aimed to get some idea about the con-
centrations of folic acid m the neighbourhood of the focus at the moment of 
the f i rs t epileptic events Furthermore a global description of the distr ibution 
of folic acid m the body was needed. 
We will discuss these items m the following order: 
1. Changes in renal function. 
2. Kinetics and metabolism of folic acid. 
3. Distribution of folic acid. 
2 3.1 CHANGES IN RENAL FUNCTION 
2.3 1.1 METHOD 
After different intervals following folate administration (90 mg^kg iv . ) blood 
was sampled (orbital puncture, under ether anesthesia). 83 Animals were giv-
en folic acid, 19 animals served as controls. Assays of the following subs-
tances were performed*: 
1. urea, creatine 
2. Na+, K+, C I - , Ca++ , P04--
3. Hb, Ht 
4. enzymes: alk. phosphatase. 
2.3.1.2 RESULTS 
The results of the laboratory assays did not show any significant di f ier-
ences between the control and folic acid injected animals. However a trend 
towards elevated urea and creatine concentrations after folic acid was pres-
ent. From this experiment we concluded, that the administration of folic acid 
* At the Laboratory of Neurology (Head: J .C .N . Kok). 
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(90 mg/kg iv . ) did not cause a major disturbance in the organism. The trend 
towards elevated ureum and Creatinin was explained by the fact, that m a 
small minority of animals (4 out of 76) they rose to levels up to 4 times nor-
mal. In these animals renal damage had possibly occurred. Folic acid may pre-
cipitate in the renal tubules, due to its limited solubility m water. 
2.3.2 KINETICS AND METABOLISM OF FOLIC ACID 
2.3.2.1 METHOD 
The determination of concentrations of folic acid and 5-methyltetrahydrofolate 
late was done following the the technique of high-pressure liquid chromato-
graphy (Lankelma 1976, Lankelma and Poppe 1978, Lankelma a.o. 1980). Two 
columns were used, one for concentration, the other for separation. 
Blood sampling was done in 1 male Wistar rat (250 g) after intra-artenal 
canulation and the application of the infusion device for freely moving animals (Arends & Nagelvoort 1981). Blood (9 samples, each about 0.1 ml.) was col-
lected during 24 hours after iv. injection of folic acid (90 mg/kg) . The 
results* are shown in Figure 6. 
mot/l 
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\ 
W 20 TI« (hrs.) 
Figure 6: Kinetics of iv. folate in one rat. The concentration course of folic 
acid and its major metabolite 5-methyltetrahydrofolate after iv. 
injection of folic acid (90 mg/kg) is shown. Folic acid is cleared 
from the blood in a two compartment fashion (T1/2 - 50 mm. for 
the f i rs t phase), its metabolite 5-methyltetrahydrofolate reaches its 
maximal value after about 2 hours. 
* These assays were performed by J . Lankelma, results modified from Lankel-
ma a.o. (1980). 
20 
2.3.2.2 DISCUSSION 
From these experiments we could conclude, that the metabolism of folic acid is 
slow compared to the development of epilepsy (which begins at 10 mm. and 
ends after 110 mm. (see below). This again points to the hypothesis, already 
mentioned by Clifford & Ferrendelli (1983), see also section 1.4, that struc-
ture rather than metabolism of the folate molecule seems the most important 
factor for its ability to induce epilepsy. 
2.3.3 DISTRIBUTION OF FOLIC ACID 
2.3.3.1 METHOD 
For these experiments the technique of whole body autoradiography was used, 
according to the Ullberg method, as described by van der Kleijn (1969)*. All 
12 rats received a heat lesion, as described for the last group m section 2.2. 
For the injections 2-1*C-folic acid (The Radiochemical Centre Amersham ®) 
was used (specific activity 55 mCi/mmol = 124 yC/mg). Cach rat received 30 
yC/kg (1.73 % of total amount of folate injected) and an additional amount of 
non-radioactive folic acid up to 90 mg/kg. In the f i rs t experiments (2 rats) 
the animals were killed after 30 minutes. After deep ether anesthesia they 
were submerged into isopentane, cooled with solid carbon dioxide to -80°C 
and stored at -20 0C. Their whole bodies were embedded in a 5 ° carboxy-
methylcellulose gel of 0 °C and frozen again. By means of a special microtome (PMV 450®) whole body sections of 30 ym. thickness were made, attached to 
Scotch tape 810®. After freeze-drymg at atmospheric pressure the sections 
were brought on a röntgen film (Structunx D/FW - Agfa-Gevaert®). Exposure 
took place at -15 "C dur ing 6 weeks. After development positive prints were 
made. In the next 10 rats only their heads were embedded, with a special 
designed frame and these animals were killed after 5 minutes, which is the 
time of f i rst occurence of epileptic peaks Besides, immediately after folic acid 
injection they received 0.7 ml tvans Blue iv. for vital staining The concen 
tration of folate was assayed m all rats for plasma, whole brain and the 
focus, liver and kidney. Except for plasma, some tissue from the sections was 
removed by means of a special designed punch device (diameter 4.05 mm.). 
The sample was dissolved in 0.4 ml. solueen and discolored by means of 
H202. Then Instagel® (to 15 ml.) was added and this solution was counted m 
a liquid scintillation counter for 15 minutes. For each rat at least 3 plasma 
samples and about 5 slices were used. From the 10 animals in the last group 5 
were used for quantitative assays of brain and focus. The results are shown 
m Figure 7 and Figure 8 and Table 3 and Table 4. 
* The preparation of the autoradiograms was performed at the laboratory of 
Clinical Pharmacy (Head: E. van der Kleijn) by N. Rijntjes. 
21 
В F 
В. 
0.4 
А2 В2 
0.7 
А
э
 Вз 
1.0 
А, Вл 
2.2 
Figure 7: "O-folate in the brain. Distribution of (2-"CJfolate in the brain 
5 min. after injection. The white areas correspond to radioactivi­
t y . Three horizontal sections through the focus are shown, from 
one rat brain, starting at 0.4 mm. below the cortical surface (A 
1-3). The distance from the the cortical surface is indicated below 
each picture. Comparing A(1-3) with photographs of the same 
rat, showing intravital Evans Blue staining (B 1-3), one will see, 
that Evans Blue and folic acid are almost equally distributed 
throughout the lesion. In the rest of the brain no folic acid is 
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seen, while Evans Blue is visible (depicted in A4 and B4). The 
central part of the lesion consists of cellular debris, which does 
not show any radioactivity. В r brain, F = focus. 
Figure 8: ^C-fo late in the body. Whole body autoradiography of two rats 
30 min. after iv. injection. Sagittal sections are shown, 24,5 
hours after heat lesion. White indicates no radioactivity (in con­
trast with Figure 7). F = focus, В = brain , L = l iver, GB = gall­
bladder К = kidney, G = gut (the mucosa contains folic acid). 
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Table 3: Results of (l-^C) folate assays 5 mm. after iv. injection. 
Under each organ heading the magnitude of concentration is given as 
the power of 10. 
RAT FA-CONC. (M) RATIO 
no. KIDNEY LIVER PLASMA FOCUS BRAIN F/P F/B 
- 3 - 4 -A - 4 - 5 
1 
2 
3 
4 
5 
6 
7 
β 
9 
10 
mean 
se 
6.1 
5.0 
5.6 
4.9 
5.9 
10.3 
8.3 
4.7 
6.8 
7.4 
6.5 
0.6 
4.1 
4.4 
5.1 
4.4 
5.0 
3.7 
5.1 
5.3 
5.0 
6.0 
4.8 
0.2 
7.0 
6.5 
9.0 
7.0 
8.6 
6.2 
7.3 
4.3 
7.6 
6.6 
7.0 
0.4 
-
1.1 
-
2.3 
-
1.0 
-
1.3 
-
1.7 
1.5 
0.2 
-
2.9 
-
1.3 
-
1.5 
-
1.0 
-
1.1 
1.6 
0.3 
-
0.17 
-
0.33 
-
0.16 
-
0.30 
-
0.26 
0.24 
0.03 
-
3.8 
-
17.7 
-
6.7 
-
13.0 
-
15.5 
11.3 
2.6 
L 
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Table 4: Results of ( 2 - " С ) folate assa 
Mean and sd a re given 
power of 10. 
TISSUE 
TYPE 
RAT 1 
kidney (whole ) 
l i ver 
plasma 
focus (brain) 
brain 
RAT 2 
kidney ( c o r t . ) 
kidney (med.) 
l i ver 
plasma 
focus (brain) 
brain 
and 
FA-
mean 
7.3 
2.2 
1.6 
5.1 
1.3 
6.3 
3.1 
1.9 
1.3 
7.5 
4.5 
t h e 
CONC 
sd 
3.1 
0.1 
0.4 
1.2 
0.6 
1.8 
0.4 
0.1 
0.2 
3.6 
1.7 
magniti, 
(M) 
exp(lO) 
-3 
-4 
-4 
-5 
-5 
-3 
-3 
-4 
-4 
-5 
-6 
ys 
de 
30 
of 
RATIO 
mm. after iv. injection. 
t h e concentrat ion as the 
TISSUE/PLASMA 
4 5 . 6 
1.4 
1.0 
0.3 
0 . 0 8 
4 8 . 5 
2 3 . 9 
1.5 
1.0 
0.6 
0 . 0 3 
2.3.3.2 CONCLUSION 
These results give an impression of the distr ibution of folic acid 5 and 30 
mm. after iv. injection. As was to be expected most can be found m renal 
tissue. In liver a very constant fraction is present, which is concentrated 
into the gall. The (2-1 ' 'C)folate-focus is clearly visible. After 5 minutes it 
has about the same anatomic boundaries as the Evans Blue extravasate. At 
that time it extends up to 1.9 mm. into the cortex of the brain (Figure 7). 
After 30 minutes (Figure 8) perhaps some diffusion has taken place into deep­
er layers. The central area of tissue destruction and the rest of the brain do 
not contain significant amounts of folic acid. 
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2.4 RECORDING THE ELECTROCORTICOGRAM 
At this point of the experiments we needed evidence, to what extent the 
jerks , observed in group VI of section 2 2, were indeed a sequel of epilepsy 
Furthermore we wanted to f ind out, which fraction of the ECoG-spikes was 
observed m the form of jerks Therefore we designed the following experi-
ment. 
2.4.1 METHOD 
In eight male Wistar rats (about 250 g) a lesion was made at the forelimb pro-
jection area. In addit ion, half spherical silver electrodes were implanted epi-
dural ly over the parietal and occipital cortex and olfactory bulb at both 
sides (see Figure 19)*. No commercially available screw electrodes could be 
used, because these were supposed to irr i tate the underlying cortex during 
more than 24 hours, when the registration should take place. The electrodes 
and the connector (a small electronic socket) were fixed with dental acrylic 
cement. In this way stable registrations could be obtained for over two 
weeks. Thanks to the connector and a slip r ing set (Air Precision®, type 
APCL-13-EEG, 6 channels) the animals could move freely in the observation 
cage. The FCoG was recorded on a Siemens Elema Mmgograf® and transmitted 
to a taperecorder (Hewlett-Packard® 3968A) for off line automatic analysis (see chapter 4 ) . In six rats, videotape recordings* were made, on which 
simultaneously the animal and the ECoG were visible on a split screen This 
was done m order to reduce the number of animals, necessary for learning 
the observations, as well as for i l lustrative purpose. 24 Hours after surgery 
a reference signal (10 Hz, 1 mV) and a baseline ECoG were recorded. Then 
iv. folic acid (90 mg/kg) was given and the resulting epilepsy registrated and 
observed. The leads were bipolar, while the two olfactory electrodes served 
as general reference to the amplifier (Figure 19). The amplification f i l ter had 
an upper limit of 70 Hz. and a time constant of 1.2 sec 
2.4.2 RESULTS 
In Figure 9 the resulting ECoG after injection of folic acid is depicted. 
From Figure 9, which illustrates a characteristic pattern, the develop-
ment of epilepsy can be described. In a period of about 100 minutes 5 types 
of epilepsy develop in consecutive order They can be classified according to 
the interval between the discharges: 
1. Irregular incidental spiking from 5-10 mm. after injection of folic acid. 
Sometimes a well developed spike-wave is present. The animal does not 
discontinue its normal activity (not shown). 
2. Gradual increment of discharges into a focal seizure pattern with dis-
charges up to 3/sec, consisting of spike-waves, ending abruptly (Fig-
ure 9A). During this 'type 1 seizure' the animal becomes unquiet and 
moves through the cage while sni f f ing. After this seizure incidental 
These electrodes with rounded tips of 0.5 mm. diameter were designed in 
collaboration with the Department of Instrumental Service (head: W.J. 
Nagel voort) and made there. 
In collaboration with the Audiovisual Department (head- M.N. Bollen). 
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Figure 9: Electrocorticogram of one rat. In part A the beginning of epilepsy 
is shown after 10 mm. Part В illustrates the characteristic dis­
charges after 30 mm. In part С the development of a focal seizure 
after 56 mm. is visible. Only the two ECoG-channels adjacent to 
the focus are shown. The upper trace shows one second marks. 
The lower tracings indicate the recordings adjacent to the focus (left parietal - r ight parietal, r ight parietal - r ight occipital, see 
Figure 19) Cal ibrat ion.! = 1 mV. For fur ther explanation see 
text . 
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spiking may resume often culminating in another 'type 1 seizure' or the 
next pattern may appear. 
3. Generally appearing after 30 min . , a constant discharge pattern with a 
frequency of 0.7-1.2/sec. emerges (Figure 9B) , resembling closely the 
human form of epilepsia partialis continua (syndrome of Kojewmkow). 
During these epileptic phenomena the animal sits quietly and does not 
seem to be depressed or unquiet. The motor phenomena are localized 
and generally limited to one side of the body. This type of epilepsy 
develops m the majority of the animals and continues until about 90 
mm. after injection of folate. 
A. Almost exclusively dur ing the 0.7-1.2/sec. epileptic activity focal sei-
zures abruptly develop (Figure 9C), beginning on the wave after a 
spike and exhibiting an organized pattern with high-frequent spikes 
(9/sec.) and slower spike waves (3 /sec.) in separated, interchanging 
clusters (Figure 9C). During these discharges the motor phenomena 
show a tendency to spread especially to the opposite side of the body, 
m a continuously changing pattern. These changes of spread during 
type 2 seizures are dif f icult to observe reliably. The animal becomes 
unquiet again. After such a seizure the Q.7-'\ .I'sec. activity directly 
reappears without an electrical silent period. 
5. After the 0.7-1.2/sec. discharges, which mostly end abrupt ly, some-
times irregular spiking remains present, with very low frequency. The 
animal enters a stage of slow-wave activity in the ECoG, during which 
these phenomena sometimes reappear or increase m frequency, their 
motor counterpart often being blocked (not shown]. 
In all eight animals the visible jerks were observed during 2 hours. 
They were counted and compared with a visual counting of ECoG spikes. The 
number of false positive findings was negligible (0-4 je rks / ra t ) . The other -
false negative - results are shown in Table 5. 
The observation therefore gave a rather good yield (median: 86 %). 
ECoG discharges were not observed reliably during the beginning of epilepsy 
and in the final period, where occasionally the motor counterpart of the peaks 
was blocked during slow wave sleep. See also Table 31 . Furthermore the epi-
leptic activity during seizures (frequency from 3-9 Hz.) was observed with a 
maximal speed of 5-6 Hz. 
In chapter 4 an additional analysis will be given of the observation 
results, compared with the phenomena m the ECoG. 
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Table 5: Comp 
ECoG-
RAT 
1 
2 
8 
srison between 
sp kes. 
OBSERVED JERKS 
MEDIAN: 
0 
567 
765 
1339 
1978 
2231 
2416 
5768 
1978 
observed jerks 
ECoG-SPIKES 
0 
973 
ИЗО 
1808 
2122 
2322 
2724 
6701 
2122 
and visually recognized 
RATIO OBS./ECoG 
_ 
0.58 
0.68 
0.74 
0.93 
0.96 
0.89 
0.86 
0.86 
2.5 SUBSEQUENT OBSERVATIONS 
Following the results of group VI in section 2.2, it was decided to expand 
that group, m order to f ind out, whether important differences could be seen 
after lesiomng of the hind- or forehmb area. According to the results of 
Angel & Lemon (1975), who studied myoclonic jerks in rats after 
1,2-dihydroxybenzene (catechol) administration (which releases sensory trans­
mission), and peripheral stimulation, it was expected, that the motor spread 
of jerks from the hindiimb region would differ in two respects from those from 
the forehmb area When we speak about 'spread of jerks' we mean the parts 
of the body, m which the jerks manifest themselves. Firstly the jerks could 
be bilateral and secondly they would be visible m a greater motor area. For 
the quantification of spread of jerks we developed a special preliminary proce­
dure. 
Beside a comparison between fore- and hindlimb epilepsy, we assessed 
the influence of variations between different observers, intensity and size of 
the lesion, different ways of administration of folic acid and the induction of 
epilepsy by penicil l in. 
All these experiments will be described m the following sections: 
1. Hind- and forehmb epilepsy. 
2. Variation between observers. 
3. Intensity and size of lesion. 
4. Ways of administration of folic acid. 
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5. Penicillin induced epilepsy. 
6. Conclusions. 
2.5.1 HIND- AND FORELIMB EPILEPSY 
2.5.1.1 METHOD 
21 Male Wistar albino rats were used. They were treated as described m sec­
tion 2.2 group V I . A 'standard lesion' with a probe diameter of 2.38 mm. and 
a ΔΤ of 20 "C in dead animals at the cortical surface was used. Lesions were 
given in 12 rats at the forelimb area (1.0 A, 3.5 R, bregma as a reference), 
in 9 animals at the hmdhmb region (0.0 A, 2.0 R). In both groups one animal 
showed no epilepsy after injection of folic acid (90 mg/kg) 24 hours later. 
The animals were observed during 2 hours in groups of three, each ani­
mal being registered m six periods of 5 minutes each with intervals of 20 
mm. So the total number of jerks mentioned, represents 25 о of the real num­
ber, which amounts (from 2.4) 2000 jerks/spikes for the forelimb area Due to 
the fact that m about 30 % of the animals the epileptic jerks continued after 
stopping the observations, maximum likelihood estimations are given for mean 
and sd of the number of jerks and the duration of epilepsy (see section 2.9). 
The results are given as ln-values. 
Apart from the number of jerks and the duration of epilepsy, the spread 
of jerks and their intensity were coded (Table 6 and Fable 7) and the number 
of seizures (type 1 and type 2 together) was counted. The spread and inten­
sity of the jerks during the seizures could not be assessed reliably, due to 
their continuously changing pattern, so these were left out for classification 
of the animals. 
For calculation of the spread in each animal a so called generalization-
factor was used. All jerks were classified on a mechanical counter according 
to Table 6. For each class of spread the ratio of the total number of jerks in 
that class divided by the total number of jerks was multiplied by the ratio of 
the total number of jerks in the same class divided by the total number of 
jerks m the same and higher classes together. This was done since the same 
spread was also present in all higher classes. From the resulting figure the 
square root was taken and the results for all classes together normalized to 
100 %. So each class of spread was a assigned a value between 0 and 100 % 
for each per iod.* This was a reliable but complicated procedure. Later on this 
calculation was replaced by simply assigning the maximal observed class of 
spread to each animal. 
The classification for intensity of jerks was - contrary to the spread -
designed during this experiment, so no conclusions regarding differences 
between intensities in both groups could be reached. 
For the calculation of this coefficient a computerprogram was written by T h . 
de Boo. 
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Table 6: Classification of spread of jerks. 
CLASS VISIBLE MOTOR EFFECT IN: 
1 only one limb (finger, or toe) 
2 only one limb (whole limb) 
3 both limbs 
4 both limbs + face (only ear) 
5 both limbs + face (ear + eyelid) 
6 both limbs + face (ear + eyelid + vibr) 
7 other (generally 6 + salivation or con-
tralateral jerking) 
Table 7: Classification of intensity of jerks. 
CLASS VISIBLE MOTOR EFFECT RESULTING IN: 
1 hardly visible contraction in limb 
2 clearly visible contraction in limb 
3 associated axial turning until 90 degrees 
4 associated axial turning more than 90 deg-
rees 
5 rolling on back 
2 .5 .1 .2 RESULTS 
The resul ts are summarized m Table 8. 
31 
Table 8: Comparison between hindi 
Statistical s ignificance: Ρ (two sided) 
Wilcoxon-test. 
GKOUF η NUMBER OF JERKS 
•ean (In) ed 
FOIELIMB 11 5 . 9 9 0 . 7 8 
HINDLIMB β 6 . 9 2 0 . 9 ] 
STATISTICAL RESULT 0 . 0 4 (A) 
DURATION OF EPILEPSY 
•can ( l o ) ed 
4.55 0.27 
4.70 0.93 
0.39 (A) 
mb and forelimb epilepsy. 
, (A) = G e h a n - t e s t , (B) = 
NUMBER OF SEIZURES SPREAD 
w d i a n а і п і в а і •ажіааі 
1 f inger 
J whole l U b 
< 0.001 (B) 0.05 (B) 
«bole face 
«hole face + 
h i n d l U b s 
0.025 CB) 
2.5.1.3 DISCUSSION 
These results revealed some expected and unexpected features. From the 
work of Angel & Lemon (1975) a greater spread for hindlimb animals was to 
be expected. This indeed was the case, as well for the minimal observed 
spread as for the maximal one. Furthermore, in one hindlimb animal, bilateral 
spread of jerks was observed during 0.7-1.2/sec. discharges, corresponding 
to the more bilateral oriented projections of the hindlimb on rat cortex. Unex­
pectedly however a higher incidence of focal seizures and a higher total num­
ber of jerks was found for the hindlimb region. We could not f ind similar 
observations in the available l iterature. 
2.5.2 VARIATION BETWEEN OBSERVERS 
Beside the author two different observers (*) did the same type of experi­
ments; they were trained by the author and afterwards performed their own 
experiments, from Iesioning to observing. In Table 9 the results of three 
f roups with forelimb epilepsy, according to the method described in section . 5 . 1 , are displayed. 
* J . Busscher and B.Arends. 
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Table 9: Results of forelimb-epilepsy in three groups with different 
observers. 
OBSERVE! NUMBER OF NO EPILEPSY CENSORED NUMBER OF JERKS 
ANIMALS OBSERVATIONS MEAN (In) SD 
DURATION OF EPILEPSY (aio) 
MEAN (In) SD 
1 
2 
3 
12 
10 
15 
1 
0 
2 
2 
4 
6 
5.99 
6.05 
6.47 
0.78 
1.11 
1.05 
4.55 
4.71 
4.74 
0.27 
0.31 
0.17 
2.5.3 INTENSITY AND SIZE OF LESION 
In section 2.2 we discussed the findings with larger lesions than the one cur­
rently used. Additionally, the forehmb epilepsy obtained by the standard 
method, described m section 2 . 5 . 1 , was compared with smaller and less 
intense lesions, obtained with different probe temperatures. The results are 
summarized m Table 10. 
Table 10: The influence of lesion intensity. 
Only m group 1 there was one animal without epilepsy (not included). 
The mean maximal number of seizures during one period is shown and 
the predominant class of spread (3 = fore- and hmdlimb): * = signif i­
cant (p < 0.05, two-sided), (*) = possibly significant (0.05 < ρ < 
0.10, two sided), Gehan and Kruskall-Wallis tost. 
CROUP EXPECTED 
1 20 
2 15 
3 10 
CURRENT 
(A) 
0.40 
0.35 
0.29 
NUMBER OF 
ANIMALS 
11 
5 
6 
NUMBER OF JERKS 
MEAN(ln) SD 
5.99 0.78 
8.45 * 1.73 
5.37 2.52 
DURATION 
MEAMdn) 
4.55 
5.26 * 
4.41 
OF EPILEPSY 
SD («ίο.) 
0.27 
0.66 
0.39 
NUMBER OF 
SEIZURES(aean) 
0.6 
6.2 (*) 
0.3 
SPREAD 
(nediao) 
3 
3 
3 
From these results one can see, that as the lesion grows smaller, the 
number of jerks becomes larger, but the variance increases a lot too. Dura­
tion of epilepsy is transiently prolonged. These results confirm the findings 
of Reichenthal and Hocherman (1977), that superficial cortical structures are 
important for the generation of epileptic discharges. The current lesion (group 1, see Table 10) seemed the optimal choice, when taking into account 
the effects of lesions of a different size. 
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2.5.4 WAYS OF ADMINISTRATION OF FOLIC ACID 
In order to investigate the possibility, that other routes of administration 
would better meet our requirements, some animals were given folic acid (90 
mg/kg) intraperitoneally or subcutaneously after a standard heat lesion on 
the hmdlimb region. Results are given in Table 11. 
Tabi 
T h e 
is s 
Tabi 
t h e 
ROUTE 
I V . 
I P -
a c . 
e Π : Infi uence of different rot 
latency (median time 
tatistically 
e 10). Sc. 
ιν. route. 
NUMBER OF 
ANIMALS 
β 
6 
5 
changed 
tes 
of f i rs t perioc 
(Wilcoxon test 
administration is associa 
NO EPILEPSY 
0 
1 
3 
LATENCY 
• e d i a o ( m t a . ) 
10 
30 ( * ) 
50 * 
of administrât 
m whic 
two 
ted w 
NUMBER 
MEAN 
6 .92 
5 91 
5 .06 
S I 
t h 
OP 
on of folic acid. 
h epilepsy is observed) 
ded, 
a hie 
JERKS 
( I n ) SD 
0 . 9 3 
1.08 
2 95 
fo r P-values see 
her variance than 
DURATION OF EPILEPSY 
MEAN ( I n ) SD ( » I O . ) 
4 . 7 0 0 . 2 4 
4 . 7 4 0 . 2 8 
4 . 6 1 0 . 2 9 
These results reflect the farmacokmetic differences due to the route of 
administration. The higher variance after se. administration added to the 
preference of the iv. route. 
2.5.5 PENICILLIN AND EPILEPSY 
A pilot experiment was performed m order to f ind the optimal amount of peni-
cillin necessary to induce epilepsy to a comparable degree as after folic acid. 
From the available l iterature (Fanello 1976) we chose for 300.000 I. Li . /kg or 
higher doses. Penicillin was obtained from the Dept. of Clinical Pharmacy and 
was freshly dissolved m aqua dist. Results are summarized m Table 12. 
The animals in group 1 had jerks, which were almost invisible; on the 
contrary those m group 3 had violent jerks and the intensity was great ( ro l l -
ing on the back). The intermediate group very much resembled the folate 
induced epilepsy (see Table 12). Only the spread of the jerks was signif i -
cantly greater than m the folate-treated animals (Wilcoxon test, ρ < 0.05 two-
sided) . 
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Table 12: Results of penicillin induced partial epilepsy. 
Group 2 develops epilepsy at the same level compared to folic acid. Note 
the higher amount of penicillin necessary (0.76 vs. 0.20 mmol.). ? = No 
estimation of the SD was possible, due to 100 % censored observations. 
GROUP DOSE NUMBER OF NO EPILEPSY MOLAR EQUI- NUMBER OF JERKS DURATION OF EPILEPSY 
(IU/kg) ANIMALS VALENT MEAN SD MEAN SD 
(»Ol. J (In) (In) 
PENICILLIN 
1 300000 2 0 0.51 Ί.37 - A.17 
2 430000 9 2 0.76 6.62 1.22 4 54 0 39 
3 600000 4 0 1.01 > 6 . 0 3 7 > 4 . 6 7 7 
FOLIC ACID 
12 1 0.20 5.99 ,0 .78 4.55 0.27 
2.5.6 CONCLUSIONS 
The experiments, mentioned m this section gave us answers to a number of 
questions. These were necessary for optimahzation of the lesion, standardiz­
ing the observations and validating the observed jerks with ECoG-fmdings. 
Furthermore it was shown, that penicillin could evoke epilepsy to the same 
extent as folic acid. From these the standard lesion could be defined: 
1. A probe having a diameter of 2.38 mm. 
2. Causing an elevation of temperature m dead animals at the cortical sur­
face of 20 "C. 
3. Localized over the hmdhmb-projection area. This region was preferred 
because of the larger number of jerks, type 2 seizures and greater dis­
tance to the face area compared with the forelimb region. 
4. 'Activated' by means of iv. injection of either folic acid (0.20 mmol/kg) 
or penicillin (0.76 mmol/kg) after 24 hours of recovery. 
Furthermore some interesting findings were made. The observed di f fer­
ence m spread between hind- and forelimb epilepsy was in line with the f i n d ­
ings from other studies. The increased number of jerks and seizures after 
activation of a hindlimb lesion however was not expected. Decreasing the 
intensity and size of a lesion resulted m a greater number of epileptic jerks 
at the cost of increased variance. The duration of epilepsy however was 
more constant. Finally, despite the fact, that penicillin caused epilepsy to the 
same degree as folic acid, the difference m spread of jerks found m a rela­
tively small group reminded us, that perhaps more subtle differences between 
penicillin and folate induced epilepsy might be found. This is investigated 
more thoroughly m chapter 3. 
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2.6 ANATOMY OF THE LESION 
During the foregoing experiments on all animals brain sectioning was per-
formed. In 8 animals PAS-stammg and microscopical examination of the lesion 
was done. 
2.6.1 METHOD 
Animals were killed after the last experiment under ether narcosis. During 
this narcosis Evans Blue was injected iv. (0.7 ml.) and 5 minutes later the 
animals were decapitated. The brains were dissected and the lesions macro-
scopically inspected. The extent of the lesion surface was measured (for the 
necrotic and Evans blue colored area) and the depth of the lesion (for necro-
sis, Evans blue area and tissue swelling) was assessed. Bleeding at the brain 
surface or m the brain was noted. Eight lesioned brains were fixed m for-
malin and stained according to the PAS-procedure*. 
2.6.2 RESULTS 
When examining the lesion after application of the 2.38 mm. probe and an 
estimated elevation of temperature of 20 "C at the surface of the cortex of 
dead animals, four regions were discerned. These are drawn schematically m 
Figure 10 and can be described as follows: 
1. Zone of total tissue destruction (A) , present m about half of the ani-
mals, tr iangular or ellipsoid on cross section. 
2. Zone of edema and cellular damage (B ) , in this area vital Evans Blue 
staining occurs, indicating damage of blood-brain barrier function. 
3. Zone with PAS-positive astrocytes (C), possibly representing 'activated 
astrocytes' (Brotchi a.o. 1978). 
4. Zone of subcortical edema (D) in white matter. 
In chapter 5 we will present more information about the relation between 
these anatomical features and the degree of epilepsy. 
* The staining of the slices was done by S.J. van Santwijk Teerlink. 
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Figure 10: Schematic drawing of the lesion. The four zones are described m 
the text. 
2.7 CHOICE OF THE VARIABLES 
After the experiments, mentioned until now, we were able to define the vari­
ables, which were to be used for future experiments. The following were cho­
sen, as the result of the knowledge, obtained with regard to the types of 
epilepsy encountered (section 2.4), the important role of jerk intervals (sec­
tion 2.A) and the reliability with which spread of jerks could be observed (section 2.5). Since observation of jerks seemed to be a fa ir ly good and sim­
ple way for the registration of epilepsy, we decided that the following var i­
ables would deserve further attention (see Table 13). The limits for the jerk/ 
spike intervals were chosen after careful analysis of the ECoG's. 
Since the intervals between jerks/spikes were of great importance and 
the number of jerks/spikes to be counted was great, an automatic analysis for 
calculating the results of the observations was designed (see chapter 3 and 
appendix) and for spike recognition in the ECoG (chapter 4 and appendix). 
The final definitions and terminology will be given m these chapters and are 
summarized m the list of terms (chapter TERMINOLOGY). 
Two major issues still had to be resolved, concerning the selection of 
animals for fur ther experiments and regarding the statistical procedures, 
including calculations of the number of animals required for comparison 
between different groups ( i .e. different anticonvulsant d r u g s ) . These will be 
dealt with in sections 2.8 and 2.9. 
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Table 13· List of 10 variables used for f u r t h e r analys is . 
T h e recognition of the se izure types was easiest done visually, 
into account t h e f irst ten intervals . 
VARIABLE SCORED DEFEHDERCE ON THE UPPER LIMIT 
JERK/SPIKE irrERVALU) (SEC ) 
duration of e p i l e p s y (mm ) 
t o t a l nuaber of jerka/spikea 
loog iDterval jerka/spilcea + 
•fidiuB in terva l jerka/apikea + 0 80 
ehort in terva l jerka/apikea + 0 33 
seiEure type 1 ( f i r s t 10 jerks/sp ikes ) + 0 Θ0 
s e i c u r e type 1 ( f i r s t 10 jerks/spikee) + 0 33 
d i s t r i b u t i o n of jerk/spike in terva le • 
spread of jerks 
i n t e n s i t y of jerka 
t a k i n g 
LONER LIHIT 
(SEC ) 
0 80 
0 33 
0 33 
2.8 SELECTION OF THE ANIMALS 
Because the experimental design became more definit ive, we fe l t , that criteria 
for rejection should be formulated. During the experiments, described in this 
chapter and later on, brain sectioning (see section 6 2 1) was performed rou­
t inely. This was done to f ind out, whether obvious reasons existed, why 
animals showed deviations from the normal pattern of epilepsy. Some could be 
found and will be mentioned here. They are listed m Table 14, which summa­
rizes the criteria for rejecting an animal out of the initial population. 
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Table Ί4 Criteria for rejecting an animal out of the initial population 
In the r ight column the number of animals, excluded dur ing the f i rs t 
100 standard lesions (to be described m chapter 3) is listed to show 
the initial number of failures 
CATEGORY CRITERION FOR REJECTION NUMBER EXCLUDED 
TECHNICAL 1) Failure of operation or injection, death after operation 1 
FUNCTIONAL 2) Spontaneous epilepsy before cheaical activation Even when epilepsy after injection 
of folic acid is normal these animals will not be considered to belong to the target 
population 2 
3) No epilepsy after injection of folic acid An animal is considered to have no epil-
lepsy, when four or less jerks are observed 4 
ANATOMICAL 4) Extravasation of blood under the pia mater (not removable blood during section) when 
at least the eise of Evane blue lesion area 4 
5) Иажінаі depth of tissue necrosis exceeds 2 0 mm In that case too mich damage to the 
pyramidal cells is supposed to be present 4 
6) Subcortical bleeding of more than 0 2 ao diameter 1 
2 8 1 DISCUSSION 
The number of animals, excluded from the final population m the experiments, 
described further in this thesis, amounted to 8 %, varying from 16 % in the 
beginning to A % at the end Failure of injection or operation or death after 
operation seldom occurred Animals exhibiting spontaneous epilepsy m general 
showed too large lesions after brain dissection, resembling group IV of 
section 2 2 Therefore they were excluded Those animals, in which no epi­
lepsy after injection was present, without obvious reasons such as failure of 
lesion of injection, were found throughout the experiments Their folate con­
centrations m blood were at the same levels as those of epileptic animals The 
threshold of four jerks was chosen, because the ECoG experiment (see section 
2 4) showed a false positive rating of maximally four jerks Lxtravasation of 
blood at the surface of the brain led to an enormous increase of epilepsy It 
is well known from clinical experience, that the presence of blood (possibly 
through its breakdown products) is a strongly epileptogenic factor That s 
why the seldom occurring subcortical bleedings were excluded too In most 
animals a minimal amount of blood was found under the arachnoid, the quanti­
ty of it bearing no relation with the degree of epilepsy The exclusion of ani­
mals with lesions deeper than 2 0 mm was also done on theoretical grounds, 
apart from the experience gained during the f i r s t experiments m this chapter (see section 2 2), indicating that lesions containing an area of dead tissue 
extending into the subcortex or deeper, could not be activated by folic acid 
This f inding was confirmed during the experiments that will follow later 
By means of this list we hoped to get a more homogeneous population of 
epileptic animals and to reduce the bias, that arises when no clear criteria 
are present By applying enterions 2 and 5, mentioned in Table 14, some 
animals with normal epilepsy were excluded, but these formed only a small 
proportion of the total number of not included animals 
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The number of animals, excluded from the final population for the var i -
ous reasons, mentioned above, was carefully noted for each experiment or 
treatment. This was done, because an increase of the number of excluded 
animals might be an effect. In reality throughout all experiments in this the-
sis this happened only once (see Table 42). 
2.9 STATISTICAL PROCEDURES 
As final part of this chapter we will formulate and discuss the statistical con-
siderations which underlied the experiments described later on* . Three funda-
mental issues were considered: 
1. The duration of observation; 30 % of animals continued to have epilepsy 
for more than 2 hours after the injection We decided to stop all obser-
vations after 2 hours, because they required a high level of concentra-
tion from the side of the observer. The number of jerks after that 
period generally was small (see section 3 2.3). This gave rise to so 
called censored observations (see TERMINOLOGY). 
2. The population distr ibution of the variables. 
3. The number of animals, required for the purposes, mentioned further m 
this thesis Efforts were made m order to be able to limit the number 
of animals, where possible. 
The resulting procedures will be discussed in the following sections: 
1. The required number of animals. 
2. A group sequential design. 
3. Statistical tests. 
4. Estimation of mean and sd. 
5. Tests for normality. 
2 9.1 THE REQUIRED NUMBER OF ANIMALS 
The following results are based on comparisons between samples on the basis 
of pilot studies by means of a t - test , assuming a lognormal distr ibut ion. The 
resulting calculations are therefore dependent on this assumption. As we will 
show later (in section 2.9.5), this assumption was not val id. Nevertheless 
these calculations formed the basis, on which the design of testing of anticon-
vulsant drugs was founded, together with the design for sequential analysis, 
that is described in the next section. Therefore they are mentioned here 
Assuming a lognormal distribution for the variables duration of epilepsy 
and number of jerks, we define a reductionfactor (R) and a second variable 
RS (d is the standard deviation of the ln-values of the variable under study 
All statistical problems were analyzed by W. Doesburg and Th . de Boo from 
the Department of Statistical Consultation of this University (head: P. van 
Eiteren). 
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and m the estimated mean): 
R = m(c)/m(d) с - control animals d = drug animals 
RS = ln(R)/d 
For known values of RS we can d e r i v e t h e n u m b e r of animals r e q u i r e d f o r a 
c e r t a i n power. T h e power (1 - β) of a t e s t is t h e p r o b a b i l i t y of o b t a i n i n g a 
s i g n i f i c a n t test r e s u l t , when a real d i f f e r e n c e is p r e s e n t . T h e relat ion 
between RS and t h e r e q u i r e d number of animals at d i f f e r e n t power levels of 
the test is g i v e n in Table 15. 
Table 15: Number of animals, 
The power is t h e p r o b a b i l 
real d i f f e r e n c e is p r e s e n t . 
values of RS and p o w e r , 
t v of с 
r e q u i r e d to o b t a i n a g i v e n power. 
bt 
T h e nun-
u s i n g 0. 
a i n m g a s i g n i f i c a n t r e s u l t , when a 
b e r of animals is shown f o r g i v e n 
0b as level of s i g n i f i c a n c e . T h e 
r e s u l t s are based on t w o - s i d e d t e s t i n g . For one s ided t e s t i n g t h e n u m ­
b e r of animals r e q u i r e d should be 
RS 
0.50 
0.75 
1.00 
1.25 
1.50 
0.50 
32 
16 
10 
7 
6 
mu I t i p h e d w i t h 0 . 7 5 . 
POWER OP TEST 
0.80 0.90 
70 90 
31 40 
18 23 
12 15 
9 11 
Suppose, we are i n t e r e s t e d m t h e number of animals r e q u i r e d m o r d e r 
to compare the f o r e - and h i n d l i m b g r o u p m section 2 . 5 . We wi l l assume t h a t 
the r e d u c t i o n f a c t o r f o r t h e number of j e r k s is equal t o 2.53, as was f o u n d in 
section 2.5. T h e r e s u l t i n g RS = 1.48 ( sd = 0 . 8 6 ) . In Table 16 t h e power of 
such an exper iment can be f o u n d . For η = 10 and RS - 1.50 the power is 
0 . 8 5 . 
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Ta 
T h e power of a 
u s i n g 0.05 as 
assumed. 
RS 
0.50 
0.75 
1.00 
1.25 
1.50 
эіе 16: T h e power of a t e s t f o r η and RS. 
t e s t f o r some values of η ( n u m b e r of animals) and RS, 
level of s i g n i f i c a n c e . A lognormal d i s t r i b u t i o n is 
η = 5 
< 0.50 
< 0.50 
< 0.50 
< 0.50 
< 0.50 
D = 10 η = 15 η 
< 0.50 -=0.50 
< 0.50 0.50 
0.50 0.70 
0.75 0.90 
0.85 0.96 
- 20 
0.50 
0.60 
0.85 
0.96 
0.995 
2 . 9 . 2 A GROUP SEQUENTIAL DESIGN 
In o r d e r to reduce t h e number of animals r e q u i r e d f o r a c e r t a i n t e s t , a 
sequent ia l des ign may be u s e d . One p a r t i c u l a r d e s i g n , a t h r e e stage g r o u p 
sequential t e s t , was i n v e s t i g a t e d . In t h e f i r s t s t a g e , six animals are t a k e n 
f r o m each g r o u p ( c o n t r o l s and t r e a t e d ) . If t h e t e s t resul t f o r these two sam­
ples is not s i g n i f i c a n t , t h e n six addi t ional animals are taken f r o m both 
g r o u p s . If t h e t e s t r e s u l t f o r both samples (of 12 animals) is st i l l not s i g n i f i ­
c a n t , then the t h i r d stage is reached, w h i c h consists of t a k i n g t h r e e a d d i ­
t ional animals. 
Using computer s i m u l a t i o n , c r i t i c a l t e s t values f o r each stage were e s t i ­
mated to reach an overa l l level of s ign i f icance of 5 %. The r e s u l t i n g est imated 
power and mean expected tota l number of animals ( p e r sample) f o r d i f f e r e n t 
values of t h e r e d u c t i o n f a c t o r R are g iven in Table 17. 
Th is t h r e e stage t e s t should be compared w i t h a simple t e s t , us ing f i f ­
teen animals m each sample. It can be seen, t h a t a ( l a r g e ) r e d u c t i o n m t h e 
tota l number of animals r e q u i r e d can be r e a c h e d , d e p e n d i n g on the magni tude 
of t h e r e d u c t i o n f a c t o r R. 
A t t h i s stage of o u r i n v e s t i g a t i o n , o n l y r e d u c t i o n f a c t o r s in t h e o r d e r of 
2.5 were o b s e r v e d . In t h i s case only a modest sav ing m animals can be 
e x p e c t e d . For t h i s reason and f o r s i m p l i c i t y of t h e d e s i g n , th is sequential 
t e s t was not u s e d . 
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Table 17: Estimated power of a three stage group sequential design. 
The procedure is described m the text. The estimated average sample 
number (= mean number of animals per sample, required m this design) 
is given for certain magnitudes of the reductionfactor R. 
Reductionfactor (R) 
1.5 2.0 2.5 3.0 4.0 5.0 
POWER 0 . 1 4 0 . 3 2 0 . 5 2 0 . 6 6 0 . 8 5 0 . 9 2 
AVERAGE 
SAMPLE 
NUMBER 14.5 13.8 13.0 12.1 11.0 10.1 
2.9.3 STATISTICAL TESTS 
For statistical testing of differences between populations tests were used, that 
do not require an assumption of the distr ibution of the underlying population. 
All tests were two sided. For the duration of epilepsy and the number of 
jerks/spikes (total, long-,medium- and short-interval) the Gehan-test was 
chosen, which compares ranks and takes into account, whether an observation 
is censored or not. 
In the case of spread and intensity of jerks we decided to use from now 
on the maximal observed values obtained for each animal. These maximal val­
ues always occurred m the periods from 40-100 mm. after injection. So for 
these variables it will not matter, whether an observation is censored or not. 
The same holds true for the fact, whether or not seizures have been present, 
because they never appeared for the f i r s t time after 100 mm of observation. 
Spread, intensity and the occurrence of seizures were tested by means of the 
χ -test. An expected value of at least 1 m each cell was taken as a necessary 
condition to use the test. 
One drawback, also due to the use of censored observations, was the 
fact, that no overall analysis could be made of the effect of one treatment 
over different groups (for example a drug effect). To this end each group 
was compared to the control-group and the results were combined to form an 
opinion about the overall effect of the treatment. The duration of these 
observations would have to be doubled (from 2 until 4 hours) to get r id of 
these censored values, which was not feasible, both from the view of efficient 
use of time, as well as regarding imminent fatigue and loss of quality of 
observation. We recall, that this limitation only holds for the duration of epi­
lepsy and number of jerks. 
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2.9.4 ESTIMATION OF MEAN AND SD 
Due to the presence of censored observations in about 30 % of the animals , 
because of the limited observation period of 2 hours, we could not use the 
classical statistical estimators for the mean and the standard deviation of the 
two mam variables, the number of jerks/spikes (total and long-, medium- and 
short- interval) and the duration of epilepsy. Due to the fact, that the val-
ues for the number of jerks could not be ordered to their magnitude (values 
obtained could be for example 144, 498, 399, 591, >47, >495), one was forced 
to assume, that the distr ibution of this variable belongs to some parametric 
family of distr ibutions. In preliminary studies it was found, that the number 
of jerks after 30 mm. as well as the delay time between injection and f i rs t 
epileptic spike in the ECoG very well f i t ted to a lognormal distr ibution. This 
was tested for various groups, ranging from 10 to 22 animals, by the 
Shapiro-Wilk test for normality. 
Instead of the classical estimation, maximum likelihood (ML) estimation, 
which can take censored observations into account, was used to obtain estima-
tors for the mean and sd, called m and d (Wolynetz 1979). 
The distribution of the variables was initially assumed to be lognormal. 
2.9.5 TESTS FOR NORMALITY 
As was mentioned before, the assumption of a lognormal distribution could not 
be held, but normality tests on known, uncensored, test results for number 
of jerks and delay-time for f i rs t spike suggested this in the beginning. No 
tests for normality in the case of censored observations were available at that 
time. In order to obtain more information about the distr ibution of the var i -
ables, we decided at a later stage of the experiments to observe one group 
dur ing 4 hours. An additional need for this was the f inding, that initially m 
the valproate experiments (chapter 6) a large discrepancy was found between 
the actual observed number of jerks and the estimated number. This was due 
to the fact that some animals continued to have very low frequent epilepsy, 
thus contributing significantly to the estimated number. Therefore the thresh-
old value for a censored observation at f i rst defined as more than 4 jerks 
seen m the last period was changed into a value of more than 10. This new 
definition was applied for the f i rs t time to a group, observed for 4 hours, 
which consisted of 21 animals, injected with penicillin (see chapter 3 ) . Results 
of the normality tests for the definit ive values after 4 hours are summarized 
in Table 18. 
The assumption of a normal distribution was therefore adopted through-
out the experiments fur ther m this doctoral thesis. Consequently from this 
moment the number of jerks was shown m a not transformed way. All former 
results (partially published m Arends et al 1981) were recalculated, according 
to the new definition for censored values and with the omission of the loga-
rithmic transformation. 
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T a b l e 18: Results of normal 
P-values of n o r m a l i t y tests 
h o u r s . W = Shapiro-Wi lk test 
s i d e d , N.S. = not s i g n i f i c a n t . 
VARIABLE X TEST 
durat ion of 
epilepsy 
W 
D 
t o t a l number 
of j e r k s 
W 
D 
i t y t e s t s . 
p e r f o r m e d on measurements a f t e r f o u r 
D = D ' A g o s t h m o t e s t , Ρ = P-value two 
Ρ FOR X 
0.636 
0.354 
0.354 
N.S. 
Ρ FOR LOG X 
0.025 
0.011 
0.235 
U.S. 
1 
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Chapter 3 
REFERENCE VALUES 
In order to be able to assess the value of antiepileptic drug treatment, or 
other measures, we composed a group of animals, from which reference values 
could be obtained for folate and penicillin induced epilepsy*. These animals 
served as controls for other experiments, which will be described in chapter 
6. The lesions were made according to the standard procedure, described in 
chapter 2 (section 2.2 and 2.5.6). The way the original observed values were 
worked up m order to obtain a profile of epilepsy, will be described in more 
detail in section 3.1 (method); the list of definitions of the variables can be 
found m chapter TERMINOLOGY. The results of the procedure are listed m 
sections 3.2, 3.3 and 3.4. In section 3.4 we will emphasize the role of 
rhythmic events in epilepsy. This chapter therefore is subdivided in the fol-
lowing sections: 
1. Method. 
2. Folic acid induced epilepsy. 
3. Penicillin induced epilepsy. 
4. Relation between jerk interval and some other variables. 
3 1 METHOD 
The description of the method is divided in four subsections: 
1. Preparation of the animals. 
2. Counting jerks and their intervals. 
3. Evaluation of the other variables. 
4. From individual to group values. 
3.1.1 PREPARATION OF THE ANIMALS 
Male albino Wistar rats (240-260 g) received a 'standard' heat lesion (probe 
diameter 2.38 mm at hindlimb area). The heating apparatus consisted of the 
original Antex TCSU1 ® set instead of the DELTA® power supply, used m 
chapter 2. A thermocouple was inserted near the t ip of this probe and to 
induce an elevation of 20 "C (like the standard lesion from chapter 2) a probe 
* All experiments were performed by a team consisting of M.L.F. Schoofs, 
Th . van der Velden and the author. 
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temperature of 130 "С was required (ice-water as a reference). For the 
copper-constantane thermocouple this was equivalent to a voltage of 5.7 mV. 
After a recovery of 24 hours folic acid (0.20 mmol./kg) or penicillin (0.76 
mmol./kg) were injected iv. Solutions were freshly made every week and 
stored at 0 "C. The composition of these solutions is described m sections 2.2 
and 2.5.5. Two observers from the team each registrated three animals dur­
ing one session. Each animal was observed during 2 hours following the iv. 
injection, in six periods of 5 mm. with intervals of 15 mm. The observation 
included the counting of the jerks (see below, section 3.1.2) and the assess­
ment of seizures, their classification and the scoring of spread and intensity 
for each period (see below, section 3.1.3). 
3.1.2 COUNTING JERKS AND THEIR INTERVALS 
When a jerk was seen, the observer pressed a button, that gave a signal, 
which was recorded on paper and magnetic tape . The time sequence of the 
jerks was followed by the observer as closely as possible. After the observa­
tions the results were analyzed off line by the impuls recognition program (see Appendix). This counted the signals and calculated the interval to the 
foregoing one (the 'jerk interval ') . According to the limits (0.33 and 0.80 
s e c ) , described m Table 13 (section 2.7), all jerks were classified according 
to their intervals into: 
• long interval jerks, called 'LOI-jerks' 
• medium interval jerks, called 'MEI-jerks' 
• short interval jerks, called 'SHI-jerks' 
Each jerk was numbered from 1 to η and each jerk interval represented 
graphically by plotting it against this number (Figure 11). This was done to 
recognize the global pattern of epilepsy. 
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Figure 11: Graphic representation of jerk intervals. In this graph each jerk 
interval Τ (y-axis) is plotted against its number N (x-axis). 
The left part (A) contains all jerk intervals less than 0 8 sec. (SHI and MEI j e r k s ) ; in the right part (B) all other intervals are 
shown (LOI jerks) . This is a characteristic result of one animal. 
Three patterns of epilepsy can be seen, designated as type 2, 3 
and A (see section 2.4). This animal was a folic acid control. 
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F u r t h e r m o r e the j e r k i n t e r v a l s were d i v i d e d m classes, r a n g i n g f r o m 0.1 
t o 100 sec. For t h i s c lass i f icat ion a logar i thmic scale was u s e d , which gave a 
c l e a r l y recognizable v isual p a t t e r n fsee F i g u r e 1 2 ) . In i n t e r p r e t i n g t h e 
r e s u l t i n g f r e q u e n c y h istograms one should bear in m i n d t h e r e f o r e , t h a t t h e 
logar i thms of t h e class w i d t h s are e q u a l . In F i g u r e 12 an example of such a 
j e r k i n t e r v a l h i s t o g r a m f o r t h e same r a t as in F i g u r e 11 is s h o w n ; the loga­
r i t h m of t h e class w i d t h is 0 . 2 . When the j e r k i n t e r v a l is 1 s e c o n d , t h e log 
i n t e r v a l is 0; 0.1 sec. becomes - 1 ; 10 and 100 sec. are t r a n s f o r m e d t o v a l ­
ues of 1 and 2. A d d i t i o n a l l y , t h e time course of t h e j e r k s was p u t m a c u m u ­
lat ive c u r v e (see F i g u r e 1 2 ) . 
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N 
зйъ 
- 1 
F i g u r e 12: 
10 LOG(SEC) 
Τ +2.6 
1250 
Τ 7200 S 
The h istogram Histogram and cumulat ive c u r v e of j e r k m t e r v a l s 
of j e r k i n t e r v a l s and cumulat ive c u r v e of t h e rat f rom F i g u r e 11 
are s h o w n . In t h e left p a r t CA) the h i s t o g r a m f o r t h e j e r k i n t e r ­
vals is shown f o r t h e rat f rom F i g u r e 1 1 . Two predominant class­
es are p r e s e n t : - 0 . 7 ( 0.2 s e c . ) and 0.1 ( 1.3 s e c ) . In t h e 
r i g h t p a r t ( B ) t h e cumulat ive c u r v e is s h o w n ; t h e per iods w i t h o u t 
o b s e r v a t i o n s o r w i t h o u t epi lepsy are v i s i b l e as hor izonta l p a r t s of 
t h e c u r v e . 
From F i g u r e 12A t h e predominant classes ( d e s i g n a t e d as ' j e r k i n t e r v a l 
modes' o r 'J l-modes') w e r e used to character ize t h e animal's r h y t h m of e p i l e p ­
s y . T h e p r e c i s e d e f i n i t i o n of J l-mode can be f o u n d in the c h a p t e r 
TERMINOLOGY To o b t a i n t h e tota l number of j e r k s and t h e number of L O I , 
MEI and SHI j e r k s , t h e o u t p u t , shown m Table 19, was u s e d . 
For t h e est imation of t h e mean and sd f o r t h e medium and s h o r t i n t e r v a l 
j e r k s t h e animals w i t h less t h a n 10 j e r k s in these two categor ies were d i s r e ­
g a r d e d . We decided t o do t h i s , because f a i l u r e o r delay m t h e observat ions 
m i g h t cause a number of false negat ive and p o s i t i v e j e r k s m both classes. In 
all tables t h e number of animals, inc luded f o r t h e MEI and SHI j e r k s , wi l l be 
ment ioned. T h i s p r o c e d u r e has the e f f e c t , t h a t a d d i t i o n of t h e mean number 
of s h o r t , medium and long i n t e r v a l j e r k s wi l l y i e l d a h i g h e r va lue than t h e 
estimated mean tota l n u m b e r of j e r k s . 
48 
Table 19: O u t p u t of t h e automatic j e r k c o u n t i n g p r o g r a m . 
For t h e same rat as shown in F i g u r e Π a n d F i g u r e 12 t h e o u t p u t of the 
impuls p r o g r a m is s h o w n . PERIOD is an epoch of 5 m i n u t e s . The 
r e s u l t i n g tota ls are t h e basis f o r t h e est imat ion of t h e g r o u p mean f o r 
the number of j e r k s . Because t h e animal had more t h a n 10 j e r k s in 
per iod 6 ( t h e last o b s e r v a t i o n p e r i o d ) all values are c o n s i d e r e d to be 
c e n s o r e d . T h u s f o r t h e est imation of mean and sd values of > 1250, > 
5 7 1 , > 172 and > 507 s e r v e as i n p u t . 
PERIOD 
1 
2 
3 
4 
5 
6 
TOTAL 
LOI-JERKS 
U 
62 
232 
108 
108 
57 
571 
MEI-JEHKS 
1 
52 
19 
64 
23 
13 
172 
SHI-JERKS TOTAL 
0 5 
1 115 
20 271 
216 388 
202 333 
68 138 
507 1250 
3 . 1 . 3 E V A L U A T I O N OF THE OTHER V A R I A B L E S 
T h e o t h e r v a r i a b l e s , w h i c h had to be eva luated d u r i n g t h e o b s e r v a t i o n s , 
w e r e : 
1. Spread of LOI jerks. 
2. Intensity of LOI jerks. 
3. Number and type of seizures. 
4. Unwanted side effects. 
The spread of the LOI jerks was scored for each of the six periods, accord­
ing to Table 6 (section 2.5.1). The maximum of all six values was regarded 
as representative. For the intensity the same procedure was followed (for 
classification see Table 7, section 2.5.1). The number of seizures was counted 
on a mechanical counter, apart for type 1 and type 2. The distinction 
between the two types and conditions, necessary m order to call a certain 
sequence of jerks a seizure (see section 2.7), are described in chapter 
TERMINOLOGY and Table 13 Whenever an unexpected phenomenon, such as 
a side effect, was observed this was also noted on the form. Each observer 
therefore noted the number of seizures (type 1 and 2 ) , the observed spread 
and intensity, and side effects after each period of observation. Furthermore, 
as described above, he counted the jerks, by pressing a button. This proce­
dure guaranteed a quiet course of the experiment, without loss of important 
data. 
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3.1.4 FROM INDIVIDUAL TO GROUP VALUES 
The data, obtained thus far for the individual animals, were collected and for 
each group worked out, according to a standard procedure. The resulting 
group characteristics for each variable are displayed in Table 20. 
Table 
In this table is 
summarized, in о 
VARIABLE 
duration of ep i lepsy 
t o t a l number of jerks 
number of LOI jerks 
number of MEI jerks 
number of SHI jerks 
s e i z u r e s type 1 
•eiEures type 2 
spread of jerks 
i n t e n s i t y of jerks 
jerk interva l mode 
20: Group character i s t ics of t h e var iables . 
shown, how t h e character i s t ic epileptic events were 
r d e r to be able to compare g r o u p s . 
GHOUP-CHAHACTERISTIC 
estimated mean and s e for a l l animals with 4 or more jerks. See a l s o 
TERMINOLOGY 
estimated 
est imated 
estimated 
estimated 
number of 
number of 
number of 
number of 
number of 
number of 
number of 
number of 
mean and se for a l l animals with 4 or more jerks 
mean and s e for a l l animals with 4 or more jerks 
mean and s e for a l l animals with 10 or more jerks 
mean and s e for a l l animals with 10 or more jerks 
animals with one or more s e i z u r e s type 1 
animals with one or more s e i z u r e s type 2 
animals with spread to face 
animals with ажіаі turning 
animals with one or two Jl-modes; 
animals with a Jl-mode above .8 s e c ; 
animals with a Jl-mode of 1.3 s e c ; 
animals with a Jl-mode below .8 s e c . 
3.2 FOLIC ACID INDUCED EPILEPSY 
Five groups of animals (n=77) were given folic acid without special treatment. 
Each group received an additional subcutaneous injection with physiological 
saline (1 m l . ) , because they also served as controls for the drug experi­
ments, described in chapter 6. The results are presented in the following 
sections: 
1. Duration of epilepsy and number of jerks. 
2. Seizures, spread and intensity. 
3. Jerk intervals. 
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3.2.1 DURATION OF EPILEPSY AND NUMBER OF JERKS 
In Table 21 the results for duration of epilepsy and number of jerks are giv­
en for each group. 
Table 21: Reference values of folic acid epilepsy (duration and num­
ber) 
Review of results of folic acid induced epilepsy m 77 reference animals, 
concerning duration of epilepsy and number of jerks. N = number of 
animals included; between ( ) the number of animals excluded is men­
tioned. Nm is the number of animals with 10 or more medium interval 
jerks. Ns is the number of animals with 10 or more short interval jerks. 
MEAN and SD are estimated according to the maximum likelihood proce­
dure (see section 2.9.1); mean is the calculated mean without taking 
into account the number of censored animals; 26 animals had censored 
values (34 %). DURATION (χ 100) is duration of epilepsy. TOTAL 
NUMBER is total number of jerks. LONG INTERVAL is the number of 
long interval jerks. MEDIUM INTERVAL is the number of medium inter­
val jerks. SHORT INTERVAL is the number of short interval jerks. 
AVERAGE is the average MEAN and mean. AVERAGE mean/AVERAGE 
MEAN is a quotient, that represents the ratio of the calculated and the 
estimated mean. * = the injected physiological saline contained NaOH (pH=11); this group served as controls for the experiments with Pheny­
toin. 
NO N 
I 15(3) 
2 15(A) 
3 17(1)* 
4 15(1) 
5 15(2) 
AVERAGE 
AVERAGE me 
DATE 
nov.79 
dec.79 
feb 80 
apr 80 
aug.80 
DURATION 
HEAD 
62 
61 
63 
64 
65 
63 
an/AVERACE MEAD 
SE шеап 
59 
58 
60 
60 
61 
60 
0.95 
TOTAL 
МЕЛИ 
737 
773 
771 
751 
1013 
809 
NIMBER 
SE mean 
127 597 
169 646 
175 536 
159 585 
201 790 
631 
0.78 
LONG 
MEAN 
383 
375 
372 
382 
486 
400 
INTERVAL 
SE mean 
61 312 
61 325 
79 2ββ 
60 319 
106 374 
324 
0 81 
MEDIUM INTERVAL 
MEAN 
150 
135 
129 
151 
197 
152 
SE wan MB 
28 123 15 
33 111 15 
29 SB 15 
46 101 15 
35 148 13 
113 
0.74 
SHORT 
MEAN 
253 
367 
484 
262 
528 
379 
INTERVAL 
SE mean Ne 
54 203 12 
121 288 11 
160 319 9 
84 189 13 
91 358 12 
267 
0.70 
From Table 21 we can see, that, although no major differences between 
the five groups were present, the standard error was rather great. A com­
parison with the hmdhmb group from chapter 2 (section 2.5.1), where a log-
normal instead of a normal distribution was supposed for the estimation of the 
mean, showed, that the retransformed mean for that group had a value of 
1560 estimated jerks, while the retransformed standard deviation amounted 
1829 jerks (variation coefficient of 117 %), so the difference with the proce­
dure followed now was small (variation coefficient in this experiment: 81 %), 
and the standard deviation resulting from these experiments was not greater 
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than the one mentioned in chapter 2. Furthermore one can see, that duration 
of epilepsy was constant, while the number of SHI jerks showed the greatest 
variabi l i ty. For the SHI jerks the greatest difference between the calculated 
mean, which does not take into account the fact, that 34 % of the values is 
censored, and the estimated mean,was found The MEI jerks have an interme­
diate position, as they form part of the type 1 seizures, occurring in the 
beginning of the epilepsy, and of the type 2 seizures, which consist predomi­
nantly of SHI jerks (see also section 2.4 for a ECoG description of these phe­
nomena). From these values, and also from the calculations of power, 
described in sections 2.9Л and 2.9 2 it will be clear that in isolated groups 
with limited size (n = 15) a rather great reduction of number of jerks or 
duration of epilepsy must be present - generally at least threefold - in order 
to achieve a good result (a power of at least 0.80). 
3.2.2 SEIZURES, SPREAD AND INTENSITY 
In the groups with folic acid induced epilepsy, type 1 seizures and 2, spread 
and intensity were evaluated. The results are listed m Table 22. 
Table 22: Reference values of folic acid epilepsy (other variables) 
Results of folic acid induced epilepsy in 77 reference animals, concern­
ing seizures, spread and intensity Under TYPE 1 and 2 SEIZURES the 
number of animals with one or more seizures of that type is represented 
as well as the mean number of seizures For SPREAD and INTENSITY 
the number of animals showing spread to the face (class 4 or more) or 
axial turn ing (class 3 or more) is given and the median maximal spread 
and intensity. Some animals had intensity scores between 2 and 3, due 
to slight axial t u r n i n g . % = proportion of animals with seizures 1 or 2, 
spread to the face or axial turning 
TYPE 
H 
2 0 
1 4 
1 6 
2 0 
1.9 
9 
10 
8 
9 
11 
[ZDIES 
•eao M 
9 
11 
9 
β 
Π 
8PUAD 
•edian 
eye 
«Τ« 
ear 
ear 
eye 
Η 
И 
IKTEHSITY 
aedian 
ажіаі < 90 
ax ia l < 90 
ажіаі < 90 
alighe акіаі 
ажіаі < 90 
These results show, that type 2 seizures formed the greater part of all 
seizures. It is remarkable, that the proportion of animals having type 2 sei­
zures, spread to face, or axial turning was almost equal. This raised the 
question, to what extent these phenomena were linked to each other (see 
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below, sect ion 3 . 4 ) . As f o r t he maximal obse rved spread of j e r k s , a bimodal 
d i s t r i b u t i o n was f ound (F igu re 13) . 
on FOLATE EPILEPSY 
N 
15. 
LIMBS EAR EYE VIBR 
Figure 13: Spread of fo la te ep i lepsy . In t h i s h is togram f o r 77 animals w i t h 
fo l ic acid induced epi lepsy t h e maximal observed spread of LOI 
j e r k s is r ep resen ted . Two peaks were seen, one f o r spread l imi t -
ed to both limbs and the o the r f o r spread to the v i b r i ssae . N = 
number of animals. 
From F igu re 13 we can see, tha t 62 % of t h e animals showed spread of 
j e r ks to the face . We assumed, tha t t h i s was the resu l t of so-cal led secondary 
ep i leptogenesis , t ha t ex tends beyond the p r i m a r i l y damaged area. In chap te r 
5 we wi l l p resen t anatomical da ta , tha t con f i rm th i s v iew. 
For i n tens i t y of j e r k s , wh ich was eva luated accord ing to the degree of 
associated axial t u r n i n g , no bimodal d i s t r i b u t i o n was f o u n d . Ax ia l t u r n i n g is 
not supposed to ar ise f rom one localized pro jec t ion area , b u t can be evoked 
f rom eve ry local izat ion w i t h i n the rat motor cor tex (Dawson & Holmes 1966). 
3 .2 .3 JERK INTERVALS 
For all the 77 animals the J l - h i s t o g r a m (see F igure 12A) was s tud ied and 
none, one o r two J l -modes were seen in each ra t accord ing to the de f in i t i on 
in chapter TERMINOLOGY. The resu l ts are d isp layed in Table 23. 
From the resu l ts ment ioned in Tab le 23 we can conc lude , t ha t the fo la te 
induced ep i lepsy is h i g h l y o rgan i zed , and tha t two v e r y constant rhy thms 
predominate, i . e . 0.77 Hz. and 5 Hz. Th i s is m con t ras t w i t h the f i n d i n g s 
f o r the tota l number of j e r k s . Th is f ea tu re of fo late induced ep i lepsy is the 
most remarkab le , f ound t hus f a r , and we t h i n k it represents a cent ra l p r o -
cess m the epi leptogenesis m th is pa r t of the b r a i n , because o the r e x p e r i -
mental animal epi lepsies m sensor imotor cor tex and human epi lepsia par t ia l i s 
cont inua fo l low the same pa t te rn (see chap te r 7 f o r d i scuss ion ) . A d d i t i o n a l l y , 
in F igure 14 t h e d i s t r i b u t i o n of J l -modes above 0.33 sec. f o r all fo late t rea ted 
animals is g i v e n . 
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Table 23: Reference values of folic acid epilepsy (Jl-modes). 
Review of the results regarding the modes of the jerk intervals 
("Jl-modes") of 77 animals with folic acid induced epilepsy. Under the 
heading JI-MODE 4 items are included: the number of animals with a 
(long interval) mode of 0.8 sec or more with their median value, the 
number of animals with a Jl mode of 1.3 s e c , the number of animals 
with a (medium or short interval) mode of less than 0.8 sec. with their 
median value and the number of animals without any Jl-mode. N is the 
number of animals and the median for all animals. Τ = total number of 
animals or the median. Note the very constant rhytms of 1/1.3 = 0.77 
Hz. and 1:0.20 = 5 Hz. This latter f igure is distorted due to the limit­
ed speed of observation. 
1 
2 
3 
A 
5 
>. 0.8 Bedian 
JI-HODE (»ec ) 
1.3 < 0 8 aedian 
14 
IS 
13 
15 
12 
69 
10 
9 
9 
β 
10 
46 
12 
6 
10 
10 
10 
0.20 
0.20 
0 20 
0.20 
0.20 
0.20 
SO 
N 
FOLATE EPILEPSY 
0 8 12 
J I mode (log sec) 
Figure 14: Jl-modes of folate epilepsy. Distribution of Jl modes longer than 
0.33 sec. m 73 rats with folate induced epilepsy. In four rats no 
mode could be distinguished. The additional area m class - 0.3 (0.40 - 0.63 sec.) is shown because 4 rats also had a secondary 
mode in this class, which represents part of the MEI-jerks, that 
occur during type 1 seizures and at the end of type 2 seizures. 
N = number of animals. 
In section 3.4 studies on the relation between the Jl-rhythms, spread 
and the other variables, especially type 2 seizures, is described. 
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3.3 P E N I C I L L I N INDUCED EPILEPSY 
Two g r o u p s of animals (n=39) w e r e g i v e n p e n i c i l l i n w i t h o u t special t r e a t m e n t , 
except a subcutaneous in ject ion of 1 m l . p h y s . sa l . T h e r e s u l t s are p r e s e n t e d 
in t h e f o l l o w i n g s e c t i o n s : 
1. D u r a t i o n of ep i lepsy and number of j e r k s . 
2. S e i z u r e s , s p r e a d and i n t e n s i t y . 
3 . J e r k i n t e r v a l s . 
3 . 3 . 1 D U R A T I O N OF EPILEPSY AND NUMBER OF JERKS 
In Table 24 t h e r e s u l t s f o r d u r a t i o n of ep i lepsy and n u m b e r of j e r k s are g i v ­
en f o r each p e n i c i l l i n g r o u p and f o r reasons of c o m p a r i s o n , f o r all fo la te a n i ­
mals t o g e t h e r . 
Table 24: 
Review of 
Refe 
t i o n ) 
rence values of penic i 
* 
r e s u l t s of p e n i c i l l i n mducec 
c o n c e r n i n g d u r a t i o n of epi lepsy and 
Table 2 1 . 
NO N 
1 2 1 ( 4 ) 
CI 2 1 ( * ) 
2 1 8 ( 0 ) 
С ) = 
DATE 
••r so 
mmy 60 
ηαν Θ0 
AVERAGE ( P E N I C I L L I N ) 
AV м а п / A« HE AN 
AVtfUCL ( f O L I C A C I D ) 
SIGNiriCANCC 
G r o u p 1, o b s e r v e d 
DURATION I0TAL NUMBER 
HCAN SE ввап MEAN SE штап 
6 i J 62 1 0 9 6 I M 9 8 0 
Ь 7> 1 3 0 1 0 6 0 
65 2 62 B93 1 ) 7 734 
6b 62 1002 8 6 6 
0 9 5 0 86 
6 ) 6 0 BD? 6 3 1 
0 0 7 6 0 0 0 6 
l lm ep i lepsy ( n u m b e r 
e p i l e p s y 
number 
d u r i n g 4 
LONb INTERVAL 
HCAN 
6 1 8 
6 0 9 
614 
4 0 0 
5E швшп 
81 ъъг 
90 62В 
96 3 0 9 
»32 
0 8 7 
324 
ü 002 
of 
in 39 
j e r k s 
h o u r s . 
HEDIUH INTERVAL 
MEAN SE - e e n N B 
2 В 162 2 1 
26 16» 21 
22 9 7 16 
134 
0 BV 
113 
0 0 9 4 
and d u r a -
r e f e r e n c e animals 
hor 
SHORT 
H l AN 
3>β 
3B5 
3 6 7 
3 79 
legend see 
INTERVAL 
SC •••η Na 
70 2 9 » 19 
»8 2 9 5 1 9 ) 
SA 2 4 9 10 
2 79 
0 76 
2 6 7 
0 l o o 
From Table 24 we can see, t h a t no major d i f f e r e n c e s between t h e two g r o u p s 
were f o u n d . T h e tota l and long i n t e r v a l number of j e r k s were a l i t t l e h i g h e r 
in t h e p e n i c i l l i n animals T h e s t a n d a r d e r r o r was of t h e same m a g n i t u d e as 
f o r t h e fo l ic acid t r e a t e d animals. Here too one can see, t h a t d u r a t i o n of 
epi lepsy has t h e most constant v a l u e s , w h i l e the number of SHI j e r k s shows 
the g r e a t e s t v a r i a b i l i t y . T h e f i r s t g r o u p of animals was o b s e r v e d also d u r i n g 
f o u r h o u r s ( r e s u l t s see Table 24 between b r a c k e t s ) . As can be seen, t h e 
number of SHI and MEI j e r k s d i d not o r o n l y s l i g h t l y increase a f t e r two 
h o u r s , due to t h e f a c t t h a t no more seizures were o b s e r v e d . However, c o n ­
clusions a b o u t t h e meanmgfu lness of t h e est imat ion p r o c e d u r e cannot be 
d r a w n f r o m t h i s g r o u p alone. T h e est imation of t h e mean g u a r a n t e e d t h e best 
c o r r e c t i o n f o r censored o b s e r v a t i o n s avai lable to us at t h i s moment. 
55 
3.3.2 SEIZURES, SPREAD AND INTENSITY 
In the two penicillin treated groups type 1 seizures and 2, spread and inten­
sity were evaluated. The results are shown in Table 25. 
Table 25: Reference values of penicillin epilepsy (other variables). 
Results of penicillin induced epilepsy in 39 animals concerning seizures, 
spread and intensity. Under TYPE 1 and 2 SEIZURES the number of 
animals with one or more seizures of that type is represented as well as 
the mean number of seizures. For SPREAD and INTENSITY the number 
of animals showing spread to the face (class 4 or more) or axial turning 
(class 3 or more) is given and the median maximal spread and intensity. 
Some animals had intensity scores between 2 and 3, due to slight axial 
t u r n i n g . % = proportion of animals with seizures 1 or 2, spread to the 
face or axial t u r n i n g . Ρ = penicil l in, F = folic acid. 
NO TYPE 1 SEIZURES TYPE 2 SEIZUIES SPREAD IRTENSITY 
M теши R шлжа Я aedian N Bedian 
1 12 2.1 IS 3 17 vibri·. 13 «жі«1 < 90 
2 9 2 0 6 4 IA vibri·. В ажиі < 90 
Ζ Ρ 54 54 79 54 
Ζ F 40 61 62 58 
The proportion and number of both types of seizures were the same for 
folate and penicillin induced epilepsy. As for the maximal observed spread of 
jerks, here too a bimodal distribution was found (Figure 15), which for peni­
cill in induced epilepsy was different from the folate induced one. 
Remarkably, no intermediate steps between localized spread to the limbs 
and spread to the face were seen in penicillin epilepsy. Due to the limitations 
of our experimental procedure we were not able to look for spread extending 
to areas beyond the face. Axial turning was present in penicillin treated ani­
mals to the same degree as m folate induced epilepsy. 
In the group animals, observed for 4 hours, no changes m number of 
seizures, and maximal spread and intensity were seen, confirming our view 
expressed in section 2.9.3, that for these variables the fact of limited time of 
observation was having no influence on their evaluation. 
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3 5 , PENICILLIN EPILEPSY 
Ν 
Figure 15: Spread of penicillin epilepsy. In this histogram the maximal 
observed spread of LOI jerks is represented for 39 animals with 
penicillin induced epilepsy. N = number of animals. There are 
two peaks. It is remarkable, that in the case of penicillin no 
intermediate stages of spread to ear or eye are present, but that 
always the spread extends to the vibrissae as soon as the area of 
the face is reached. This difference is significant ( ρ < 0.005, 
two sided, x 2 - t e s t ) . 
3.3.3 JERK INTERVALS 
For all the 39 penicillin animals the Jl-histogram (see Figure 12A) was studied 
and none, one or two Jl-modes were seen, according to the definition in 
chapter TERMINOLOGY. The results are displayed in Table 26. 
From the results mentioned m Table 26 we can conclude, that the peni­
cillin induced epilepsy is characterized by the same dominant rhythms as the 
folate induced form. 
Additionally in Figure 16 the distr ibution of Jl-modes above 0.33 sec. for 
all penicillin treated animals is given. 
A remarkably similar distribution of Jl-modes was found for both types 
of epilepsy. Contrary to spread, which seems a more dynamic phenomenon, 
dependent both on the type of epilepsy inducing drug and lesion size (see 
also section 2.5), the jerk interval distr ibution does not seem to be dependent 
on the type of epilepsy inducing d r u g . The rhythm of epileptic events there­
fore seems primarily a property of the local neuronal circuit alone. The sta­
bil i ty of these rhythms may depend on the total activated pool of neurons and 
therefore different epilepsy inducing agents may influence this aspect of epi­
lepsy. In the case of penicillin we noted (section 3.1.1), that the number of 
LOI-jerks was higher, although the distr ibution of jerk intervals was not 
changed. Thiscould indicate a greater stability of the prevailing LOI-rhythm 
m penicillin induced epilepsy We will turn now to the relation between J l -
mode and seizures, spread and intensity in order to t r y to f ind the s ignif i­
cance of the LOI-rhythms for the other aspects of epilepsy. 
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Table 26: Reference values of penicillin epilepsy (Jl-modes). 
Review of the results regarding the modes of the jerk intervals 
("Jl-modes") of 39 animals with penicillin induced epilepsy. Under the 
heading MODE 4 items are included: the number of animals with a (long 
interval) mode of 0.8 sec. or more, with the median value, the number 
of animals with a Jl-mode of 1.3 s e c , the number of animals with a 
(medium or short interval) mode of less than 0.8 sec. with their median 
value and the number of animals without any Jl-mode. TP is total num­
ber and median for penicil l in, TF the same for folate. Note again the 
very constant rhytms of 1/1.3 = 0.77 Hz. and 1:0.20 = 5 Hz. This lat­
ter f igure is distorted due to the limited speed of observation. 
»Q θ ЯаОівп 
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0.20 
0.20 
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N 
- β I I 
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Figure 16: Jl-modes of penicillin epilepsy. Distribution of Jl-mode of 39 rats 
with penicillin induced epilepsy. N = number of animals. The 
additional area m class - 0.3 ( 0.40 - 0.63 sec.) is shown 
because 2 rats also had a secondary mode m this class, which 
represents the MEI-jerks;these are found during type 1 seizures 
and in the course of seizures type 2. No significant differences 
with the distribution of folate epilepsy is found ( 0.90 < ρ < 
0.95, two sided, x 2 -test, for the classes < 0 . 1 , 0.1 and ^0.1 or 
no mode). 
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3.4 RELATION BETWEEN JERK INTERVAL AND SOME OTHER VARIABLES 
Of course relationships must exist between several aspects of the epileptic 
process, which are described here. In order to analyze the mutual relations, 
we could not apply methods based upon multivariate analysis, because a great 
part of our data was obtained at a nominal level of measurement. 
We therefore analyzed chronologically the development of epilepsy. The 
relation between type 1 seizures, which occur as earliest important event, and 
the resulting Jl-mode will be presented f i r s t The relations between Jl-mode 
and the probability of seizures and spread to the face, and the connection 
between spread and intensity of jerks will be reviewed afterwards. In advance 
we can state, that only the relation between Jl-mode and type 2 seizures and 
the connection of Jl-mode with spread seemed relevant A detailed account 
will follow now. 
The type 1 seizures already develop before LOI-rhythms are established, 
so the Jl-mode only could be considered as being dependent on the probabil i­
ty of occurrence of type 1 seizures. An account of their relationship for folic 
acid induced epilepsy is given m Table 27. 
Table 27: Relation of type 
TYPE 1 SEIZURES 
FOLIC ACID 
NUMBER OF ANIMALS 
+ 
PROPORTION ( X ) 
+ 
1 seizures and 
modes. 
< 1 . 3 
2 
9 
6 
1J 
ДІ-MODE ( 
1.3 
20 
26 
Í 5 
57 
developm 
s e c . ) 
> 1 . 3 
6 
6 
19 
13 
ent of LOI J l -
NONE 
3 
5 
10 
11 
A clear difference between animals with and without type 1 seizures was 
not seen. 
Then we looked for the relation between dominant jerk interval (= J l -
mode) as an independent variable and the probability of occurrence of type 2 
seizures and spread of jerks to the face as dependent variables. This was 
done, because in earlier findings the Jl-mode proved to be a most prominent 
and stable feature of the heat lesion focus. Furthermore generally the domi-
nant LOI-rhythm appeared before type 2 seizures emerged. This type of sei-
zures, comparable to the so-called afterdischarges, becomes visible in the 
ECoG during the wave of long interval spikes (see Figure 9C1, section 2 4) . 
The importance of the long interval spike rhythm for the occurrence of sei-
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zures was a l ready shown b y o t h e r s ( f o r example S h e r w i n 1978, see also 
c h a p t e r 4) and c o n f i r m e d t h e importance of s t u d y i n g t h i s r e l a t i o n . T h e 
r e s u l t s of t h i s approach f o r o u r reference g r o u p s are g i v e n in F igure 17 and 
F i g u r e 18. 
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I i g u r e 17: J l-modes and the o c c u r r e n c e of t y p e 2 s e i z u r e s . The re lat ion 
between J l-mode and p r o b a b i l i t y of t y p e 2 seizures for folate and 
p e n i c i l l i n induced epi lepsy is s h o w n . T h e d i s t r i b u t i o n of J l -
modes is d e p i c t e d and t h e p r o b a b i l i t y of t y p e 2 seizures w i t h i n 
each class is d r a w n as t h e d o t t e d area T h e r a t i o of o c c u r r e n c e 
of t y p e 2 seizures f o r p e n i c i l l i n and fo late epi lepsy is not d i f f e r ­
ent (0 20 < ρ < 0.30 two s i d e d , x 2 - t e s t ) 
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g u r e 18: J1-mo des a i d s p r e a d 
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j e r k s . T h e d i s t r i b u t i o n of the J l-modes 
f o r both forms of epi lepsy is shown and t h e p r o b a b i l i t y of spread 
to the face w i t h i n each class is d e p i c t e d as t h e d o t t e d area T h e 
rat io of o c c u r r e n c e of spread to t h e face f o r p e n i c i l l i n and folate 
epi lepsy is d i f f e r e n t ( p < 0.001 t w o s i d e d , x 2 - t e s t ) o u t s i d e t h e 
J l - m o d e of 1.3 sec (0.1 log s e c ) . 
From F i g u r e 17 and F i g u r e 18 it is c l e a r , t h a t t h e p r o b a b i l i t y of o c c u r ­
rence of t y p e 2 seizures and spread t o t h e face is associated w i t h the location 
of t h e J l - m o d e . O u t s i d e t h e j e r k i n t e r v a l class of 1.3 sec. spread of j e r k s t o 
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the face is less closely associated with the J l - rhy thm in penicillin induced 
epilepsy, compared with the folate induced form. Drug induced changes in 
type 2 seizures or spread therefore only can be interpreted correctly by con-
sidering them m conjunction with their effects on the Jl-mode. Therefore we 
decided to calculate in future the expected number of animals presenting with 
type 2 seizures and spread to the face from the Jl-modes, according to the 
results displayed in Figure 17 and Figure 18. This allowed a more accurate 
evaluation of relative drug effects. In penicillin induced epilepsy no animals 
without a Jl-mode were found. For penicillin animals treated with antiepileptic 
drugs, without a distinct Jl-mode, the same probabil i ty for spread to face 
and type 2 seizures is assumed as for the animals showing a Jl-mode -> 1.3 
sec. 
The intensity of jerks generally depends on the number and localization 
of cortical pyramidal neurons f i r ing at the same time and therefore it is a 
function comparable to spread of jprks. On the other hand axial turning is a 
movement of muscle, that can be evoked from every site of the motor cortex 
(Dawson and Holmes, 1966), so due to this lack of somatotopic organization, 
evaluation of intensity might also partly serve as a marker of 'internal f i r ing 
power' as opposed to the external f i r ing power' represented by the secondary 
spread to the face. It was found (see Table 28), that a high degree of over-
lap existed between these two functions in control animals. 
Table 28: Relation between spread and intensity 
SPREAD INTENSITY 
FOLIC ACID NO AXIAL TURNING 
- FACE 26 
+ FACE 4 
SPREAD AND INTENSITY CONCORDANT ( ): 
SPREAD AND INTENSITY DISCORDANT: 
of LOI and MEI jerks 
AXIAL TURNING 
7 
40 
N % 
66 86 
11 14 
Because the intensity of the jerks also may depend on combined facilitat-
ing and inhibiting influences to the spinal cord, care must be taken during 
the interpretation of changes of this variable due to drug treatment. Spread 
of jerks on the other hand is observed as an all-or-none phenomenon and will 
be less dependent on changes m these circui ts. 
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3.5 DISCUSSION 
Reviewing the data from this chapter we will discuss, why we needed to 
include this number of variables in our test. 
First of all we tr ied to develop and validate a method. This necessitates 
including all possible variables in the beginning and selecting them continu-
ously throughout the experimental period. The variables, which we used until 
now, can be divided m two groups· those, who account for the whole epilep-
tic process (duration of epilepsy and number of jerks) and those, which 
describe some essential features not dependent on the total observation time 
(Jl-mode, type 1 seizures and 2, spread and intensi ty) . In most animal mod-
els for epilepsy (Purpura 1972), only the second type of variables is used. 
This is a convenient way of test ing, but one can wonder, to what extent the 
two types of variables represent different aspects of epilepsy. For instance m 
this chapter one has seen, that despite the great uniformity of Jl-modes, 
there was a considerable variation of the total number of jerks. These two 
sets of phenomena may have a different sensitivity to drugs or other meas-
ures. A drug supposed to modify the Jl-mode in a group of animals, would 
not necessarily have to induce a proportionate modification m number of 
jerks. On the other hand a drug limiting the number of jerks could do so 
without changing the Jl-mode. 
In the second place we observed, that several variables (number of 
jerks, jerk intervals and seizures) were composed from heterogeneous ele-
ments. For instance two types of seizures exist with different frequency 
characteristics. We assumed, that anticonvulsants would also antagonize these 
types of seizures di f ferent ly, since m other animal tests seizures with di f fer-
ent frequency characteristics of the discharges show quite a distinct sensitiv-
ity to drugs The reader is referred to Krall (1980) for a comparison of the 
maximal electroshock (high frequency) and the subcutaneous pentetrazol test (low frequency), Swmyard and Woodhead (1982) for additional data on bicu-
culline, Picrotoxin and strychnine. These authors compared electrically 
induced seizures with chemically induced ones. But also on maximal and mini-
mal electroshock seizures, both evoked by the same method, different drugs 
have a dissimilar influence (Woodbury 1972, p. 571). 
The th i rd reason was formed by the fact, that clinically and experimen-
tal ly, focal seizures are too often considered to be just a variant of their 
generalized counterparts, having a common sensitivity to drug therapy (Swm-
yard m Purpura 1972, p. 446). This may be a too much simplified view (Jas-
per 1972, p. 588). We for instance observed, as already mentioned above, m 
our model two different types of seizures and furthermore found indications 
that underlying low frequent rhythmic epileptic activity could be an important 
clue with regard to the probability of type 2 seizure generation. Looking for 
interactions between the different manifestations of partial motor epilepsy 
therefore seemed necessary. 
Finally, we studied in this chapter, to what extent folic acid and penicil-
lin induced epilepsy were different from each other. In addition to the f ind-
ings in chapter 2 (section 2.5.5) some distinct features were found. Most 
important, an increased tendency of spread to regions of the face was found 
again, which m penicillin epilepsy consists of a direct involvement of the 
vibrissae as soon as the facial motor area is reached, whereas after folate 
injection intermediate stages are present, without involvement of the v ibr is-
sae. The association between the Jl-mode and spread was less close in peni-
cil l in epilepsy, when the LOI Jl-mode fell outside the most common class of 
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1.3 sec. Furthermore the number of long interval jerks was slightly higher 
after penicillin induced epilepsy, whereas the Jl-mode itself and its relation to 
type 2 seizures remained unaltered. 
Before describing the results of the tests of the anticonvulsant drugs 
(chapter 6) we will present the electrocorticographic features of epilepsy in 
more detail (chapter 4) and give some anatomic, metabolic and blood flow data 
about the focus (chapter 5). These experiments were considered to be essen-
tial in order to assess the final value of the method, used for these investi-
gations. 
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Chapter 4 
ELECTROCORTICOGRAPHIC FEATURES 
No model concerning epilepsy is considered to be complete without ample anal­
ysis of the changes found in the electroencephalogram. We therefore decided 
to develop a method of analysis for the partial motor epilepsy observed by 
us, based on the electrocorticographic f indings. In order to eliminate the 
amount of data to be processed and to f ind objective measures of rhythms and 
wave forms, we conceived a method of automatic analysis, which could be 
usod m addition to, but not instead of, the visual inspection of the electro-
corticogram*. 
However, despite the fact that this approach yielded some very valuable 
and essential information, it was clear, that the kind of information, included 
in the EEG signals, differed from the data, obtained by merely observing the 
animals. Furthermore the amount of time, spent for these experiments, was 
great. Therefore this kind of analysis was restricted to problems, which could 
not be resolved otherwise. 
In this chapter the results of the electrocorticograms (ECoG's) of 8 rats 
are presented, according to the following issues. 
1. Design of the experiments. 
2. Automatic analysis. 
3. Pitfalls during spike recognition. 
4. Development of partial motor epilepsy. 
5. Intenctal-ictal transit ion. 
6. The spike and-wave complex. 
7. Spread of discharges. 
8. Observation versus ECoG. 
9. Conclusions. 
This method of automatic analysis was further developed and programmed by 
J . Moleman and J . I . Кар (under supervision of J.P.C, de Weerd) from the 
Dept. of Clinical Neurophysiology (head: S.L.H. Notermans). 
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4.1 DESIGN OF THE EXPERIMENTS 
Lesions were made at the sensorimotor cortex (hmdlimb area) of 10 male albi­
no Wistar rats (from Γ NO), weighing about 250 g . , according to the proce­
dure described m sections 2.2 and 3 . 1 . 1 . The additional electrode placement 
was done following the method in section 2.4. For these experiments the sil 
ver electrodes were chlorinated m order to be assured of recording an optimal 
signal (Cooper et al 1974). In Figure 19 the relation of the position of the 
electrodes to the focus is shown schematically. 
Figure 19. Standard position of the electrodes. Upper view of the skull of 
the rat with electrode position and projection of the mean diameter 
of the focus. 
All recordings were bipolar with both olfactory electrodes serving as a 
common reference for the amplifier (Siemens Elema®) All signals were record­
ed on magnetic tape (HP 3968A®) for the off line analysis. 
Because these implantations were time consuming, and the lesion could be 
activated for 48-72 hours, each animal received an injection of folic acid, pen­
icillin or a combination of both three times every 24 hours after recovery. In 
2 rats the ECoG signal was too noisy due to interposition of material (blood or 
acrylic cement) between one or more epidural electrodes and the brain All 
ECoG's were visually inspected. Furthermore in all animals each period of 2 
hours following iv. injection was analysed in one run by means of the pro­
grams mentioned in the appendix. In six rats the ECoG and observation 
impulses were additionally run during six consecutive epochs of 5 minutes 
with intervals of 15 m m . , in order to get insight in the development of epi­
lepsy. Furthermore the grapho-elements of the epileptic discharges at regular 
spike-intervals around 1.3 sec. were studied in this way as well as the rela­
tion between ECoG-spikes and the observed Jl-mode. 
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4.2 AUTOMATIC ANALYSIS 
From the available l iterature (Rémond 1977, MacGillivray 1977) and EEC's 
obtained during earlier experiments in our laboratory, we conceived a fair ly 
simple method of spike recognition, described in the appendix. We did not 
aim to design or use an elaborate method, which could serve to eliminate com-
pletely the need of visual pattern recognition, such as described by Lopes da 
Silva et al (1977). We supposed, that the spikes in the ECoG represented all 
epileptic events. As can be seen from Figure 9 and Figure 21 these discharg-
es were clearly recognizable from the background act iv i ty. Therefore we were 
able to consider a simple triangular form of the spike, with its maximal height 
amounting at least 3-4 times the standard deviation of the normal signal, as 
the representation of epileptic discharges (see Figure 44). Additionally, the 
minimal and maximal width of the spike, opposition of phase between the adja-
cent channels 1 and 2 and a maximal delay between the spikes m these chan-
nels served to separate epileptic ones from movement art i facts. 
Through a set of 11 parameters and several display programs the actual 
values of these variables could be fitted to the visually recognizable spikes. 
For fur ther details see the appendix. 
4.3 PITFALLS DURING SPIKE RECOGNITION 
Depending on the choice of the variables a number of false positive or neg-
ative findings was seen. Different detection thresholds from 2 until 6 times 
the standard deviation gave the following results (Figure 20) in one rat dur-
ing one epoch of 5 mm. 
10 log U«c ) Ρ--
Figure 20: Detection threshold and number of false peaks. In part A the 
spike histogram of one epoch of 5 mm. m one rat is shown, 
obtained with a detection threshold of 2 σ. In part В the same 
results are shown for 4 o. The dark area m A represents the 
number of spikes obtained with a threshold of 4 σ. The white 
area m A corresponds to the number of presumed false positive 
f indings. In В the dark area corresponds with the findings 
obtained with a threshold of 6 a, so the white area shows the 
number of false negative results. 
According to Zetterberg (1973) the critical threshold for spike recogni­
tion amounts 3-4 sigma, which is the same level as we found throughout the 
experiments. 
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Due to the fact, that the amplitude of the high frequent spikes ( > 3 
Hz.) was lower than in the less frequent ones, generally more false neg­
atives were seen in the left part of the histograms. 
The choice of the level of the peakbase and the upper/lower limits of the 
peakwidths turned out to be critical too. We will not give detailed examples, 
but suffice to say, that the results of each run were only considered to be 
val id, if they f i t ted the visually recognized events. For the spikes at inter­
vals of 0.33 sec. or more a 100 % recovery rate was possible. Sometimes the 
computerprogram even detected spikes, which until then were overlooked. 
4.4 DEVELOPMENT OF PARTIAL MOTOR EPILEPSY 
The development of partial motor epilepsy m one representative animal is 
shown m Figure 21. 
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Figure 21 : Spike interval histograms, i l lustrating the development of partial 
motor epilepsy. In part 1-6 the spike histogram for six periods 
of 5 minutes is shown (period intervals of 15 m m . ) . On the 
abscis the spike interval classes from -1 until 2 6 log sec. (0.1 -
300 sec.) are shown, on the ordinate the number of spikes. For 
further explanation see text. 
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From period 3 m this f igure two spike interval modes ("Sl-modes") 
become visible. In period 4 and 6 small shifts of the r ight Sl-mode towards 
its neighbouring class at the left side and back are seen. These small shifts 
of the modes between adjacent classes were present in half of the animals, 
greater displacements never occurred. In period A, the left Sl-mode (repre-
senting a seizure type 1) has disappeared. From this period on a long inter-
val spike rhythm remains present, accompanied by some 'epileptic noise' at 
both sides of the Sl-mode during subsequent periods. In this animal no high 
frequent epileptic activity belonging to type 2 seizures, was present. 
From this picture one can see, that it takes time for the rhythm (often 
called "pseudorhythm") of epileptic activity to become organized. After the 
organized low frequent activity has been present for some time, the epilepsy 
terminates abruptly without becoming dysrhythmic again. Subtle changes of 
this rhythm have been shown to precede seizures of the afterdischarge type 
(type 2 seizures), according to Sherwm (1978). The mtenctal-ictal transition 
will be described m the next section. 
4.5 INTERICTAL-ICTAL TRANSITION 
The moment epileptic discharges change from isolated events into a sequence 
of spikes, representing a well developed seizure, is a critical point m epilep-
togenesis. It has been however diff icult to give an appropriate prediction of 
this "point of no re turn" . As was mentioned m section 1.1 (neurophysiology 
of epilepsy), analysis of cellular events does not explain the increase m 
synchronous f i r ing ability of a whole population of neurons at such a moment. 
The analysis of local neuronal circuits and their internal interactions requires 
techniques, which are not well developed. 
Systematic observations of this transition have been published now and 
then. Walker (1950), uti l izing the penicillin focus, stressed the gradual 
increase in spike frequency preceding a seizure. This pattern also was seen 
by us and the seizures, which developed m this way, were called "type 1 
seizures". These mostly occurred m the beginning of the process of epilepto-
genesis and occasionally throughout less rhythmic parts. Petsche et al (1978) 
analyzed focal penicillin epilepsy in two different regions of the brain. A 
gradual increase of discharges, evolving into a seizure, was only seen by 
them m the frontal pregranular cortex, but not m the area striata of cats. 
It seems therefore, that this type of seizures is not common to all brain 
regions. In accordance with th is, Ralston (1958) stated, that a steadily 
progressing spike frequency was found only m a minority of the mtenctal-
ictal transit ions. He stressed the appearance of small rhythmical discharges 
superimposed on the slow component of the mtenctal spike-and-wave complex. 
This pattern of discharges was referred by him as "afterdischarge". We have 
called them type 2 seizures. 
Angelen et al (1972) found a th i rd type of mtenctal-ictal transit ion, 
during which an abrupt increase of spike-frequency appeared without preced-
ing spike-and-wave complex. This type of seizures was never seen m our 
material. 
Mares (1978) studied electrical afterdischarges m rat sensorimotor cortex 
and found several types of seizures 
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These observations did not reveal anything about the predictabil i ty of 
the time occurrence of seizures. Sherwm (1978) found, that the afterdisc-
harge type of seizures often was preceded by double or t r ip le spikes, but 
this phenomenon had no predictive value. By analyzing pairs of discharge 
intervals in cats with focal penicillin epilepsy, he was able to show, that com-
plex changes m the interval-pair relationship preceded the onset of this type 
of seizures by 5-10 minutes However no common features could be found, 
which would lead to a satisfactory prediction for all individuals, because 
marked differences between them were seen. The individual changes, preced-
ing ictal act iv i ty, remained constant. The dominant mtenctal f i r ing pattern 
was pseudorhythmic with a frequency of 0.3-1 Hz. 
A comparison of these findings from the l i terature with our own observa-
tions shows, that the distinction between the two types of seizures, that we 
have made, is a sensible one. Furthermore the prediction of type 2 seizures 
remains di f f icul t . The interaction between low and high frequent epileptic 
activity in our material seems satisfactorily described by relating the type 2 
seizure occurrence to the long interval Jl-mode (section 3.4) , a finding analo-
gous to the results of Sherwm (1978). 
4.G THE SPIKE-AND-WAVE COMPLEX 
The spike-and-wave complex is the most generally recorded epileptic event at 
the cortical surface. However it is a very incomplete descriptor of the epilep-
tic act iv i ty, found in the whole cerebral cortex (Petsche et al 1978). General-
ly the wave of the spike-and-wave complex is considered to be an inhibitory 
response following the excitation caused by the spike (Branch and Martin 
1959). In human petit mal epilepsy the wave has a similar role (Gloor 1979), 
leading to impaired cognitive functioning. In several animal species this type 
of epilepsy may be simulated by the synchronous f i r ing of multiple foci (Mar-
cus 1972), indicating that both petit mal "waves" and those during focal epi-
leptic discharges share some basic properties. In our hCoG material the 
spike-wave was an ubiquitous f inding, except when the frequency of the dis-
charges exceeded 3 Hz. Perhaps its disappearance above this frequency indi-
cates the breakdown of a particular inhibitory mechanism within the focus. 
In order to study the spike-wave complex more accurately, we included 
its recognition m the results of our automatic analysis. As the spike interval 
might influence the form and duration of this complex, we only included spike 
and waves m the interval class of 1.3 sec. The results are shown m Table 29 
and indicate, that the relative amplitude of the wave increases as time pro-
gresses during epileptogenesis. The limited number of f ive animals (in one 
animal no Jl-mode of 1.3 sec. became apparent), however, precludes a defin-
itive conclusion. 
This is in agreement with the description given by Petsche et al (1978), who 
found, that during epileptogenesis the wave becomes more apparent in the 
superficial layers of the cortex. It is not known, whether this finding impli-
cates a more efficient inhibition throughout the cortex cerebri. 
Because the spike waves only occur at frequencies below 3 Hz. in the 
rats seen by us, and considering the resemblance between multifocal spike-
waves and petit mal epilepsy, only the drugs able to bring about changes m 
the discharges below 3 Hz., are supposed to be the ones with potential anti-
petit-mal properties. Reversing this hypothesis, phenytom and carbamaze-
pme, both not effective in petit mal (see section 6.1) , should not be able to 
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Table 29: Ratio of the spike/wave amplitude dur ing epileptogenesis. 
For five rats the ratio for the f i rs t and last period dur ing the f i rs t 
activation is given. A minimal difference of 0.3 is considered as a real 
change (- = decrease, 0 = no change, + = increase). N^number of 
peaks. 
RAT FIRST PERIOD 
N 
18 
14 
34 
60 
29 
R 
2.4 
3.9 
2.3 
3.4 
3.3 
LAST 
Я 
β 
61 
23 
88 
157 
PERIOD 
R 
2.5 
2.1 
1.3 
1.7 
1.3 
CHANGE 
0 
-
-
-
~ 
change the long interval rhythm or type 1 seizures, which indeed proved to 
be the case m folic acid induced epilepsy. 
4.7 SPREAD OF DISCHARGES 
As shown in chapters 2 and 3, the spread of the jerks was easy to observe 
and classify. Determining spread of discharges in the ECoG is more d i f f icul t , 
but not impossible. First one has to f ind out, whether the peaks, visible at a 
distance from the focus, are conducted m a passive or active way. In our 
registrations we did not f ind any spike latency significantly longer than 0 
msec, (mean latency on channel 3: -8.6 ± 8.2 m s e c , on channel 4: -15.2 ± 
20.8 m s e c ) . Therefore passive conduction seems more l ikely. The expected 
relative amplitude of the peaks m the 4 derivations, used by us, can be rep­
resented schematically according to Figure 22. 
Because channel 3 will present the lowest spike amplitude, a proper 
choice of the detection threshold will yield a lower number of spikes recogniz­
ed on this channel than on the others. The ratio of recognized spikes on 
channel 1 and 3 will be a representation of the spread of the discharges pro­
vided, that the process of epileptogenesis remains constant over a certain 
time and limited to a relatively small area. Because the observed spread 
slowly extended beyond the primarily damaged tissue into the projection area 
of the face, this latter condition seems to be met. An example of an ECoG 
analysis of spread yielded results shown m Table 30. The detection threshold 
for channel 1 and 2 was 4 a, on channels 3 and 4 a value of 2 σ was chosen. 
R and О change in a corresponding fashion. R is a valuable parameter 
for future studies. 
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Figure 22: Relative amplitude of peaks on the four ECoG channels. The 
maximal amplitude arises at the centre of the focus. The geometri­
cal distances of the electrodes towards this centre are calculated 
according to Figure 19. The lowest amplitude will be present m 
channel 3. 
Table 30: Development of spread of ECoG-discharges m one rat. 
One activation is shown. The ratio of the detected spikes on channel 3 
and 1 (R) and the maximal observed spread (O) and intensity ( I ) , see 
also Table 6 and Table 7, are given for 6 consecutive periods (from 
10-110 mm. after injection of epileptogenic agent). In the f i rs t period 
the occurrence of a type 1 seizure, during which no observed spread is 
registrated, elevates the ECoG ratio. Since the spread during this sei­
zure is not taken into account dur ing the observation, this f igure is 
left out of consideration. 
PERIOD 
1 
2 
3 
4 
5 
6 
N 
54 
20 
29 
45 
65 
36 
R 
(0.33) 
0.15 
0.31 
0.36 
0.37 
0.53 
0 
2 
2 
3 
5 
5 
6 
I 
1 
2 
2 
3 
2 
1 
4 . 8 OBSERVATION VERSUS ECOG 
In section 2.4 we a l r e a d y s h o w e d , t h a t t h e o b s e r v e d j e r k s were rel iable e s t i ­
mates of t h e e p i l e p s y , when compared to t h e ECoG-spikes. In t h i s section we 
wi l l p r e s e n t samples of t h e ECoG spikes and o b s e r v e d j e r k s of one r e p r e s e n ­
t a t i v e rat ( F i g u r e 24) and a comparison of long i n t e r v a l Sl-modes w i t h t h e i r 
J I - c o u n t e r p a r t s , because t h e a c c u r a t e assessment of long i n t e r v a l r h y t h m was 
essential f o r o u r t e s t s . 
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23: Review of ECoG and observation results m one rat during one 
activation. In part I ECoG samples of the f i rs t four periods of 5 
mm. (from 10 - 70 mm. after injection of penicillin) are shown. 
The uppermost trace shows 1 sec. marks. The following traces 
2-5 represent the ECoG, trace 7 the observed jerk-impulses. The 
lower left f igures show the Sl-histogram, the lower right the cor­
responding Jl-histogram of the 5 mm. period. In their r ight 
upper corners the total number of spikes/jerks is given. I - 1 
mV. 
In part II the total result for the 2 hours period is shown, a) 
representing all spike-intervals, b) the histogram and cumulative 
curve and in c) the form of the spike-wave is made visible (mean, σ and N). For further explanation see text . 
In period 1 a seizure type 1 is visible, which was not recognized at the 
beginning. In this period a bad observation yield is seen. In period 2 a 
(pseudo)rhythm appears with double spikes, the second one diff icult to rec-
ognize by the detection program, due to its presence during the foregoing 
complex. In the observation these double spikes were not always seen as sep-
arate jerks too. Period 3 shows imminent type 2 seizures (afterdischarge 
type) , observed to a limited degree. From period 4 type 2 seizures are pres-
ent, correctly observed. In period 6 a return to a long interval (pseu-
do)rhythm and an occasional seizure type 1 is seen (not shown). 
Comparison of the SI- and Jl-histograms of this rat indicates, that the 
LOI Jl-modes are located m the same class. Furthermore the Jl-histograms 
have a more scattered pattern due to the limited synchronizing ability of the 
human observer. 
The 2 hours analysis (part II) shows, that in this animal a definite LOI-
rhythm was present and a lot of SHI-spikes, due to seizures of the afterdisc-
harge type. The spike-wave complex presents a second peak only during the 
second period and a remarkable change of wave-form, without concomitant 
alteration of rhythm in period 6. 
Despite the limitations, present m both automatic ECoG analysis and 
observation of epilepsy, the overall reliability of both is il lustrated in this 
example. In Table 31 the correlation is shown between the location of LOI S l -
and Jl-mode for all 6 animals. 
Table 31 : Comparison between LOI SI- and Jl-modes. 
The results of the f i rs t activations of six rats are shown. Correspond-
ing intervals are designated as *. When no comparison can be made (no 
SI- or Jl-mode present or no epilepsy), the cell is left blank. Different 
intervals are shown as - . These are seen only at the beginning (rat 6) 
or end (rats 2 and 4) of the discharges. 
RAT 
1 
2 
3 
4 
5 
6 
1 
+ 
+ 
+ 
+ 
~ 
2 
+ 
+ 
+ 
+ 
3 
+ 
-
+ 
+ 
4 
+ 
• f 
+ 
5 
+ 
+ 
-
+ 
6 
+ 
+ 
TOTAL 
+ 
+ 
+ 
+ 
+ 
+ 
Finally, during the development of the epilepsy minor shifts of the S l -
mode were found between adjacent interval classes. 
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4.9 CONCLUSION 
The results obtained in this chapter, served to expand our knowledge about 
the organization of partial motor epilepsy m rats. The ECoG and automatic 
analyses gave valuable information concerning the development of the Jl-mode 
and the spike-wave complex and served as a reference for the percentage 
(see section 2.4) and interval-mode of observed jerks. On the other hand the 
observed spread served as a reference for its evaluation in the ECoG. Final-
ly the transitions between isolated discharges and seizures were described. 
More detailed information than given here would necessitate electroencephalog-
raphy of deeper structures and even more complicated techniques We did not 
apply these, because they would bring us too far from our goal, t ry ing to 
f ind some practical application of the test. 
Mere observation of the animals in order to assess drug effects seems 
just i f ied. The epileptic jerks were found to be associated with peaks in the 
ECoG Furthermore a considerable proportion of them was recognized (86 %, 
see Table 5) . Besides, the LOI jerk and spike interval modes were located at 
the same site (see Table 31). 
An alternative method of investigating the involvement of deeper struc-
tures might be the measurement of the regional glucose metabolism. We will 
present an account of this experiment, and one, measuring the regional vas-
cular volume in the next chapter. These results were dif ferent from what we 
expected. 
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Chapter 5 
METABOLISM, REGIONAL BLOOD FLOW AND ANATOMY OF THE 
FOCUS 
Due to the fact, that we aimed at standardizing the method of heat lesion and 
chemical induction of epilepsy, we felt the need to know more about the 
metabolism, regional blood flow and some anatomical aspects of the focus in 
order to gam insight m some general factors, possibly important for epilepsy 
and antiepileptic effects. We therefore performed a set of three experiments, 
which will be discussed separately m this chapter: 
1. Regional metabolism. 
2. Regional blood flow. 
3. Relation between anatomy and epilepsy. 
5.1 REGIONAL METABOLISM 
Epilepsy and alterations in the cerebral energy metabolism may be intimately 
linked (Sokoloff 1981). A two to fourfold increase is seen m experimental sei­
zures (Duffy and Plum 1981) Focal cortical motor epilepsy with seizures can 
result m a two fold increase of glucose utilization (Collins 1976a and b) How­
ever one should be aware, that the intensity of the epileptic process is the 
major determining factor with this respect. Energy supplies are only exhaust­
ed in cases of status epilepticus (Duffy and Plum 1981). In case of 
pyridoxme-deficiency, associated with status epilepticus however a decreased 
energy metabolism is found (Sokoloff 1969). In focal and human epilepsies the 
situation is more complex. Inactive foci m patients are characterized by hypo-
metabolism rather than hypermetabolism (Engel et al, 1982a, b and с ) . Despite 
the fact that in animals a state of hypermetabolism is frequently found during 
partial epilepsy (Kennedy et al 1975, Collins 1976b), the low discharge rates, 
seen in our model made it doubtful , whether and to what extent a metabolic 
activation would be present m the heat lesion focus. We therefore performed 
an experiment, designed to get a global insight in this problem. The method 
of ^C-deoxyglucose (see Sokoloff, 1969, 1977, Sokoloff et al 1977, Sokoloff 
1979 and 1981, and Plum et al 1976) was used. The ^C-deoxyglucose method 
was designed after it was discovered, that this substance accumulates in the 
form of deoxyglucosephosphate in the brain (Sols and Crane 1954, Wick et al, 
1955 and 1957, Tower 1958, Bachelard et al 1971 and Horton et al 1973). 
Slight modifications were made, m the sense, that the duration of the experi­
ment was set to 2 hours instead of 45 m m . , due to the fact that our epilepsy 
lasted about 2 hours. 
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5.1.1 METHOD 
24 Male Wistar rats were used*. 21 Of them received a standard heat lesion 
(see section 6.2). After one day all animals were injected with 
^C-deoxyglucose iv. (30 pCi/kg, spec. act. 283 mCi/mmol, diffusely labeled, 
from Radiochemical Centre Amersham®). 2 Hours later the animals were deeply 
anesthetized with ether, received 1 ml. Evans Blue iv. and 5 mm. later they 
were decapitated. Their heads were submerged m isopentane, cooled with sol­
id carbondioxide to 80 "C and thereafter mounted m a stereotaxic frame to 
allow good positioning of the brain Horizontal sections** of the heads were 
made according to the method described m section 2.3.3. Between the injec­
tion of deoxyglucose and the kil l ing the animals received folic acid (90 mg/kg 
iv.) at varying intervals. The resulting epilepsy was classified according to 
the following scale: 
1 Sporadic jerks. 
2. Regular jerks without dominating rhythm. 
3. Regular jerks at 1.3 sec. intervals. 
4. Like 3 + type 2 seizures. 
After development of the autoradiograms, the radioactivity was measured by 
means of scintillation counting***(see section 2.3.3) and visually determined 
photometric density**** (Kodak ® densitometer, 1 mm. aperture). The amount 
of radioactivity turned out to be linearly related with photodensitometric val­
ues, the latter showing less variation. The photometric density therefore is 
used throughout this publication. All results are given with reference to the 
olfactory bulb. During all measurements the necrotic centre of the focus was 
not included, which was visible within the Evans Blue colored region (to 
detect this region, normal photographs***** were made, on which this area 
was clearly visible). Each value mentioned m Table 32 is the mean of at least 
3 mpasurements, except for the collides and hippocampus, where generally 2 
and exceptionally only 1 measurement was possible. 
* These experiments were performed at the Central Animal Laboratory (head: 
W.J. I , van der GuldenJ, m the section for radio-active experiments m col­
laboration with G.J.F. Grutters and P. A.M. Klaassen. 
** The preparation of the autoradiograms and the development of the photo­
graphs was performed at the Laboratory of Clinical Pharmacy (head - C. 
van der Kleijn) by N.V.M. Rijntjes. 
*** at the Laboratory of Neurology (head: J . C . N . Kok) by T.J .A.M. van der 
Velden, С. Henke, M L.F. Schoofs and the author. 
**** By С. Henke. 
***** developed at the Photography Section (head: F.J.J. Dehue) of the 
Department of Neurology (head: B.P.M. Schulte) by F.J.J. Dehue, 
N.G.J. Dijkstra and J.H.G. Wijnen. 
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5.1.2 RESULTS 
The results are displayed m Table 32. 
Table 32: Regional glucose utilization m a rat brain with lesion and 
partial motor epilepsy. 
INT. = class of epilepsy (see above). DUR. is duration of epilepsy 
( m m . ) . HL = heat lesion. FA = folic acid. For CORTEX the panelal 
cortex (site of lesion) is taken, the HL was made at the right side One 
animal without heat lesion was excluded due to congenital brain malfor­
mation (cerebellar hypoplasia). In one other animal the 
^C-deoxyglucose injection was incomplete. 
- r e l a t i v e photographic dens i ty (re f . o l factory bulb (xlOO)-
EPILEPSY HL FA RAT CORTEX STRIATUM THALAMIS COLLICULI 
INT DUR. NO SUPERIOR INFERIOR 
0-4 Hin min. L R L R L R L R L R 
120 
120 
HO 
90 
30 
10 
10 
4 
6 
7 
11 
21 
22 
24 
1 
2 
3 
166 - 156 
121 - 126 
126 - 114 
117 - 129 
133 - 119 
ΙΟβ - 96 
108 - 112 
125 - 114 
125 - 157 
115 - 100 
162 - 160 
137 - 130 
138 - 125 
131 - 121 
122 - 119 
106 - 106 
114 - 96 
136 - 119 
131 - 155 
115 - 113 
145 
138 
112 
121 
120 
112 
106 
119 
140 
112 
134 
138 
125 
112 
108 
106 
104 
107 
167 
181 
128 - 112 
112 - 104 
98 - 107 
115 - 98 
113 - 106 
94 - 96 
80 - 92 
106 - 86 
100 - 114 
81 - 80 
147 - 144 
127 - 125 
124 - 118 
135 - 119 
133 - 115 
104 - 112 
86 - 108 
128 - 97 
113 - 155 
94 - 102 
ŒAN 
iTANDARD DEVIATION 
124 -
17 -
129 
16 
124 
20 
122 - 129 
14 - 27 
103 -
15 -
120 
19 
119 
18 
70 
60 
35 
30 
H O 
45 
45 
30 
20 
45 
10 
5 
IE AN 
STANDARD DEVIATION 
92 
50 
110 
110 
70 
70 
50 
50 
70 
10 
30 
16 
9 
β 
13 
14 
18 
17 
15 
23 
19 
134 
118 
109 
113 
87 
102 
109 
111 
104 
191 
178 
178 
122 
92 
96 
124 
109 
115 
170 
145 
119 
120 
92 
109 
115 
15 
124 
31 
141 
118 
102 
116 
101 
123 
117 - 113 
131 - 120 
114 - 112 
110 - 112 
119 - 121 
12 - 20 
132 
121 
109 
116 
85 
116 
112 
116 
114 
122 
184 
207 
112 
122 
102 
100 
113 
116 
121 
119 
116 
12 
130 
33 
100 
109 - 98 
120 - 114 
100 - 114 
89 - 105 
100 - 96 
74 - 72 
91 - 89 
97 - 93 
100 - 102 
98 - 96 
109 - 100 
94 - 97 
11 - 11 
127 - ПО 
117 - 121 
146 - 142 
108 - 124 
93 - 114 
127 - 130 
100 - 104 
107 - 124 
110 - 104 
118 - 124 
108 - ПО 
100 - 100 
114 
14 
117 
13 
96 
98 
90 
94 
117 - 112 
ПО - 100 
109 - 112 
95 - 89 
76 - 77 
109 - 104 
83 - 100 
IIB - 115 
100 - 94 
101 
13 
99 
11 
136 - 120 
123 - 115 
107 - 102 
ПО - 100 
109 - 102 
96 - 102 I 
94 - 90 
109 - 105 1 
104 - 133 [ 
107 - 97 | 
109 - 107 | 
14 - 13 
5.1.3 DISCUSSION 
The results of these experiments show great resemblance to those from Rei-
vich et al (1975) with respect to the global relative levels of metabolism. The 
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inferior collide for example has the highest activity However, when we 
compare their results for the structures, mentioned above, with ours, no 
significant correlation is present One reason will be, that these structures 
have a similar level of glucose metabolism m contrast to for example the cere-
bellum, see also Figure 24, which exhibits a lower glucose metabolism confined 
to the Purkinje cell layer. The variance of the results m the former and 
probably also slight physiologically induced differences preclude this correla-
t ion. A second reason for the lack of correlation of our results with those 
from Reivich et al might be the presence of the lesion. 
Due to the fact, that the accumulation of deoxyglucose is dependent on 
the actual plasma concentration, the rate of accumulation will show an expo-
nential decay. As the epilepsy in most rats started late due to a variable time 
of injection of folate, the epileptic activity m a number of animals could not 
contribute to a visible rise m metabolism at al l . A second factor which tended 
to obscure the results is the fact, that analysis of one investigation concern-
ing partial motor epilepsy in rats and its metabolism (Collins 1976d, Collins et 
al 1976b and Collins 1978) showed, that only animals having focal seizures 
were able to generate a major activation of the cortical metabolism Other sei-
zure types, like limbic motor seizures (Ben A n 1981) were considered to be 
too intense and generalized to be comparable with partial motor epilepsy. 
Taking into account these factors, only rat no 9 was supposed to show an 
activated metabolism in cortex and thalamus. The results with this rat are 
shown m Figure 24. 
This rat showed the expected increase of glucose util ization. However, 
some animals without epilepsy showed activation of the focus, inferior coll ide 
and thalamus too, for the latter two areas sometimes even at the contralateral 
side of the lesion. The area of the focus m rat 2, who only had a heat 
lesion, also showed a large difference with the other side (see Table 32). So 
the possibil i ty, that the lesion alone under certain - unknown - circumstances 
activated the local metabolism, is likely A complete review of other investi-
gations m this field is - beside the different types and intensities of epilepsy 
m the studies - hampered also by the fact, that most investigations lack suf-
ficient statistical evidence (for example Sharp and Evans 1982) 
We presume, that m the animals, studied by us, partial motor epilepsy 
without focal seizures is not associated with an increased utilization of glucose 
within the focus and related brain areas. Partial seizures and the presence of 
the lesion can increase the glucose util ization. In order to establish the rela-
tion between metabolism and the regional blood flow a similar experiment was 
started with 1*C-ant ipyrme as a marker. 
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Figure 24: Measurement of regional glucose metabolism. С = cortex, F = 
focus, S = striatum, Τ = thalamus, SC = superior coll ide, 1С = 
inferior coll ide, CB - cerebellum. An activated area much larger 
than the extravasated Evans Blue or folate is present in the cor­
tex around the lesion. Furthermore the thalamus and to a lesser 
extent the striatum as well as the inferior collide are activated. 
Under each photograph the distance to the cortical surface is giv­
en in mm. 
5.2 REGIONAL BLOOD FLOW 
In order to assess changes in regional blood flow in and around the focus we 
performed the following experiment. We chose the method of "C-ant ipyr ine (for references see Reivich et al 1969, Sakurada et al 1978). An accurate 
measurement of blood flow is not possible by means of this substance (Saku­
rada et al 1978) due to incomplete diffusion. We assume therefore, that the 
concentration of "O-ant ipyr ine only represents the vascular volume. 
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5.2.1 METHOD 
We applied basically the same method as described for the other autoradio-
graphic (section 2.3.3) and deoxyglucose (section 5 . 1 . l ì experiments. 24 Male 
Wistar rats were used and 21 of them received a standard heat lesion. The 
folic acid injections, 24 hours later, were varied as in section 5.1.1 and 10 
seconds before decapitation each animal was injected with ' ' 'C-antipyrine iv. 
(from the Radiochemical Centre Amersham®), 30 vCi/kg in 1 ml fys. sal . , 
spec, act. : 58 mCi/mmol. All other steps were similar to the sections 2.3.3 
and 5 .1 .1 . Care was taken to measure a representative portion in all sam-
ples. 
5.2.2 RESULTS 
The results are shown in Table 33. 
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INT. -
(mm. ) 
cortex 
s ide. 
mcomp 
ed. 
EPILEPSY 
INT. DUH. 
0 - 4 m m . 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
2 10 
2 15 
4 3 0 
4 3 0 
4 3 0 
4 4 0 
2 4 5 
1 5 5 
3 5 5 
2 6 5 
4 6 5 
4 6 5 
MEAN 
Тг ble 33: 
= class of epi 
. HL -
( s u r r o u n 
η one 
lete. 
HL 
. 
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
STANDAKD DEVIATION 
heat 
d m g s 
rat (no 
In 
FA 
•in. 
1 2 0 
1 2 0 
1 2 0 
. 
4 0 
-
4 0 
-
1 1 0 
1 1 0 
1 1 0 
4 0 
4 5 
4 5 
4 5 
5 0 
7 0 
5 0 
7 0 
7 0 
» 0 
9 0 
9 0 
rats 5 
Mea 
leps 
sûrement 
У ( 
lesion. 
of 
16) 
, 6 
of regional vascu 
;ee above) 
FA = folic 
. DUR. I S 
acid. For 
lesion) is t a k e n , 
the 
12, 
- r e l a t i v e vascular 
RAT 
NO 
2 3 
2 4 
CORTEX 
L 
116 
126 
143 
134 
124 
1 3 0 
125 
114 
120 
9 3 
117 
127 
1 2 0 
116 
125 
107 
110 
И З 
U I 
1 3 3 
1 0 3 
105 
И З 
118 
И 
R 
- 1 1 3 
- 126 
- 144 
- 8 0 
- 75 
- 81 
- 95 
- 9 3 
- 101 
- 1 0 3 
- 131 
- 9 2 
- 1 0 3 
- 106 
- 120 
- 1 1 3 
- 1 1 0 
- 79 
- 87 
- 101 
- 91 
- 8 3 
- 9 5 
- 101 
- 18 
intravenous ι 
13 and 23 
v o l i n e ( r é f . l e 
STRIATUM 
L 
115 
101 
143 
133 
120 
1 1 3 
99 
157 
134 
121 
110 
138 
101 
132 
97 
120 
105 
130 
1 2 3 
130 
121 
16 
R 
- 117 
- 108 
- 1 4 3 
- 107 
- 115 
- 1 3 3 
- 97 
- 139 
- 118 
- 112 
- 112 
- 146 
- 119 
- 118 
- 9 0 
- 107 
- 109 
- 107 
- 117 
- 116 
- 117 
- 14 
ar vo urne 
durat ion of ep ilepsy 
CORTEX the parietal 
the HL was ma 
niection of lfcC 
not all 
f t о f a c t o r y 
THALAMUS 
L 
1 0 9 
97 
1 2 9 
1 2 3 
1 1 6 
105 
1 0 4 
1 4 9 
H I 
1 0 8 
9 8 
1 3 6 
9 9 
1 2 4 
9 4 
1 1 2 
1 0 3 
112 
1 1 7 
109 
1 1 3 
14 
R 
- 109 
- 102 
- 126 
- I l l 
- 1 1 4 
- 1 0 2 
- 101 
- 1 4 4 
- 9 5 
- 107 
- 100 
- 1 3 0 
- 107 
- 126 
- 91 
- 87 
- 9 5 
- 101 
- 1 0 3 
- 9 5 
- 107 
- 14 
reg 
b u l b 
de at t h e 
-anti 
ons could 
( x l O O ) - -
COLLICULI 
SUPERIOR 
L 
1 1 3 
1 2 4 
130 
1 3 3 
1 3 5 
1 3 3 
112 
1 6 4 
1 5 0 
1 4 8 
129 
1 4 6 
127 
141 
1 4 0 
1 2 4 
142 
1 6 3 
1 3 6 
15 
R 
- 1 1 7 
- 121 
- 122 
- 139 
- 1 3 1 
- 142 
- 1 2 0 
- 1 7 2 
- 155 
- 1 4 2 
- 127 
- 1 7 2 
- 1 2 9 
- 1 4 9 
- 1 3 5 
- 1 3 0 
- 1 5 0 
- 1 6 5 
- 1 4 0 
- 17 
r iqht 
p y r m e was 
be mclud 
INFERIOR 
L 
117 -
1 2 3 -
137 -
130 -
1 5 8 -
142 -
121 -
172 -
165 -
1 6 0 -
1 3 4 -
1 6 3 -
127 -
1 5 3 -
137 -
1 4 3 -
1 5 5 -
1 8 0 -
1 4 5 -
19 -
R 
1 1 3 
128 
135 
137 
129 
141 
1 1 6 
1 7 8 
162 
150 
145 
179 
117 
158 
136 
142 
1 5 4 
1 7 6 
1 4 4 
21 
-
HIPPOCAMP. 
L 
1 1 3 -
105 -
132 -
116 -
121 -
121 -
116 -
169 -
142 -
1 4 3 -
115 -
155 -
121 -
139 -
119 -
137 -
132 -
1 4 8 -
1 3 0 -
18 -
R 
115 
1 0 9 
127 
108 
121 
1 2 3 
1 0 3 
169 
137 
1 3 5 
1 1 3 
1 6 4 
1 1 3 
105 
1 1 9 
1 3 4 
1 6 9 
" І 2 7 
22 
In all ant ipynne photographs more regional differences were seen than in 
the deoxyglucose experiments, for instance m the thalamus (the thalamic nuc­
lei). 
From Table 33 some aspects emerge. The pattern, found for ant ipynne, 
was not similar to the one, obtained for deoxyglucose. The results are com­
parable to similar antipynne experiments by Reivich et al (1975), with the 
exception of the superior coll ide, which m our experiment has a relatively 
greater vascular volume. No explanation for this could be found. No statisti­
cal significant differences were present, when epileptic rats were compared 
with the not epileptic ones. Generally, a decrease of the vascular volume at 
the side of the lesion was observed. This decrease was not present in the 
three rats without heat lesion (Table 34). 
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Table 34: Degree of 
lesion. 
red 
The level of significance 
( * ) : 0.05 < ρ < 0.10, 
uction 
( s i g n -
of th 
test) 
two s i d e d ) . 
RATNUMBER 
5 
23 
6 
18 
22 
15 
24 
13 
11 
4 
θ 
10 
19 
12 
21 
20 
14 
17 
9 
7 
MEAN 
SD 
SIGN 
CORTEX 
- 4 0 
-39 
- 3 8 
- 3 0 
- 2 8 
- 2 4 
- 2 4 
-21 
-21 
-19 
-16 
- 1 6 
- 1 4 
- 1 2 
- 8 
- 4 
0 
5 
10 
13 
- 1 6 
15 
* 
% 
e vascL lar volume at t h e site of t h e 
is given u n d e r 
REDUCTION 
STRIATUM 
- 8 
-12 
3 
-19 
-11 
-5 
-4 
18 
-10 
- 8 
-18 
2 
6 
-10 
17 
- 1 
-11 
- 4 
11 
(*) 
THALAMUS 
- 4 
- 1 4 
-7 
- 9 
- 2 2 
- 1 2 
- 1 
- 3 
- 1 3 
- 1 
- 1 0 
2 
- 4 
1 
9 
- 3 
- 3 
- 6 
7 
* 
SIGN ( * : ρ < 0 . 0 5 , 
BULB.OLF. 
- 5 
- 4 
8 
- 1 3 
- 9 
- 6 
6 
- 2 
- 1 
- 5 
- 2 
- 1 
- 1 
0 
1 
7 
3 
3 
9 
- 5 
- 1 
6 
5.2.3 DISCUSSION 
From Table 34 we can see that the reduction was most marked m the sur­
roundings of the lesion. Generally, the area of reduced vascular volume 
extended from the whole frontal region to the occipital cortex, with the 
exception of the area striata. In Figure 25 the photographs of rat 18 illus­
trate these f indings. 
The reduction of vascular volume, which probably reflects a reduction in 
regional blood flow (however the adaptation through changes m pressure are 
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1.5 
GB H 
Figure 25: Measurement of regional vascular volume. С = cortex, F = focus, 
S = striatum, Τ = thalamus, SC = superior coll ide, 1С = inferior 
coll ide, CB = cerebellum, Η = hippocampus. A decrease of vascu­
lar volume is seen in an area much larger than the extravasated 
Evans Blue or folate and is present m almost the entire the cor­
tex around the lesion. Furthermore the vascular volume of the 
thalamus and to a lesser extent striatum are also decreased. 
Under each photograph the distance to the cortical surface is giv­
en m mm. 
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not known), was found to extend throughout the hemisphere of the same 
side, but not m olfactory bulb or brain stem regions. Presumably these 
results are the consequence of a local brain swelling and associated increase 
in intracranial pressure m the compartment of the r ight hemisphere. In some 
rats also a slight bulging of the falx was visible. A second conclusion is, that 
the regional metabolism and blood flow are not coupled under these - patho-
logical - circumstances. 
The degree of epilepsy and vascular volume were not related to each 
other (Spearman rank correlation coefficient: r = 0.32, not signif icant). An 
association between the vascular volume and the glucose utilization was not 
found too. 
Mies et al (1981) designed a double tracer autoradiographic technique 
with "C-deoxyglucose and 1J11 -antipyrme. After local penicillin application 
they found an increased glucose utilization around the focus, and m the tha-
lamus, but no concomitant increase in regional blood flow was seen. They also 
found sometimes a lack of enhanced glucose uti l ization, while regional blood 
flow was increased. Their findings also implicated a lack of correlation 
between glucose utilization and blood flow. 
We conclude, that some impairment of the regional blood flow is present 
throughout the experiments and an increased intracranial pressure m the 
r ight hemisphere. The significance of these changes is not exactly known. 
The depletion of supply of glucose does not seem a limiting factor in partial 
motor epilepsy (see section 5.1 and 5.1.3). Perhaps near the center of the 
focus (m the folate-permeable par t ) , a degree of acidosis might be the result, 
influencing the process of epilepsy and the local distr ibution of antiepileptic 
drugs, especially phénobarbital. 
5.3 RELATION BETWEEN ANATOMY AND EPILEPSY 
In section 2.6 we already described the procedure of brain dissection and a 
schematic f igure (Figure 10) of the boundaries and properties of the four t is-
sue components, seen during preliminary studies. In this section we present 
some results concerning the association between anatomical features and the 
amount and type of epilepsy. The preliminary microscopic studies did not 
show any relation between the form of the lesion and the resulting epilepsy. 
Unexpectedly, by varying the size of the lesion through the application of a 
lower probe temperature (see section 2.5.3) it was shown, that the number of 
jerks and seizures increased as the lesions grew smaller, however at the cost 
of increasing variance. We therefore could expect that the greater the lesion, 
or the deeper the necrosis, the less intense epilepsy would be generated. In 
order to f ind out, whether this effect was present m rats with a standard 
lesion and folic acid injection, we compared the number of jerks with the sag-
i t ta l , coronal and frontal diameters of the lesion, for the area penetrated by 
Evans Blue and necrosis m 83 animals*. No significant relations were found. 
The other variables, such as spread to the face, turned out not to be related 
to the size of the lesion too. In Figure 26 one such measurement is shown 
graphically. 
This experiment was carried out by B .T .H.J . Arends. 
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Figure 26: Relation between number of jerks (Ν) and the surface of the cor­
tical necrosis (O). No statistical significant relation is present 
Although therefore no direct relation could be established between the 
histometnc features of the standard lesion and the variables, quantifying sev­
eral aspects of epilepsy, we were able to determine the anatomical area, to 
which the primary damage was limited In the three f i rs t control groups (47 
animals) standard histometnc measurements were performed and the following 
results were obtained (in 3 rats no accurate measurement was possible), see 
Table 3b. 
We compared these figures with the distances between the somatotopic 
projections on the motor cortex, as judged by minimal latency of myoclonic 
jerks (Angel and Lemon 1975). The centre of the the forelimb area is located 
1.0 - 1 5 mm from that of the hmdlimb and therefore will be included in 
almost all lesions The centre of projections to the face, which extend over a 
large area (Welker 1971), is located at a distance of more than 3 mm. from 
the site of the lesion and therefore will be outside the area of primary damage (ι e for Evans Blue and folate permeable region) As was indicated in chap­
ter 3 (section 3 2.2 Figure 13) a bimodal distr ibution of the spread of the 
LOI-jerks was observed Both limbs were always involved (corresponding to 
our expectation based on the anatomic boundaries of the lesion) and spread to 
the face area was only seen m 1/3 of the animals Whether or not such a 
secondary spread occurs, is not primarily dependent on anatomical features, 
because no direct relation was found between the size of the lesion and sec­
ondary spread. The latter therefore must be the consequence of a sequence 
of functional factors, one of which seems to be the LOI-rhythm of the jerks 
In conclusion we can say, that anatomical factors did not predict the quantity 
of characteristic epileptic events, but set the limits for the primary spread. 
Furthermore the distinction between primarily and secondarily epileptogenic 
tissue seems to provide a good basis for judging drug effects on the spread 
of discharges 
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Table 35: Histometnc features of the standard lesion. 
The Evans Blue diameter includes the central necrotic area. One fourth 
of the total lesion surface is necrotic. 4 (Out of the 44) animals were 
totally free from any tissue death. One should not forget, that, accord-
ing to histologic preparations (section 2.6) and the "O-ant ipyrme 
experiment (section 5.2) the cerebral edema extends into a larger area. 
The Evans Blue area roughly corresponds with the folate permeable part 
of the focus (see section 2.3.3, Figure 7) . 
VARIABLE MEAN SD MEDIAN (mm.) 
SURFACE 
Ev.Blue (sagitt. diam.) 
necrosisCsagitt. diam.) 
EXTENSION INTO CORTEX 
4.5 0.7 
2.3 
motor cortex (lam.I-Vl) 2.15 0.05 
Evans Blue 0.9 
necrosis 1.4 
Chapter 6 
TESTING SIX ANTICONVULSANTS 
After having defined the method to be used (see chapter 2 and 3) and having 
gained additional information in chapter 4 and 5, we tr ied to assess the value 
of the method by testing six major anticonvulsants: 
1. Valproate (VPA) 
2. Phénobarbital (PB) 
3. Phenytoin (PHT) 
4. Carbamazepme (CBZ) 
5. Clonazepam (CP) 
6. Ethosuximide (ESM) 
These six were considered to represent the anticonvulsants m use presently 
m most patients with epilepsy. The relevant data concerning their pharma-
cology will be discussed below and m section 7.2. This chapter contains the 
following sections· 
1. Literature data 
2. Method of test ing. 
3. Results. 
4. Review. 
6.1 LITERATURE DATA 
A great amount of data is available about the six substances mentioned above. 
However with respect to their mode of action as anticonvulsants the informa-
tion is scarce and a wide gap is present between reported pharmacological and 
neurophysiological effects. 
In this section only those facts, relevant for our topic of study, will be 
given, together with some general information about the drugs. In this sec-
tion each anticonvulsant will be reviewed separately. 
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6.1.1 VALPROATE 
Valproic acid is a short chain branched fatty acid (2-propylpentanoic acid; 
dipropylacetic acid), that was used as a solvent after its synthesis in 1882 
(Kupferberg 1982). It's structure is displayed in Figure 27. 
C H 3 C H 2 C H 2 ^ Ρ 
сн3сн сн^ он 
Figure 27: Molecular structure of valproic acid. From Kupferberg 1980 (with 
permission). 
Because of its s t ructure, which is remarkably different from the other anti­
convulsants, the substance resembles certain endogenous fatty acids, which 
renders pharmacological studies and its determination (usually by gas-liquid 
chromatography) more d i f f icu l t . Valproic acid (M = 144, 6.94 mg/ml is equiv­
alent to 1 μΓηοΙ./Ι) is not very soluble m water, however the sodium salt is. 
VPA is rapidly and almost completely absorbed in humans (Levy and 
Lai,1982) and at least to a great extent m other animals, including rdts (Fer-
randes and Eymard, 1977), even when using different routes of administra­
t ion. Plasma protein binding is high (up to 90 %) and saturable at high dos­
es. This binding is not affected by other drugs, due to the facts that 
valproate is more t ight ly bound to albumin, the other drugs have mostly lower 
molar concentrations than valproate and albumin, and because valproate has 
more binding sites for this protein (Levy and Lai 1982). Its half life is short, 
varying from 9.5-17.7 hours m humans (Levy and Lai,1982) to 1.6 hours in 
mice (Lacolle et al, 1978). Its distribution m the body appears to be rapid, 
but limited, with slow accumulation of the substance m olfactory bulb in mice 
and monkeys (Schobben, 1979). 
The metabolism of valproate is species dependent (Ferrandes and 
Eymard, 1977), but similar m man and rats. A great deal is excreted within 
24 hours as glucuromdated valproate or to a varying level unchanged. Fur­
thermore two metabolites are present: 2 n-propylglutanc acid - a beta-
oxidized substance-, which is further metabolized, and products of omega-
oxidation like 2-n-propyl 5-hydroxyvaleric acid. A t h i r d unidentified 
metabolite was found m urine of man, but not m rats. According to Jakobs 
and Löscher (1978) beta oxidation is preferred m rats, dogs and humans, but 
omega-oxidation in mice. Schobben (1979) was able to identify one metabolite, 
thought to be the beta oxidized 2-propyl-3-pentenoic acid, in several species (dog, monkey, man), which appears in the blood in significant amounts after 
administration of valproate. Due to its longer half life this metabolite might 
be able to add to the therapeutic effect of valproate. However for none of the 
metabolites, mentioned above, the therapeutic efficacy has been assessed. 
The antiepileptic action of valproate is beyond doubt ( f i rst report by 
Meunier et al 1963). In rats the median effective dose, necessary to protect 
against maximal electroshock seizures (= MES-test) amounts 490 mg/kg (after 
oral administration) and 140 mg/kg (after intraperitoneal injection (Swmyard 
and Woodhead 1982). The protective index after oral administration (median 
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toxic dose/median effective dose) is low (0.57). In the subcutaneous metrazol 
test (=scMET) the median effective oral dose is 180 mg/kg (protective index: 
1.56). Because the latter test is believed to represent drugs active against 
petit mal (supposed on associative grounds), it is generally thought, that 
valproate is specifically active against petit mal and more generally primarily 
generalized epilepsies. Valproate is also moderately effective against bicucul-
Ime and Picrotoxin and allylglycme induced seizures m rats (Swinyard and 
Woodhead 1982, Ashton and Wauquier 1979a). Finally, VPA effectively sup-
presses seizures after amygdaloid kindling (Ashton and Wauquier 1979b). The 
action of valproate was also tested in other species. In mice the median effec-
tive dose for MES and scMET tests amounts 665 and 388 mq/kg orally (protec-
tive indices 1.90 and 3.26) (Swinyard and Woodhead, 1982). In cats valproate 
only slightly elevated the seizure threshold in bemegnde induced seizures at 
doses from 200 mg/kg s c , whereas it did not alter the clinical or ECoG 
course of the seizures (Van Duyn and Beckmann, 1974). The same authors 
also tested valproate after local implantation of cobalt m the cat brain and 
were not able to see changes in focal spiking, which occurred at a frequency 
of 0.56 V - 0.17/sec. This was also reported earlier by Mutam et al (1968) 
and Fanello and Mutam (1970a). The former were able to demonstrate a sub-
stantial increase m threshold of hippocampal electrically induced afterdisc-
harge. In cats too. Pellegrini et al (1978) tested the effect of valproate 
against penicillin induced (350.000-400.000 I .U . / kg . i v . ) generalized epilepsy. 
This type of epilepsy is electroencephalographically and behaviorally similar to 
human myoclonic petit mal (for review see Gloor, 1979) No dose-dependent 
and consistent reduction of number of bursts could be obtained. This resem-
bled closely the phenytom effect, but was different from the consistent effect 
of ethosuximide found m the same model (Guberman et al 1975). However rel-
atively low doses of valproate were used m this experiment (50-130 mg/kg) . 
Amygdaloid kindling m cats (Leviel and Naquet, 1977) preceded by daily 
injections of valproate ( 50 mg/kg) led to a great decrease of afterdischarge 
duration, but not to a decrease in clinical manifestations like clonus of the 
whiskers, chewing etc. as during phénobarbital treatment (5 mg/kg) . After 
stopping the valproate, a carry over effect was present lasting at least 9 
days. Generally spoken, the therapeutic index of valproate m non primates 
after acute administration is not high. In the monkey valproate is active 
against chronic aluminium oxide induced secondarily generalized seizures at 
doses producing plasma levels in the range of 50-150 mg/1 (Lockard et al 
1977) In this investigation also a carry-over effect lasting 2 weeks was seen 
and besides, a permanent seizure reduction start ing after 4 weeks, following 
an initial transient decrease at a lower dose. In man valproate has been 
shown to be superior to placebo (Memardi, 1971, Suzuki et al 1972, Richens 
and Ahmad 1975). Recent reviews (Gram et al 1982, Pinder et al 1977 and 
Simon and Kiffm Penry 1975) do not point to a the superiority of valproate 
above other drugs, nor do they allow firm conclusions about the relation 
between effect and plasmaconcentration and between effect and duration of 
therapy. However important carry over effects are consistently observed, 
and it is generally agreed that the effect of valproate is not synchronous with 
its plasmaconcentration course (for example see Rowan 1978) This should not 
be confused with the association, found between the mean plasmaconcentration 
and degree of seizure reduction observed m groups of patients (Gram et al 
1979). Consequently daily doses do not need to be given at intervals equal or 
less than the plasma half- l ive of valproate m order to ascertain adequate sei-
zure control. 
Side-effects of course have been noted. A complete description falls out-
side the scope of this review, but it will suffice to slate, that m acute 
experimental epilepsy transient motor side effects dominate (Kulig 1976), while 
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m man acute hypnotic (Boxer et al 1976) and chronic but not clearly defined 
psychotropic effects (Sommerbeck et al 1977) are reported. According to 
Smith and Carl (1982) only chronic treatment with VPA lowers serum folate, 
but not brain folate levels. 
Concerning the mode of action of valproate we will not go into detail, 
but refer to Kupferberg (1980) and Johnston and Slater (1982). We will only 
mention the results of Godm et al (1969) who showed that GABA-content of 
rat brain increased after intraperitoneal administration of doses of 200 mg/kg 
or more. Schmutz et al (1979) studied the modulation of GABA effects by sys-
temic or local application of VPA on single nerve cells. VPA, given 200 mg/kg 
ip. slightly potentiated GABAergic inhibition m 1 out of 8 rats. From these 
and other experiments it's not likely that at anticonvulsant levels VPA exerts 
its effects mainly through a direct potentiation of this central inhibitory 
GABAergic transmission. 
Concluding this review it will be clear, that despite the definitely anti-
convulsant action of valproate, many aspects require elucidation, especially 
the action of VPA on partial seizures. More controlled clinical trials are a 
requisite, but this should be supported by more sophisticated data from ani-
mal experiments. Especially a search toward potentiating combinations of valp-
roate with other drugs seems warranted, excluding pharmacokinetic interac-
tions. This requires comparative information about the action of all 
anticonvulsants on the seizure complex of partial epilepsies and data about 
factors underlying its development. In this chapter we will t ry to present 
such kind of information. 
Supported by one good animal study on the combination PB and PHT (Leppik and Sherwm, 1977), we think that many of the reported potentiations 
can be explained by interactions on the kinetic level. When experimentally 
data could be obtained, showing different anticonvulsant profiles between 
valproate and other drugs, this would strongly support study designs for 
clinically useful combinations of drugs, which are hard to undertake and for 
partial epilepsies still lack sufficient scientific just i f icat ion. 
6.1.2 PHENYTOIN 
Phenytoin is a 5,5-diphenylhydantoin (5,5-diphenyl-2,4-imidazolidinedione) 
commonly known as diphenylhydantom (Glatzko 1982a). Its chemical structure 
is shown m Figure 28. 
TO 
N 
H 
Figure 28: Molecular structure of phenytom. From Levy 1980, with permis-
sion . 
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Phenytoin CM = 252.26, 3.96 mg/l is equivalent to 1 pmol./l) is used as 
the acid form or as the sodium salt in different preparations. It is poorly 
soluble in water, however alkalmization raises its solubility considerably. 
The absorption of phenytom is to a great degree dependent on the type 
of formulation or food constituents (Woodbury 1982b). Due to its limited solu-
b i l i ty , transport to the blood stream is saturable and depends on the speed at 
which phenytom is cleared from the blood into the tissues. The plasma bind-
ing of PHT is high (80 % m rats receiving 33 mg/kg ip , and about 86 % m 
humans, see review Woodbury 1982b). Conard et al (1971) however found m 
a comparative study different figures for plasma binding m rats (89-91 %) and 
man (92-95 %) and obtained at a drug level of 40 mg/l a free rat/human drug 
ratio of 1.6. The high protein binding of the drug is a source of several 
interactions. The elimination of phenytom is saturable, causing kinetics, com-
patible with a Michaelis-Menten equation (Martin 1977, Guelen and van der 
Kleijn 1978). Consequently there may be an exponential rise m plasma con-
centration, when the dosage increases. Its half life therefore is dependent on 
the actual plasma concentration. In patients at therapeutic level the average 
half life is 22 hours (Woodbury 1982), rats eliminate half of the drug within 
60-70 mm. (Coiburn and Gibaldi 1977). PHT distributes freely m the body 
because it is unionized at pH 7.4 (Woodbury 1982). Within 15 mm. the maxi-
mum volume of distr ibution is reached. The ultimate tissue concentrations m 
bram m rats, mice and probably humans are higher than m plasma, due to 
larger tissue binding (Leppik and Sherwm 1977, Woodbury 1982). Important 
redistribution phenomena are found, which take place after a single injection 
of PHT (Woodbury 1982) and give rise to a fast initial decrease of plasma and 
thus brain concentrations. 
Phenytom is mainly metabolized by para-hydroxylation of one of its phe-
nyl groups into 5-(p-hydroxyphenyl)-5-phenylhydantoin (HPPH). This route 
of elimination however depends on comedication, especially phénobarbital (Woodbury 1982b, Chang and Glatzko 1982) There are species differences (Chang and Glatzko 1982) but the significance of this is unknown. 
The antiepileptic action of the drug was discovered by Merrit and 
Putnam (1938) and PHT has been of great value in the treatment of epilepsy. 
It is very active m preventing the tonic hmdlimb extension m the MES-test (median effective oral dose m rats being 29 82 mg/kg, a protective index of > 
100) (Swmyard and Woodhead 1982). The same author (Swmyard et al 1952) 
found a median effective se. dose of 9 mg/kg (testing was done after 30 
mm. ) . Median effective bram concentrations m the MCS-test amount 12 2 
ymol/kg , with a brain/plasma ratio of 1.21, (Leppik and Sherwm 1977 and 
1979).They additionally found a median effective subcutaneous dose of 30 
mg/kg, when the tests were performed after 2 hours. PHT is also effective 
against maximum seizure manifestations of allylglycme (Ashton and Wauquier 
1979a), but does not afford protection against the scMET test (Swmyard and 
Woodhead 1982). Against some other chemically induced seizures (bicuculline 
and Picrotoxin) m the rat phenytom is not effective (Swmyard and Woodhead 
1982). Other studies m the rat include local application of penicillin at the 
sensorimotor cortex under ethylcarbamate anesthesia (Gartside 1978). He 
found, that PHT, 20 mg/kg i v . , given after spikes reached their maximum 
amplitude, only suppressed this amplitude, but not the frequency of spikes. 
In amygdaloid kindling m the rat phenytom is effective, its median effective 
dose being 31.5 mg/kg ip. (Ashton and Wauquier 1979). In the cat Guberman 
et al (1975) could not show any consistent effect of phenytom on generalized 
penicillin epilepsy. PHT administered to cats, appears to have only a moderate 
and transient effect on the duration of hippocampal afterdischarge (Schmutz 
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et al 1981). In the chronic aluminium hydroxide monkey model (Lockard et al 
1975) the therapeutic plasma level is 5-12 mg/ l . In man 10 - 20 mg/l is con-
sidered to be adequate (Kutt 1982). Thp drug is considered to be of no value 
in the treatment of petit mal epilepsy, but no good clinical studies have been 
done so far (Gram et al 1982). Its superiority over other anticonvulsants m 
epilepsy has not been convincingly shown until now (Gram et al 1982). 
Because almost immediate distr ibution into brain tissue takes place, phenytom 
will have a fast effect after iv. administration (cf. Leppik and Sherwm 1977), 
but redistribution prevents long lasting effective brain concentrations. In 
equilibrium states the plasmaconcentration will be a good indicator for the 
amount of drug in the brain. Even then, there is a marked variabil i ty m 
individual effective and toxic dose (Kutt 1982). 
Summarizing the reported effects of PHT m several species and models it 
appears, that phenytom has a strong but limited anticonvulsant spectrum, 
from which it is however not easy to predict its action in human epilepsies. 
However it seems certain, that phenytom does not influence the frequency of 
focal discharges m rats, where as generally focal seizures and their spread 
are prevented by the d rug . In this respect PHT is better studied than VPA. 
Side-effects of phenytom are widely recognized. Acute administration 
causes early motor incoordination m most species, except m rats (Swmyard 
and Woodhead 1982). However in rats, too, a depressant effect on the ECoG 
can be recognized (Gartside 1978). According to Woodbury (1982c) often 
excitatory effects are present when the substance is given to animals m high-
er concentration. From all chrome side effects m man (review Kutt and Solo-
mon 1980, Dam 1982) we only mention the encephalopathy, including loss of 
cerebellar neurons (Gabreëls 1970) and neuropathy, decrease of folate plasma 
levels (Houben et al 1971 and Reynolds 197o) and drug interactions, due to 
enzyme induction. The interaction between some anticonvulsants and serum 
folate levels initiated the study of the epileptogenic action of folate in our 
laboratory. No acute interaction between phenytom and folate is known (Smith 
1979 and Carl and Smith 1983). 
The mechanism(s) of action of PHT have been thoroughly investigated. 
Without going into detail again and referring to Glaser et al (1980), chapters 
19-25 and 27, and Woodbury (1982c), we will brief ly summarize the relevant 
issues. Several neurophysiological mechanisms have been reported: stabiliza-
tion of membrane potential, increase of threshold for action potential genera-
t ion, decrease of nerve conduction velocity, decrease m spike amplitude, 
inhibition of repetitive f i r ing and post tetanic potentiation and restoration of 
abnormally increased excitabil ity of neurons by hyponatremia or hormonal fac-
tors. The biochemical mechanisms are: decrease of sodium mfluxves m mem-
branes by blocking Na-channels, stimulation of active sodium/potassium 
coupled transport (increasing permeability of mainly epithelial cells like gl ia), 
inhibition of calcium influxes (explaining perhaps some hormonal side effects), 
inhibition of protein synthesis (in vivo but not m v i t ro ) , interaction with 
membrane phosphorylation with specific binding to dipalmitoyl and dioleyl lec-
ithins, inhibition of transmitter release (possibly linked to phosphorylation or 
calcium-mflux), and prevention of the increase of cyclic nucleotides after 
veratrme and ouabame (probably accumulating secondary to depolarization). 
It is dif f icult to couple its anticonvulsant effects to one or more of these 
mechanisms. 
Concluding this far from exhausting review on PHT we can expect a dif-
ferent - m the sense of smaller, but not less effective - anticonvulsant pro-
fi le of this substance than valproate. Here too the search toward useful com-
binations, supported by more experimental data, seems warranted. 
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6 .1 .3 PHENOBARBITAL 
Phénobarbi tal is a 5 , 5 - s u b s t i t u t e d b a r b i t u r i c acid ( 5 - e t h y l - 5 - p h e n y l b a r b i t u r i c 
a c i d ) . A pheny l g r o u p at C-5 or N o f fe rs select ive an t i convu lsan t ac t i v i t y on 
a b a r b i t u r a t e . When a lky l side chains at C-5 or N are too l ong , convu lsant 
p roper t ies of ba rb i t u ra tes appear ( P n c h a r d 1980, Johannessen 1982). In F ig -
ure 29 some s t r u c t u r a l fea tures of b a r b i t u r a t e s , impor tant f o r act ion on neur -
al exc i tab i l i t y are shown. 
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F i g u r e 29: S t r u c t u r e of phénobarb i ta l and related ba rb i t u ra tes S t ruc tu ra l 
features of ba rb i t u ra tes important fo r act ion on neural exc i t ab i l i t y 
are shown. In В and С d o t t e d l ines r e p r e s e n t bonds w i t h 
u n c h a n g e d p o r t i o n s of the phénobarb i ta l molecule shown m A . 
DMBB: 5 - e t h y l - 5 - C 1 , 3 - d i m e t h y l b u t y l ) b a r b i t u r i c ac id . CHEB: 
5 - e t h y l - 5 - ( 2 - c y c l o h e x i l i d y n e - e t h y l ) b d r b i t u r i c ac id . From P n c h a r d 
(1980) w i th permiss ion. 
Phénobarbi tal is a much s t ronger acid than o ther ba rb i t u ra tes (pKa = 
7 . 3 ) . Th is g ives r ise to important sh i f ts of the d r u g across membranes d u r -
ing ex t race l lu la r pH changes( Pncha rd 1980, Johannessen 1982). Con t ra r y to 
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the sodium salt, the free acid is not freely soluble in water. Its molecular 
weight is 232.23, 4,31 mg/l being equal to 1 ymol/l. 
PB is readily absorbed (Maynert 1982), but food and preparation factors 
are important. The distr ibution of the drug is somewhat more complicated. 
According to Maynert (1982) penetration into the brain m animals and prob-
ably humans is slow, due to the small oil/water partit ion coefficient of the 
d rug . Reed (1980) however showed, that all drugs with an oil/water partit ion 
coefficient greater than 0.04 (for phénobarbital it amounts 0.49) are complete-
ly cleared during a single passage through the brain. Protein binding would 
then be the limiting factor. The protein binding of phénobarbital is not high 
(63 % in rats, according to Leppik and Sherwin 1979). It is therefore sup-
posed, that slow penetration of several membranes (for instance the laminated 
myelin sheaths) in the brain precludes phénobarbital from exerting a fast 
effect. We know from studies in the cat (1961) that PB f i rs t accumulates m 
grey matter and after some hours becomes evenly distr ibuted in the brain. 
Leppik and Sherwin (1977 and 1979) however found, that 30 minutes after the 
start of iv. infusion of PB m the rat the median effective brain concentration 
amounted 8.2 ymol/kg (for MES-test), whereas two hours after subcutaneous 
administration the median effective brain concentration was even higher 
(12.2цтоІ/кд), so this gives no support to the often advanced opinion, that 
slow penetration of phénobarbital would be the cause for delayed effects of 
the d rug . The half-l ife of PB is long, ranging from 96 hours m humans 
(Maynert 1982b) to several hours m rats (own observations). 
The metabolism of PB is generally directed to detoxification, without 
active metabolites being formed (Porter and Penry 1980, Maynert 1982). The 
major metabolite is para-hydroxy-phenobarbital, but N-glucosidation, aliphatic 
hydroxylation and hydrolysis represent alternative routes. 
The antiepileptic action of phénobarbital was found after clinical observa-
tions and used for the f i rs t time by Hauptmann in 1912 (Swinyard 1980 and 
1982). Phénobarbital is active m rodents against MES and scMET seizures to 
a similar degree (Swinyard and Woodhead 1982). The ED-50 for MES 2 hours 
after subcutaneous injection is 5 5 mg/kg (Leppik and Sherwin 1977) or 21 
mg/kg, when the test is performed after 30 mm (Swinyard et al 1952). This 
action takes place below the toxic dose. Against bicucullme and Picrotoxin 
induced seizures it is somewhat less effective, whereas PB is ineffective 
against strychnine induced epilepsy (Swinyard and Woodhead 1982). Phéno-
barbital is more potent in antagonism of seizures than other barbiturates (Prichard 1980 and 1982), but still no neurophysiological model has been 
found, where the same difference between PB and the other barbiturates 
emerged. However Aston and Domino (1961) were able to demonstrate, that m 
motor and reticular electrical afterdischarges, PB raised motor threshold more 
than the reticular one, whereas pentobarbital raised both equally. Phenytoin 
raised only the cortical threshold. This difference may explain the relative 
hypnotic potencies of the three drugs compared to their antiepileptic action. 
Other studies on focal epileptic discharges have also shown that PB is a 
potent drug against afterdischarges m isolated cortex (Vazquez et al 1975) 
and against mtenctal spikes in hippocampal slices, exposed to penicillin (Ol i -
ver et al 1977). In the latter model phenytom was less and diazepam a l i t t le 
more potent. In rabbits with chronic cortical freeze foci (Morrell et al 1959) 
strong evidence was provided, that PB and PHT oppose epileptic discharge by 
different mechanisms: PB inhibited spread from the focus to adjacent cortex 
and diencephalon and additionally suppressed the f i r ing of the focus itself, 
while phenytom was a better inhibitor of cortical spread, but had no effect 
on the focus or on spread to the diencephalon. There has been litt le quant i-
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tative comparison of the effects of various barbiturates on epileptic foci 
(Prichard 1982). Important was also the f ind ing, that under certain circum-
stances PB may have a stimulating effect on a cortical focus. Several times 
the drug has been reported to lower the afterdischarge threshold (Prichard 
1980). Gangloff and Monmer found a decrease of it m the rabbit (1957). In 
man (Fuster 1953) and animal (Klemm and Mallo 1966) epileptic discharges 
tend to become more prominent during barbiturate induced slow waves. 
Another example of the potency of PB to act by reinforcement of mechanisms 
already present m normal circumstances, is found m hippocampus, where PB 
can induce spiking of pyramidal cells (Bradley and Nicholson 1961). In kin-
dling phénobarbital retards the epileptogenesis more effectively than the other 
antiepileptic drugs (Albertson et al 1978, Wada 1977, Wauquier and Ashton 
1979 and Wise and Chinerman 1974). In the monkey the effective plasma con-
centrations are 20-40 mg/l (Lockard et al 1975), m man 10-40 mg/l (Booker 
1982). However some individuals are well controlled at plasmalevels below 10 
mg/ l . No sophisticated studies are known, delineating clearly the type of epi-
lepsies, for which PB is most useful. It is not given against petit mal 
epilepsy despite the fact, that - a possibly transient - activity against it has 
been reported (Schmidt and Wilder 1968). Generally the combination 
phenobarbital/phenytom is used, because it is thought to have a potentiating 
effect. Leppik and Sherwm (1977) however proved, that m rats the effect of 
both drugs rugs was merely additive. Retrospectively Volanschki et al (1975) 
were unable to f ind such an additivo effect m man; they concluded, that sei-
zure control was related to a plasma level of either phénobarbital or phenytom 
within the therapeutic range, but not for both drugs together. 
Side-effects of PB have precluded its widespread application in humans 
during the last years. It is able to induce paroxysmal hyperactivity in chi l-
dren and may lead to cognitive impairment. For a review the reader is 
referred to Kuhg et al (1980) and Mattson and Cramer (1982). Even without 
taking into account questions, which can be resolved only at the human level, 
the problem of interference with cerebral functioning in animals is a diff icult 
matter, especially concerning the issue of development of tolerance during 
chrome administration. Of all other side effects, noted for PB, we only men-
tion the induction of metabolism (Kutt and Pans-Kutt 1982) and lowering of 
folate levels (Houben 1971 and Reynolds 1975) after chronic administration. 
See also Smith (1979). 
The mechanism of action of PB still is a well studied secret. The inter-
ested reader is referred to the following monographs Glaser et al (1980), 
chapters 28-35, and Prichard (1982) Important issues are the distinction 
between phénobarbital and other barbiturates, which is clearly present in epi-
lepsy models, but stil l not found m neurophysiological ones (see above). Fur-
ther differences between PB , other barbiturates and PHT m these experi-
mental situations could provide clues for its anti-epileptic actions. One of the 
most important effects of phenytom, the post tetanic potentiation is absent 
with PB. Some of the actions of PB, concerning the action on the EFG and 
the reticular formation are brief ly touched above. Finally local kinetics 
depending on pH-changes across cellular membranes must be taken into 
account m order to explain the effects of PB. 
In conclusion, phénobarbital is a very interesting anticonvulsant, having 
not only inhibi tory, but a subtle combination of inhibitory and excitatory 
effects, which renders it a more anticonvulsant than hypnotic d rug , but also 
may lead to substantial unwanted side effects m individuals more susceptible 
for the excitatory component. Again, for PB relative effects on the seizure 
complex m partial epilepsy have better been studied than for VPA. Based on 
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the reported data we expect, that PB - m our model - will have an 
antiepileptic profi le intermediate between that of VPA and PHT. 
6.1.4 CARBAMAZEPINE 
Carbamazepme (CBZ) is an immostilbene having a carbamyl side chain at the 
5-position (Kutt and Pans-Kutt 1982b). It differs from Imipramine only by 
having a double bond between the positions 10 and 11 and by having a short­
er side chain. In comparison with the succimmide, hydantom, barbiturate and 
benzodiazepine anticonvulsants, CBZ lacks a saturated C-atom and the amide 
group is in the side chain rather than in the r i n g . The structure of CBZ and 
some related compounds is shown in Figure 30. 
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Figure 30: Molecular structure and major biotransformation pathway of carba­
mazepme. From Suria and Killam 1980 (with permission). 
Its anticonvulsant properties, tested in animals, were f i rs t reported by 
Theobald and Kunz (1963). The drug was developed m the laboratories of 
J.R. Geigy AG (Basel, Switzerland) m the late 1950's Carbamazepme ( M = 
326.26, 3.96 mg/l = 1 vmol/l) is a neutral lipophilic substance, virtual ly inso­
luble in water. 
In several species (rats, dogs, monkeys and man) it is slowly and errat­
ically absorbed (Morselli and Bossi 1982), the vehicle being very important. 
Addition of propyleneglycol accelerates absorption. When m rats an oral dose 
is given, peak levels are attained after 8 hours, after ip. injection within 
0.5-1 hour. Plasmabinding of CBZ in experimental animals sti l l is a matter of 
guess, but according to Morselli and Bossi (1982) for rodents and monkeys 70 
- 75 % is an adequate estimation The half life of CBZ is time-dependent, 
due to auto-induction of metabolism (Faigle and Feldmann 1982). In rats, 
dogs, rabbits and rhesus monkeys the mean half-lives after single CBZ doses 
are all m the range of 1.2-1.9 hours (Faigle and Feldmann 1982, referring to 
unpublished data from Schmutz et a l) . Male rats metabolize CBZ 50 % more 
rapidly than females , an effect which is not present in humans, where the 
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not induced half-l ife amounts to 36 hours (range: 18-55). Induction causes 
the half-life to decrease by one t h i r d after 2-3 weeks and by one half dur ing 
long-term mono-therapy (Faigle and Feldmann 1982). In mice, rats, and mon­
keys CBZ rapidly and quite uniformly distributes to the various organs and 
tissues, with higher concentrations m l iver, kidney and brain (Morselli et al 
1971, Westenberg et al 1977). In rats the distr ibution of CBZ may be also 
influenced by the vehicle (Morselli et al 1971). After repeated administration a 
similar distr ibution pattern is found as after single doses. The distr ibution of 
CBZ in the brain is very similar to that of other lipophilic drugs: at shorter 
times higher concentrations are found m cortex, thalamus and hippocampus, 
and that later on subcortical structures have the highest relative concentra­
tions (Morselli et al 1973, Pantarotto et al 1979). 
The metabolism of CBZ (see Faigle and Feldmann 1982) involves A major 
pathways m humans. In order of significance they are: epoxidation of the 
10-11 double bond, hydroxylation of the six-membered aromatic r ings, 
N-glucuromdation at the carbamoyl side chain and substitution of the six 
membered rings with sulphur-containing groups. The epoxide derivative is 
pharmacologically active (see below). The rate of metabolism is such, that in 
rats after single oral doses epoxy-CBZ levels reach their peak values one 
hour after the peak level of the parent compound, whereas m man it accounts 
for 5-15 % of the amount of parent drug m the plasma. The epoxy-metabohte 
freely passes the brain in humans, but in rats possibly an impaired penetra­
tion into the brain is present (Morselli et al 1971). 
The antiepileptic action of CBZ shows a somewhat broader spectrum than 
that of РТЫ. In this paragraph only plasma concentrations will be mentioned, 
due to the fact, that suspensions of unequal strength are used , so compari­
son of the dosages is not very reliable. Swinyard and Woodhead (1982) report 
that CBZ is effective in MES-test. According to Morselli et al (1971) the 
effective bram concentration for this test in rats lies between 3.5 and 4.0 
mg/l, bram/plasma-ratio's varying from 1.1 to 1.6. No effect on subcutaneous 
bicucullme and Picrotoxin induced minimal seizures is found, while the sc. 
metrazol test is only influenced after oral doses. In amygdaloid kindling in 
the rat (Ashton and Wauquier 1979b), cats and baboons (Vvada et al 1976), 
and hippocampal afterdischarge m the cat( Schmutz et al 1981) CBZ is very 
effective. Focal epileptiform discharges in cats may be abolished by the 
d r u g , penicillin induced spikes more easily than estrogen induced ones (Julien 
and Halpern 1972). Electrically induced cortical seizures are also suppressed (Dolce 1969, Holm et al 1970). In the monkey model (Lockard et al 1979a) the 
drugs short half life and insolubility prevented accurate drug testing m the 
effective range (4-10 mg/l). In man, generalized tomc-clomc convulsions and 
partial complex epilepsy are reported to be particularly sensitive to the d r u g , 
but studies delineating the superiority of CBZ above other drugs are still 
lacking (Gram et al 1982). 
Side-effects of this drug have commonly been seen. For a review see 
Cereghino (1982). In patients drowsiness, loss of appetite, dizziness, ataxia, 
loss of accomodation have been reported by volunteers. The incidence and 
intensity of these side-effects increased with dose, but did not correlate with 
plasmaconcentrations (Levy et al 1975). Memardi (1972) was able to f ind 
nystagmus at a plasma concentration as low as 1.5 mg/l. Dose dependent anti­
diuretic properties are also reported (Perucca et al 1978, and others). Chron­
ic treatment with CBZ tends to lower plasma folate, but not brain folate levels (Smith and Carl 1982). 
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Even less is known about t h e mode of act ion of carbamazepme than f o r 
t he o the r an t iep i lep t i c d r u g s Its l imi ted so lub i l i t y makes a lot of exper iments 
d i f f i c u l t t o p e r f o r m . The repo r ted act ions of ten occu r red at concent ra t ions f a r 
above t h e the rapeu t i c one ( l i ke the post te tan ic po ten t i a t i on ) . For a rev iew 
see Ju l ien (1982) . For example, antagonism of synap t i c t ransmiss ion of t r i g e -
minal impulses was not co r re la ted w i th serum concent ra t ions 
In conclus ion carbamazepme seems to be a po ten t d r u g , hav ing a hpo-
p h i l i t y comparable to t ha t of PUT, but c o n t r a r y to PHT it is able to suppress 
focal d i scha rges . The data are not as abundant as is t he case f o r phénobar -
bi tal and p h e n y t o m . 
6 .1 .5 CLONAZEPAM 
Clonazepam is a ch lo r ina ted d e r i v a t i v e of n i t razepam 
(5 ( 2 - c h l o r o p h e n o l ) - l , 3 - d i h y d r o - 7 - m t r o - 2 H - 1 , 4 - b e n z o d i a z e p i n e - 2 - o n e ) . Ben -
zodiazepines were syn thes ized f rom 1933 (Dziewonsk i and S te rnbach , see 
Sternbach 1973). S w m y a r d and Castelhon (1966) evaluated the use of c lona-
zepam f o r t he f i r s t t ime m exper imenta l ep i lepsy , and f rom 1970 the f i r s t 
c l in ical s tud ies appeared . Benzodiazepines are a class of he terocyc l ic s i x -
membered - rmg compounds t rans fo rmed in to seven-membered novel 
h e t e r o - r m g compounds (see F igu re 31) Subs t i t uen ts m the seven posi t ion of 
r i n g A w i t h e l e c t r o n - w i t h d r a w i n g p roper t ies of heavier halogens, increase 
t h e i r an t iep i lep t i c a c t i v i t y aga ins t scMET-seizures ( S w m y a r d and Castelhon 
1966). The same has been f ound f o r the add i t ion of f l u o r i n e , ch lo r ine or two 
halogens at t h e o r t h o pos i t ion of r i n g C. T h e r e f o r e the o r d e r of potency in 
the scMET- tes t increases f rom diazepam t h r o u g h ni t razepam to clonazepam 
Basic Stnctiin 
OliMjin llltrazipi· Cloiiiipm 
F igure 3 1 : Benzodiarepme basic s t r u c t u r e w i t h modi f icat ions impor tant to 
an t i convu lsan t a c t i v i t y . From Kil lam and Sur ia 1980 (w i th permis -
s ion) . 
Clonazepam (CP) has a molecular we igh t of 315.7 (3.17 mg / l = 1 pmol / l ) 
and is v i r t u a l l y undissoc iated in the phys io log ica l pH range (D re i f uss and 
Sato 1982). Because the rapeu t i c p lasmaconcentrat ions are about 1000 χ lower 
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than of other anticonvulsants, its determination m body fluids involves com-
plicated procedures ( Knop et al 1975, Dreifuss and Sato 1982). Clonazepam is 
only soluble with the help of organic solvents. 
Absorption of CP depends on the solvent used (in propyleneglycol com-
plete absorption is found) or on micromzation (Dreifuss and Sato 1982). Plas-
ma protein binding is 47 % (van der Kleijn 1968, Browne and Penry 1973). In 
sheep (Parry 1977) free equilibration between serum and CSF is found and a 
large volume of distr ibution due to tissue binding. Detailed studies of the t is -
sue distribution of benzodiazepines (Garattini et al 1973 m rats. Morselli et al 
1973) revealed a similar pattern as for other lipophilic drugs like CBZ (see 
above), PTH and barbiturates. However desmethyldiazepam seems to accumu-
late preferentially m the cerebellofugal f iber tracts and other white matter 
(van der Kleijn et al , 1968). In man, half-lives for CP range from 26.5-49 2 
hours, with no indication of enzyme induction (Dreifuss and Sato 1982). The 
metabolism of clonazepam is rather intensive, with the 7-ammo-metabolite 
being the most important one in man. The mtro-metabolites are pharmacologi-
cally active, but only form a very small part of the plasma levels during 
chronic administration (Knop et al 1977). Randall and Kappell (1973) have 
reviewed the species differences, which will not be discussed m detail here, 
because m acute administration the immediate effect seems only to depend on 
the presence of the parent compound (cf Polsm and Barnes 1976). 
The antiepileptic action of clonazepam has been widely recognized and 
investigated. Only those papers, bearing a relation to our experimental 
work, will be reviewed. In rats CP is much more active against scMET sei 
zures than m the MES-test (Swmyard and Castelhon 1966, Swmyard and 
Woodhead 1982), the protective indices varying from over 1000 to under 1. In 
mice this difference is much less pronounced. Compared to clonazepam, the 
other benzodiazepines are relatively less active against the scMET-seizures (Swmyard and Castelhon 1966). CP is also very active against Picrotoxin, 
bicucullme (Swmyard and Woodhead 1982) and allylglycme (Ashton and Wau-
quier 1979b) induced seizures, but not against strychnine epilepsy (Swmyard 
and Woodhead 1982) m rats. The influence of clonazepam on focal discharges 
seems somewhat complex. In rats and cats a blockade of spread of afterdis-
charge, but not focal spiking was reported after local penicillin application (Edmonds et al 1974, Sharen and Kutt 1971, Stark et al 1974). Estrogen foci 
m cats are inhibited (Julien et al 1975). In cats too. Rossi et al (1973) 
reported that single iv. injections of CP suppressed strychnine or penicillin 
induced focal discharges and found that motor manifestations disappeared 
while local spiking continued. In relation with these findings Killam (1968) 
showed, that CP may crucially alter the balance of inhibitory and facihtatory 
influences, descending from the brainstem Rossi et al (1973) also found, that 
potentials dur ing seizure spread were blocked Tsuchiya et al (1976) reported 
suppression of generalized EEG abnormalities with persistence of local spiking 
too. Poire and Roger (1969) reported in a comparative study, that clonazep-
am, m considerably lower closes than required for diazepam and nitrazepam, 
had similar actions on spread, rather than on the focus of seizure act iv i ty. 
Benzodiazepines are effective m amygdaloid kindling by delay of of develop-
ment of generalized seizures (Kamei et al 1975), or blocking the spread of 
bilateral seizures without altering local afterdischarge threshold, (Wise and 
Chmerman 1974). In dogs amygdaloid kindled seizures are effectively blocked (Wauquier and Ashton 1979). In rats CP is effective m kindling at doses pro-
ducing ataxia (Ashton and Wauquier 1979a). In cats afterdischarges, produced 
after electrical stimulation of the brain cortex, are only to a small extent sup-
pressed by CP (Yajima et al 1976) In rhesus monkeys with aluminium oxide 
foci Lockard et al (1979b) found CP effective in reduction of seizures at plas-
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ma concentrations of 60-100 vg/\. In monkeys CP is very effective m 
photically induced epilepsy m the Papio Papio baboon (Meldrum et al 1975) In 
man no clear relation of seizure control and plasma concentrations have been 
found, but 20-50 pg/l is considered to be the therapeutic range (Dreifuss and 
Sato 1982). Clonazepam is found to be particularly effective m petit mal epi-
lepsy and its superiority against diazepam (Chandra 1973) and ethosuximide 
(Dreifuss et al 1975) but not against valproate (Gram et al 1982) has been 
established. Side-effects (see below) however often force discontinuation of 
this d rug . In status epilepticus the drug is a f i rs t choice (Drugs and Thera-
peutics Bulletin 1976). The effectiveness of the drug m epilepsia partialis 
continua (Huang et al 1974, Scollo-Lavizzari 1975) is achieved despite persis-
tence of the electroencephalographic focus. The influence of CP in human 
studies on focal discharges varies from a decrease (Fanello and Mutam 1970, 
Häkkinen 1973, Ahmad et al 1977 and Imuma et al 1978) and no change 
(Oller-Daurella 1969) to an increase (Hooshmand 1972). 
Side-effects of CP are numerous (Dreifuss and Sato 1982) and probably 
are associated with the great potency of the d rug . They include motor incoor-
dination, nystagmus, psychotic reactions, i r r i tabi l i ty and other personality 
changes, and especially m children and infants hypersecretion and hypersali-
vation. The development of side effects seems to be related to the rate of 
dosage increase (Elian et al 1973). Furthermore different varieties of sei-
zures may emerge and the danger of development of tolerance is present (Dreifuss and Sato 1982) In the EEG (Killam and Suria 1980) CP increases 
fast beta-activities as well as sometimes slow frequencies below 5 Hz. Evoked 
responses are depressed. 
The mechanism of action of clonazepam and related benzodiazepines is not 
completely known, but seems to be related to an indirect GABAergic mecha-
nism (Study and Barker 1981). In the years before, specific benzodiazepine 
receptors (Moehler and Okada 1977 and 1978, Braestrup et al 1977, Braestrup 
and Squires 1977) were intensively studied Apart from GABA-ergic interfer-
ence of a complex nature effects on other neurotransmitters have been 
described. However the role of neurotransmitters in epilepsy remains spécula-
t ive (Maynert 1975) and the experimental models of epilepsy thought to repre-
sent anti-GABA mechanisms (picrotoxme, bicucullme and allylglycme sei-
zures), probably all include non GABAergic properties due to the generalized 
nature of the epilepsy, and because the antiepileptic drugs are not 
segregated by them conform the expectations (see also Ashton 1982). Thus 
far no satisfactory integrated view of how the anti-anxiety property may be 
separated from the anticonvulsant or sedative act iv i ty, has emerged (Killam 
and Suria 1980) 
Conclusively, CP is a very potent anticonvulsant with corresponding 
side-effects. Its influence on focal discharges is somewhat equivocal, but 
pronounced effects are found. The spread of isolated discharges and focal 
seizures, and m some cases focal spike frequency,are depressed Focal sei-
zure threshold itself does not seem to be altered by the drug Therefore we 
can expect the drug to inhibit spread and isolated discharges primarily with a 
change of the Jl-mode. 
6.1.6 ETHOSUXIMIDE 
Ethosuximide (ESM) is a succimmide (2-ethyl-2-methylsuccinimide), of which 
the antiepileptic action was reported for the f i rs t time by Vossen (1958) and 
Zimmerman and Burgmeister (1958). Its molecular weight is 141.17 (7 08 mg/l 
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= 1 μη-ι/Ι). The drug is highly soluble m water (Glazko 1982b). The structure 
of ESM and related succmimides is shown in Figure 32. 
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Figure 32: Molecular structure of ethosux imide and related compounds. From 
Ferrendelli and Kupferberg 1980 (with permission). 
According to Vida and Gerry (1977), some features of the molecular 
structure of succmimides determine, whether or not and to what extent anti­
convulsant activity will be shown by the compounds (succimmide itself is 
devoid of any anticonvulsant act iv i ty) . At least two substitutions at the 2 
position or one substitution to the N as well as the 2 position are required. 
Small dialkyl substitution in the 2 position imparts only anti scMFT-activity (ethosuximide). Best results against both MFS as well as scMET are obtained 
with a small alkyl group to the N and when a phenyl is the 2 substituent. 
Introduction of alkyl into the 3 position of a 2-phenyl succimmide increases 
the anticonvulsant act iv i ty. Finally, as with the hydantoms, diphenyl substi­
tution m the 2 position greatly reduces anti-scMET act iv i ty. 
The absorption of ESM is almost complete (Glatzko and Chang 1982). 
Protein binding in rats and dogs is negligible (Glatzko and Chang 1982). Dis­
tr ibut ion in rats is almost homogeneous except for lower concentrations m fat 
tissue (Chang et al 1972). Plasma half lives vary from 12 hrs. m the rat to 
60 hrs. in man (Glatzko and Chang 1982). In dogs El Sayed (1978) was able 
to demonstrate rapid equilibration of CSF and plasma levels within 20-30 mm. 
The metabolism of ESM involves hydroxylation and glucuromdation at several 
sites of the molecule (Chang and Glatzko 1982). 
The antiepileptic action of the drug has been known since 1958 (see 
above). The spectrum of ESM is the counterpart of that of phenytom. ESM is 
v ir tual ly without effect m the MES-test, while it is very active against scMET 
seizures (Swinyard and Woodhead 1982). In rats the ED-50 (orally) is 54 
mg/kg (protective index of 18.76). The drug is not active against allylglycine (Ashton and Wauquier 1979b) and bicucullme induced seizures, but has mod­
erate activity against Picrotoxin induced minimal seizures (Swinyard and 
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Woodhead 1982). This pattern of selective inhibition of seizures is found 
throughout all tests and species, but no explanation can be given until now 
(see below). ESM is found to be effective against focal epilepsy in certain 
circumstances such as after local cobalt (Dow et al 1973, Kastner et al 1970 
and Scuvee-Moreau et al 1977) and bilateral local conjugated estrogen applica-
tion (Julien et al 1975). In monkeys, however, (Lockard et al 1977) focal 
aluminium-hydroxide induced seizures were exacerbated. The drug also sup-
presses generalized penicillin epilepsy (Guberman et al 1975). In man the 
drug is excellent in petit-mal epilepsy (Browne et al 1975, Penry et al 1972), 
m the plasmaconcentration range of 40-100 mg/ l . Some patients however are 
resistant. According to Sato et al (1975) the two most important factors fav-
ouring a good result of ESM are the presence of normal EEG background 
activi ty and a normal IQ. 
Side-effects of ESM have been observed. They consist mainly of nausea 
and drowsiness (Dreifuss 1982). ESM has also been reported to exacerbate 
various types of seizures. However these reports are incidental and generally 
m some 25 % of patients with absences other seizure types emerge spontane-
ously dur ing aging (Dreifuss 1982). The same can be said of the reported 
episodes of psychosis, which seem to be reciprocially related to seizure con-
t ro l . For these and other mental side-effects control groups should be provid-
ed, as the EEG spike-and-wave activity itself may interfere with cognition 
(Trimble and Reynolds 1976). No drug interactions of ESM with other anticon-
vulsants have been reported (Dreifuss 1982). 
The mechanism of action is unknown. Some things however are clear. 
Due to its water solubility and according to some experiments (Ferrendelli and 
Klunk 1982) a direct membrane stabilizing effect through interference with 
ionic mechanisms seems unlikely. On the other hand unequivocal effects of 
ESM on neurotransmitter systems are not known. Some neurophysiological 
aspects may contribute to the understanding of the specific action of ESM. 
Thalamocortical excitabil ity is decreased by the drug from interstimulus inter-
vals start ing at 0.175 and ful ly developed at 0 300 sec. (Englander et al 
1977). The drug resembles VPA in this respect (Nowack et al 1979), but dif-
fers from phenytom, which decreases the excitability in a constant fashion 
and diazepam, exhibit ing a preponderance for short intervals. Fromm and 
Kohh (1972) were able to show preferential depression of corticofugal inhib-
ition of afferent activity m the spinal trigeminal nucleus, while PHT and CBZ 
had the opposite effect. 
In conclusion ESM can be expected to have an influence on partial motor 
epilepsy, preferentially through suppression of medium or long interval jerks. 
6.2 METHOD OF TESTING 
Basically, the method described m chapters 2 and 3 was used for evaluating 
the epilepsy*. For each anticonvulsant 3-5 doses were tested after folate 
injection, each group consisting of 14-16 animals, and 2-4 doses after penicil-
lin injection. It was chosen to administer the drugs 10 mm. before the injec-
tion of the epileptogenic agent. The development of epilepsy takes another 
5-20 mm. A subcutaneous drug route was chosen m order to simulate as 
closely as possible a steady state drug level m plasma during the two hours 
* The team mentioned m chapter 3 (M.L.F. Schoofs, T . J .A .M . van der Vel-
den and the author) , also performed this series of experiments. 
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duration of the tests In the case of carbamazepme, which is dif f icult to dis-
solve and is very slowly absorbed, the drug was given 2 hours prior to the 
injection of folic acid or penicillin instead of 10 mm. In the case of valproate 
we also composed a group receiving 450 mg/kg. 3 hours in advance instead of 
10 mm. because it might have a sustained or delayed effect on epilepsy. 
For all drugs the final experiments were preceded by pilot studies (12 
animals for each drug divided over 4 groups), m which the course of the 
resulting plasma concentration after the subcutaneous injection of the drugs 
was studied. The blood samples were obtained through orbital or heart punc-
ture under ether anesthesia. For each drug three groups received different 
doses, followed by injection of folic acid, and one group only the d rug . This 
was done in order to f ind major interactions between this substance and the 
anticonvulsants**. For valproate the GLC-method was chosen init ial ly, later 
the EMIT®-method was used. For the other drugs the EMIT®-method was 
applied too, but for clonazepam HPLC-determmations (Knop et al 1975) were 
carried out*** . For VPA, PB and PHT the folic acid and 
5-methyltetrahydrofolate concentrations were also monitored (by HPLC-method, 
see Lankelma 1978)****. As no major interactions between acute administration 
of penicillin and the six anticonvulsants are known to us, no drug determina-
tions of penicillin were scheduled. 
After this pilot experiment an initial experiment was started with two or 
three different doses of each d rug . These amounts were chosen according to 
the literature data and the plasma drug levels from our pilot experiments, and 
were such that in the highest dose a small toxicity could be expected. When-
ever the lower dose showed significant effects, a smaller amount was tr ied out 
m a subsequent experiment, decreasing each time with a factor between 1.5 
and 3, until the required dose area was covered. Occasionally a higher dose 
was chosen, when no major toxicity was Found at the f i rs t level. The time 
course of the doses can be read from the date, mentioned in the tables. The 
doses for penicillin induced epilepsy were chosen, when the folate results 
were almost completed. 
All drugs were from the Department of Clinical Pharmacy, delivered m 
their pure form, except clonazepam, for which the 1 mg ampul available for 
iv. injection was used (Roche®). Carbamazepme was kindly supplied by Ciba-
Geigy®. Folate was bought from Sigma®. Penicillin G was from Gist-Brocades®. 
The solutions of the epileptogenic substances were made freshly every week 
according to the protocol m section 2.2 and 2.5.5 and stored at O'C For the 
other drugs solutions m aqua dest. were made every week, m the case of 
phenytom NaoH was added to dissolve the substanco (pH = 11). Clonazepam 
was available as Rivotril® m ampuls containing 1 ml propyleneglycol and 
diluted with aqua dest until the desired drug concentration was reached. Car-
bamazepme was suspended daily m propyleneglycol during an ultrasonic pro-
cedure. 
* * The drug determinations were done m close collaboration with E.F.S. 
Termond, T.J M. Campschreur and A .F .A . Schobben from the Laboratory 
of Clinical Pharmacy (head: E. van der Klei jn). 
* * * by H. Knop (Department of Clinical Pharmacy, University of Maastricht). 
* * * * at the Laboratory of Neurology (Head: J . C . N . Kok) by M.J.T. Jansen. 
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Each animal received a volume of 1,0 ml. except 1.5 ml for the highest 
carbamazepme dose. 
Adequate controls were added. Physiological salme was injected in most 
control animals and additional NaOH was given (pH = 11) m the f i rst Pheny-
toin controlgroup. In the carbamazepme and clonazepam experiments groups 
injected with varying amounts of propyleneglycol 400 served as a reference 
In order to be able to f ind the appropriate control group for each experimen-
tal one the date of the test should be sought, which is mentioned in the 
tables. 
Each experimental cycle consisted of 4-7 drug dosages and one or more 
control groups. Each half day day six animals were tested, divided m two 
units of three animals, except at the end of the experiments. Randomization 
was done by assigning by lot one dosage or control injection to each unit of 
three animals. To complete each group, supplementary individually random-
ized animals in groups of six were provided in order to arr ive at 15 animals 
pro group. The drug injections were given without a pr ion knowledge of the 
observers However some drugs (like VPA - wet dog shakes - and clonazep-
am) could be recognized by the nature of their side effects. Thus complete 
bl ind or random experiments could not be performed. Nevertheless, the pro-
cedure described here seemed to guarantee enough protection against obser-
vation bias. This latter problem was also partially circumvented by the fact, 
that the observers did not have any specific knowledge, about what could be 
expected to be the influence of each drug, except that they were anticonvul-
sants 
After the experiments the animals were killed through ether narcosis and 
brain sections performed, as described in section 2 6 Only those animals 
that met the criteria mentioned in section 2.8 (Table 14) were included. 
For all anticonvulsants the results are displayed m the form of three 
tables and one f igure. The f i rs t table shows the suppression of the duration 
of epilepsy and the number of jerks (all categories). The second table repre-
sents the inhibition of type 1 and type 2 seizures, together with spread and 
intensity of jerks and the Jl modes. The number of animals showing side-
effects is also listed m this table. In the th i rd table the drug antagonism 
with regard to type 2 seizures and spread of jerks is shown after adjustment 
for the Jl-mode, according to the findings from section 3 4 In the f igure at 
the end of each drug section the most important drug effects are summarized. 
In its upper part some effects from the second, and for spread and type 2 
seizures the th i r d , table are shown and m the lower block the reduction of 
the total number of jerks. For this end the reductionfactor (see section 2 9) 
was used, representing the total number of jerks for the drug group, divided 
by the total number of jerks for the control group The scale for this reduc-
tionfactor is exponential. Under the curve of the reductionfactor the relative 
contribution of the different categories (LOI, MEI and SHI) of jerks is shown 
Finally the effective dose is given (equal to a reductionfactor of 3, or IC33), 
and the TD50, calculated according to a probit analysis (Fisher and Yates 
1974, see Wissenschaftliche Tabelle Geigy 1980). 
One should bear in mind, that m the f i rs t table a reductionfactor m the 
order of 3 was required to obtain reliable positive results When the number 
of animals, included in the test, decreases below 15, larger reductions are 
necessary. For the second and th i rd table a reduction of 5 animals m each 
group was generally needed to obtain statistical significance. 
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6.3 RESULTS 
6.3.1 VALPROATE 
In Figure 33 the plasma concentration curves are shown after varying doses 
sc. 
plasmacnncenlratiun 
>00 1 VPA ("WD 
Figure 33: Plasma concentration curves of valproate.. = 4Ь0 mg/ 
kg, = 250 mg/kg, = 50 mg,'kg. All doses given sc. fol­
lowed by an injection of folic acid (90 mg/kg) 10 mm. later. The 
uninterrupted line is the curve of 250 mg/l without folic acid 
injection. Mean and SEM of three animals are given. Peak levels 
were not linear with dose, due to a longer absorption period and 
possibly by a saturable protein binding of VPA. 
Despite the fact, that folic acid tends to elevate the valproate plasma 
concentrations, no interaction in the reverse direction was found. Folic acid 
and its metabolite b-methyltetrahydrofolate were at the same levels for all 
three doses of VPA (see Figure 34). 
In Table 36 the results, obtained after administration of valproate, are 
given for duration of epilepsy and number of jerks. 
In folate epilepsy the reduction of number of jerks was most prominent 
for the short interval jerks. Remarkably, the deflections were two sided for 
the medium interval jerks, a stimulation being present at low and inhibition at 
high doses. The long interval jerks were also suppressed, but this was only 
a terminal effect. Duration of epilepsy remained constant. In penicillin epi­
lepsy no significant changes were observed. 
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Figure 34: Plasma concentration of S-methyltetrahydrofolate after VPA. Time 
(mm. after iv. folate) is given on the abscis. Mean and SEM are 
given. 
Table 36: Valproate: duration of epilepsy and number of jerks. 
DOSE is given as mg/kg sc. N = number of animals, included for dura­
tion of epilepsy, total number of jerks and long interval number of 
jerks; Nm= number of animals with 10 or more medium interval jerks; Ns 
= number of animals with 10 or more short interval jerks. DURATION (χ 
100 sec.) is duration of epilepsy. TOTAL NUMBER is total number of 
jerks; LONG INTERVAL is number of long interval jerks; MEDIUM 
INTERVAL is number of medium interval jerks; SHORT INTERVAL is 
number of short interval jerks. 4b0-3h is a dose of 450 mg-'kg given 3 
hours m advance instead of 10 mm. Statistical results: (*) for 0.05 < ρ 
< 0.10, * for 0.01 < ρ < 0.05, ** for 0.001 < ρ < 0.01 and *** for ρ < 
0.001, all tests are two-sided (Gehan-test). 
DEAN SEM 
TOTAL NUMBER 
MEAN SEM 
LONG INTERVAL 
МЕЛЯ SEM 
MEDIUM INTERVAL 
МЕАЯ SEM Nm 
SBORT INTERVAL DATE 
MEAN SEM Ns 
FOLATE - EPILEPSY 
contr.l 13 62 3 
contr.3 17 63 4 
contr.4 15 64 4 
90 15 
135 15 
200 15 
300 15 
450 16 
65 7 
61 5 
58 4 
65 4 
66 2 
737 127 
771 175 
751 159 
968 184 
661 153 
341 118 
207 54 
196 * 22 
450-3h 15 64 5 
PENICILLIN - EPILEPSY 
coatr.l 21 
contr.2 IB 
200 
300 
15 
15 
65 
65 
64 
68 
435 
1096 
893 
865 
608 
146 
131 
137 
181 
141 
383 
372 
382 
384 
325 
207 
180 
166 
618 
609 
567 
461 
61 
79 
60 
62 
76 
70 
50 
19 
81 
96 
122 
110 
150 28 15 
129 29 15 
151 46 15 
234 * 36 14 
186 (*) 27 11 
164 39 8 
34 * 6 10 
32 ** 4 12 
253 54 
484 160 
262 84 
489 135 
395 82 
162 43 
40 6 
22 (*) 2 
oov 79 
feb 80 
•pr 80 
•pr 
«pr 
80 
80 
feb 80 
feb 80 
72 (*) 18 11 
196 29 21 
118 22 16 
165 
87 
31 13 
24 13 
591 
358 
385 
355 
141 
197 5 feb 80 
19 maj 80 
10 nav 80 
may 80 
oov 80 
108 
The effect of VPA on the other variables is displayed in Table 37. 
Table 37: Valproate: other variables. 
DOSE is given as mg/kg sc. N = number of animals; 450-3h is a dose 
of 450 mg/kg given 3 hours in advance instead of 10 mm. SEIZURES 
1 or 2 represent the number of animals m which at least one such 
seizure is observed. SPREAD TO FACE stands for the number of ani­
mals with spread of LOI- jerks to the face; AXIAL TURNING represents 
the number of animals with an intensity of epilepsy such that turn ing 
around the axis is observed. Under the heading MODE 4 items are 
included: the number of animals with a (long interval) Jl-mode of 0.8 
sec. or more, the number of animals with a Jl-mode of 1.3 s e c , the 
number of animals with a (medium or short interval) Jl-mode of less 
than 0.8 sec. and the number of animals without any Jl-mode. One 
must bear in mind that some animals have two modes, one m the long 
interval range and one in the medium or short interval area. Statistical 
results: (*) for 0.05 < ρ < 0.10, * for 0.01 < ρ < 0.05, ** for 0.001 
< ρ < 0.01 and *** for ρ < 0.001, all tests are two-sided ( x 2 - t e s t ) . 
SEIZURES 1 SEIZURES 2 SPREAD TO FACE AXIAL TURMIHG NODE (sec.) 
>0.8 1.3 <0.8 
FOLATE - EPILEPSY 
contr.l 15 
contr.3 17 
contr.4 15 
90 15 
135 15 
200 15 
300 15 
450 16 2 *** 0 * *+* 
9 
9 
7 
9 
9 
3 
0 
0 *** *** 
11 
** 
* 
* 
14 
13 
15 
12 
10 
15 
6 (*) 
13 
10 
9 
β 
6 
β 
2 
2 
0 
* 
* 
*** 
12 
10 
10 
10 
β 
4 
4 
3 ** 
0 
2 
0 
(*) (*) 
0 
0 
0 
0 
0 
2 
12 
16 
nov 
feb 
apr 
apr 
apr 
feb 
feb 
пот 
79 
80 
80 
80 
80 
80 
80 
79 
2 (*) 
PENICILLIN -
contr.l 21 
contr.2 18 
200 15 
300 15 
EPILEPSY 
12 
9 
7 
1 * 
15 
6 
6 
4 
17 
14 
6 (*) 
2 *** 
13 
β 
4 
2 
20 
17 
14 
12 
14 10 
10 β 
7 6 
3 (*) 7 
0 
0 
1 
2 
feb 80 
0 may 80 
0 aov 80 
1 may 80 
8 nov 80 
From Table 37 one can clearly see, that inhibition of the dominant 
rhythm of 1.3 sec. together with inhibition of axial turn ing f i rst reached sig­
nificance in folate induced epilepsy at a not toxic dose level of 200 mg/kg. 
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Th is however was not accompanied by a p ropor t i ona te reduc t ion m the number 
of long in te rva l j e r ks (see Table 36 ) . The conclus ion the re fo re must be tha t a 
d isplacement of r hy tm took place. Indeed th is was f o u n d . T h r o u g h a t rans ien t 
increase of animals w i thou t long in terva l mode a s ign i f i can t p ropor t i on of an i -
mals reached a new slower r h y t h m of 0.1 Hz. 
We can say , tha t va lp roa te induced some so r t of d isorganizat ion w i t h i n 
t h e focus , p re fe ren t i a l l y w i th respect to long in te rva l j e r k s . This is p a r t l y 
t he reverse of the process of organizat ion of L O I - s p i k e s , descr ibed in chapter 
4. The ex is tence of a J l -mode > 9 sec. however was seldom seen in con t ro l s . 
The resu l ts of the adjustment f o r the J l -mode are l is ted m Table 38. 
Table 38: Va lp roa te : adjustment f o r t he J l -mode . 
The d i f fe rences were tes ted t h r o u g h a x 2 - p r o c e d u r e . 
VALPROATE SEIZURES 2 SPREAD TO FACE 
DOSE N expec ted observed expec ted observed 
FOLATE-EPILEPSY 
contr.l 
contr.3 
contr.4 
90 
135 
200 
300 
450 
450-3h 
15 
17 
15 
15 
15 
15 
15 
16 
15 
10 
9 
9 
8 
7 
3 
4 
7 * 
6 
9 
8 
9 
8 
6 
3 
1 
0 
2 
PENICILLIN-EPILEPSY 
c o n t r . l 21 
c o n t r . 2 18 
200 
300 
15 
15 
12 
9 
7 
4 
15 
6 
6 
4 
10 
10 
9 
8 
8 
3 
3 
3 
17 
14 
12 
11 
17 
14 
6 
2 
T a k i n g the changes of the J l -mode into account , one can conc lude, t ha t 
t he e f fec t of VPA on spread and t ype 2 seizures m fo late induced epi lepsy 
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was for a great part an apparent one. In folate induced epilepsy a separate 
inhibition of spread could not be demonstrated after correction for the J l -
mode, but it was present in penicillin epilepsy. The spread of LOI-jerks in 
penicillin induced epilepsy thus was more liable to inhibition by valproate. On 
the other hand we showed in Table 37, that VPA suppressed the long inter-
val Jl-mode only after induction of epilepsy by folic acid. Finally we it was 
found, that - in folate epilepsy - valproate after correction for its influence 
on the jerk interval rhytm, significantly inhibited the development of type 2 
seizures, but only at a rather toxic dose. Type 1 seizures were also antagon-
ized by VPA. 
Side-effects of VPA were rather severe and consisted of hypotonia and 
motor incoordination; m the 450 mg/kg group occasionally loss of r ighting 
reflex was present. 
In Figure 35 the findings for VPA are summarized. 
I l l 
FOLATE 
seizure 1 
seizure 2 
spread 
1.3 sec. 
no mode 
(Ζ 
dose 90 
plasma 120 
£ £ 
450 450 - 3 hrs. 
330 < 9 0 
seiz .1 
seiz .2 
spread 
1.3 sec. 
no mode 
_d 
P E N I -
C I L L I N 
Figure 35: Summary of the effects of of valproate. R = reductionfactor (for 
total number of j e r k s ) . Under the curve the relative proportion 
of the three subclasses of jerks is displayed С I I : LOI-
jerks, ЕЕІЗа : MEI-jerks and Y- • Л : SHI-jerks. In the upper part 
of the graph five of the other variables are depicted; only statis­
tical effects are shown (start ing from a two-sided p-value below 
0.05). Under the figurñs the mean plasmaconcentrations are giv-
en for folic acid epilepsy. Finally the ED and TD-50 are shown. 
Doses are mg/kg, subcutaneous route. 
Figure 35 illustrates the moderate effect of valproate on the number of 
jerks m folate induced epilepsy. This antagonism was mainly caused by inter-
ference with the 1.3 sec. JI-mode. 
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6.3.2 PHENYTOIN 
In Figure 36 the plasma concentration curves are shown after varying doses 
sc. 
Ю PlasmacuFK ΟΡΗ 
i 
Ι mg 
л 
Ι Ι 
/ν 
"~~~\ 
Ι 
- ^ 
•Ν. 4 . 
\ \ % 
\ 
i 
Figure 36: Plasma concentration curves of phenytom. = 60 m g ' k g , 
= 40 mg/kg, = 20 m g / k g . The line is the curve 
of 40 mg/kg without folic acid injection. No significant difference 
is present when comparing both Ί0 mg/kg groups. MEAN and SEM 
of three animals are given. Peak levels occured at the same time 
and were almost linear with dose. 
jerks. 
In Table 39 the results are given for duration of epilepsy and number of 
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τ able 
For legen 
PHENYTOIN 
DOSE 
FOLATE -
contr.l 
contr.3 
contr A 
IB 
27 
40 
60 
90 
N 
39: 
d see 
Phenyto 
tex 
DURATION 
MEAN 
EPILEPSY 
15 
17 
15 
15 
15 
15 
15 
16 
PENICILLIN -
concr 1 
contr.2 
60 
90 
21 
18 
15 
15 
62 
63 
64 
62 
62 
64 
62 
64 
EPILEPSY 
65 
65 
81 
68 
SEM 
3 
4 
4 
2 
2 
3 
4 
2 
3 
2 
6 
3 
t to 
T0TA1 
MEAN 
737 
771 
751 
866 
722 
416 
402 
612 
1096 
893 
1438 
834 
η 
duration 
Table 
NUMBER 
* 
SEM 
127 
175 
159 
185 
136 
119 
80 
112 
131 
137 
199 
154 
36. 
LONG 
MEAN 
383 
372 
382 
407 
390 
279 
336 
482 
618 
609 
1115 
687 
of epi 
INTERVAL 
SEN 
61 
79 
60 
54 
57 
* 77 
68 
82 
81 
96 
* 151 
130 
lepsy 
MEDIUM 
MEAN 
150 
129 
151 
181 
155 
135 
61 * 
107 
196 
118 
479 
90 
and number 
INTERVAL 
SEM 
28 
29 
46 
50 
32 
38 
9 
29 
29 
22 
86 
20 
Nm 
15 
15 
15 
15 
14 
10 
13 
13 
21 
16 
14 
12 
of jerks. 
SHORT INTERVAL DATE 
MEAN 
253 
484 
261 
401 
272 
82 
43 
58 
358 
385 
157 
220 
SEN 
54 
160 
84 
131 
78 
28 
6 
» 16 
70 
84 
27 
53 
Ns 
12 nov 
9 feb 
13 apr 
12 apr 
10 apr 
9 nov 
7 nov 
10 feb 
19 м у 
10 nov 
10 may 
9 nov 
79 
80 
80 
80 
80 
79 
79 
80 
80 
80 
80 
80 
In folate epilepsy a transient decrease of the total number of jerks was 
seen, accompanied by a transient reduction of the number of long interval 
jerks. On the contrary the short interval jerks were dose-dependently sup 
pressed. After penicillin epilepsy an unexplampd and transient stimulation of 
the number of long interval jerks was present. 
The effect of PTH on the other variables is depicted m Table Ί 0 . 
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For legend see 
SEIZURES 1 
PUENÏI01H 
DOSE Ν H 
FOLATE - EPILEPSY 
contr . l 15 9 
contr 3 17 5 
contr.4 15 5 
18 15 7 
27 15 7 
40 15 5 
60 15 4 
90 16 3 
PENICILLIN - EPILEPSY 
contr . l 21 12 
contr 2 18 9 
60 15 7 
90 15 2 * 
Table 
text to 
SEIZURES 2 
N 
9 
В 
9 
6 
6 
3 (*) 
6 
3 
15 
6 
5 
0 * 
40 
Та 
Phen 
ble 37. 
yt 
SPREAD TO FACE 
N 
9 
9 
7 
11 
7 
4 
7 
6 
17 
14 
10 
4 ** 
oin other 
AXIAL TURNING 
N 
11 
9 
4 
9 
4 
6 
9 
7 
13 
8 
1 
1 * 
vanabl 
> 0 . β 
Ν 
14 
13 
15 
14 
13 
7 
10 
14 
20 
17 
14 
14 
MOUE 
1.3 
Ν 
10 
9 
8 
1 0 
8 
5 
7 
7 
1 4 
10 
11 
II 
e s . 
( . е е . ) 
< 0 . β 
Ν 
12 
10 
10 
5 
β 
7 
5 * 
2 ** 
10 
β 
2 (*) 
2 * 
НО 
Ν 
0 
2 
0 
0 
2 
5 
2 
2 
0 
0 
1 
1 
SIDE-EF. 
Ν 
0 
0 
0 
0 
0 
1 
0 
3 
0 
0 
0 
4 
DATE 
n o v 79 
feb 80 
арг 80 
•рг 80 
арг 80 
nov 79 
nov 79 
feb 80 
ш у 80 
αον 80 
шау 80 
nov 80 
Contrary to VPA, phenytom did not interfere with the basic long inter­
val rhythm of 1.3 sec. The number of animals with type 2 seizures was only 
significantly changed m penicillin epilepsy. Calculation of the relative effect 
however also revealed such an influence m the highest folate dose (see 
Table 41). Intensity and type 1 seizures also were suppressed by PHT in 
penicillin induced epilepsy. 
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Table 41 : Phenytoin: adjustment for the Jl-mode. 
PHENYTOIN SEIZURES 2 SPREAD TO FACE 
DOSE N expec ted observed e x p e c t e d observed 
FOLATE-EPILEPSY 
contr.l 15 
contr.3 17 
coiitr.4 15 
18 15 
27 15 
40 15 
60 15 
90 16 
10 
9 
9 
10 
8 
5 
7 
9 (*) 
9 
8 
9 
6 
6 
3 
6 
3 
10 
10 
9 
10 
9 
6 
8 
8 
9 
9 
8 
11 
7 
4 
7 
7 
PENICILLIN-EPILEPSY 
contr.l 21 
contr.2 18 
60 15 
90 15 
12 
9 
8 
8 ** 
15 
6 
5 
0 
17 
14 
12 
12 * 
17 
14 
10 
4 
Spread and intensity of jerks only were suppressed after induction of 
epilepsy by penicillin Therefore here too a difference existed between the 
anticonvulsant action of the drug , depending on the way of induction of epi-
lepsy. However in neither case basic rhythms were disturbed as was found in 
VPA treated rats. From Table 41 we can also see that both m folate as in 
penicillin epilepsy the relative type 2 seizure threshold was increased at a 
high dosage. 
Finally, almost negligible side effects were found. 
Summarizing, the central effect of PTH was a reduction of high frequent 
jerks, at an intermediate drug-level. Only very high doses elevated focal sei-
zure threshold, which was more marked after penicillin epilepsy. Spread and 
intensity of jerks were antagonized in penicillin induced epilepsy. 
The findings for PTH are summarized m Figure 37. 
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0.5 
dose 
plasma 
4 
8 . 
16. 
32 
18 
7 
seizure 1 
seizure 2 
spread 
1.3 sec. 
no mode 
FOLATE 
—г
-
27 
12 
I 
40 
20 
60 
28 
90 
43 
1= 
с 
P E N I C I L L I N 
Figure 37: Summary of the effects of phenytom. For legend see text to Fig­
ure 35. No ED or TD-50 was found. 
From Figure 37 it is clear, that phenytom did not cause an overall effec­
tive reduction of the number of jerks. The other observed effects of PTH 
are in agreement with the general opinion put forward by Woodbury (1982c), 
that phenytom exerts its influence predominantly by affecting processes at a 
distance from the primary focus. 
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6.3.3 PHENOBARBITAL 
Under Figure 38 (see end of this section) the mean plasma concentration 
curves after varying doses se. are shown. They remained approximately at 
the same level linear with dosage, throughout the period of two hours. No 
interaction between folic acid and phénobarbital was found. 
In Table 42 the results are given for duration of epilepsy and number of 
jerks. 
Table 42: Phénobarbital: duration of epilepsy and number of jerks. 
For legend see text to Table 36. ! = more than 6 animals excluded (in 
fact 10), results of this group were left out of consideration. 
PHENOBARBITAL DURATION TOTAL NUMBER LONG INTERVAL MEDIUM INTERVAL SHORT INTERVAL DATE 
DOSE N MEAN SEM MEAN SEM MEAN SEM MEAN SEN Nm MEAN SEM N9 
FOLATE -
contr.2 
contr.3 
contr.4 
5.5 
8.5 
12.5 1 
20 
40 
EPILEPSY 
15 
17 
15 
15 
16 
15 
19 
18 
PENICILLIN -
contr.l 
contr.2 
8.5 
12.5 
20 
40 
21 
18 
15 
15 
15 
15 
61 
63 
64 
64 
73 
53 *l 
62 
64 
EPILEPSY 
65 
65 
67 
66 
63 
58 
4 
4 
4 
5 
β 
3 
4 
4 
3 
2 
6 
4 
4 
3 
773 
771 
751 
825 
706 
129 
287 
201 
1096 
893 
1279 
1071 
764 
277 
From Table 42 we can see, that the number of jerks became gradually 
reduced, in folate epilepsy more than in penicillin epilepsy. Duration of epi­
lepsy remained fair ly constant, as was found with VPA and PHT. 
The effect of PB on the other variables is displayed in Table 43. 
169 
175 
159 
190 
135 
1 44 
67 
* 46 
375 
372 
382 
489 
380 
97 *l 
184 
194 
61 
79 
60 
114 
73 
31 
38 
44 
135 33 
129 29 
151 46 
245 (*) 42 
143 28 
48 *l 17 
83 14 
18 2 
15 
15 
15 
12 
15 
7 
12 
5 
367 
484 
262 
278 
283 
? 
301 
16 
121 
160 
84 
67 
60 
? 
50 
3 
11 
13 
dec 
feb 
«pr 
api 
•pc 
feb 
dec 
dec 
79 
80 
80 
80 
80 
80 
79 
79 
131 
137 
267 
164 
148 
65 
618 
609 
822 
786 
652 
227 ** 
81 
96 
175 
120 
136 
58 
196 
118 
172 
223 
93 
38 
(*) 
* 
29 
22 
31 
45 
12 
24 
21 
16 
14 
13 
12 
10 
358 
385 
469 
154 
95 
55 ** 
70 
84 
112 
32 
18 
11 
19 
10 
12 
10 
8 
6 
may 
nov 
may 
may 
may 
nov 
80 
80 
80 
80 
80 
80 
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For legend see 
fact 10), result 
PHENOBAR­
BITAL 
DOSE N 
SEIZURES 1 
N 
FOLATE - EPILEPSY 
contr .2 15 
contr .3 17 
СОПСТ.4 15 
5.5 15 
8.5 15 
12.5 1 15 
20 19 
40 18 
PENICILLIN 
c o n t r . l 21 
contr .2 18 
8.5 15 
12.5 15 
20 15 
40 15 
9 
5 
5 
7 
5 
1 
5 
0 * 
- EPILEPSY 
12 
9 
7 
5 
5 
5 
Table 43 
text to 
s of this 
SEIZURES 2 
N 
9 
8 
9 
6 
5 
1 *l 
2 ** 
0 *** 
15 
6 
7 
6 
3 ** 
0 * 
Phénobarbi tal : oth 
Table 37. ! = More 
g roup were left out 
SPREAD TO PACE 
M 
9 
9 
7 
10 
7 
4 *l 
4 ** 
1 *** 
17 
14 
9 
12 
9 
3 * 
er v a n a b e s . 
than 6 animals excl 
of considerat ion. 
AXIAL TURNIRG 
< 0 . 8 
N 
11 
9 
4 
1 * 
1 * 
3 *l 
3 *** 
0 *** 
13 
в 
3 * 
2 * 
1 ** 
0 * 
N 
15 
13 
15 
12 
12 
10 
10 
7 
20 
17 
14 
15 
14 
13 
** 
— 
H0DE 
1.3 
N 
9 
9 
8 
4 
5 
3 * 
3 * 
4 С 
14 
10 
11 
8 
12 
5 
» е е . ) 
> 0 . 8 
Ν 
6 
10 
10 
5 
10 
β 
8 
) 2 * 
10 
β 
4 
2 (*) 
2 
5 
N0 
Η 
0 
2 
0 
1 
1 
6 
6 
10 
0 
0 
1 
0 
1 
2 
uded (m 
SIDE-EF 
**| (*) 
** 
Ν 
0 
0 
0 
0 
0 
1 
1 
12 
0 
0 
0 
0 
1 
9 
. DATE 
dec 79 
feb 80 
арг 80 
apr 80 
арг 80 
feb 80 
dec 79 
dec 79 
nay 80 
nov 80 
«ay 80 
may 80 
may 80 
nov 80 
From Table 43 one can see, that PB antagonized the 1.3 sec Jl-mode in 
folate epilepsy. In penicillin epilepsy no alteration of Jl-modes was caused, 
but nevertheless type 2 seizures and at the highest level spread were inhibit­
ed. In Tabic 44 the effect of PB after correction for changes in the Jl-mode 
is shown. 
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Table 44: Phénobarbi tal : 
! - More than 6 animals excluded 
were left out of considerat ion. 
PHENOBARBITAL SEIZURES 
DOSE N expected ob 
FOLATE-EPILEPSY 
contr.2 15 9 
contr.3 17 9 
contr.4 15 9 
5.5 15 6 
8.5 16 8 
12.5 15 I 3 
20 19 6 
40 18 5 (*) 
PENICILLIN-EPILEPSY 
contr . l 21 12 
contr.2 18 9 
8.5 15 9 
12.5 15 8 
20 15 9 (*) 
40 15 6 * 
adjustment for the 
(m 
2 
fact 
served 
10 
8 
9 
6 
5 
1 
2 
0 
15 
6 
7 
6 
3 
0 
J l -mode . 
10), resul ts of this group 
SPREAD TO FACE 
expected 
10 
10 
9 
7 
7 
3 
5 
5 
17 
14 
12 
12 
12 
11 * 
observed 
11 
9 
8 
10 
7 
1 
4 
1 
17 
14 
9 
12 
9 
3 
From Table 44 one can see, that PB had an effect on type 2 seizures 
and spread m penicillin induced epilepsy at the highest dosage. In folate 
epilepsy the action of PB could for a great part be explained by the abolition 
of the dominant Jl-mode like m the case of VPA. 
Side-effects of phénobarbital were noted at the highest doses and con-
sisted of coordination problems (ataxia in hmdlimbs). In Figure 38 the 
results of PB are summarized. 
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seizure 1 
seizure 2 
spread 
1.3 sec 
no mode 
FOLATE 
I 
1= 
Figure 38: 
dose 8.5 
Summary of the effects of phénobarbital. 
Figure 35. 
TD-50 
For legend see text to 
From Figure 38 one can see, that phénobarbital suppressed the number 
of jerks to a moderate degree in both forms of epilepsy. Changes in the 1.3 
sec. Jl-mode were only found in epilepsy induced by folate 
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6.3.4 CARBAMAZEPINE 
As was described m section 6.2 carbamazepme was suspended in propylene-
glycol 400, 75 mg/ml, by ultrasonic treatment. Oral administration of CBZ m 
methylcellulose suspension did not yield the plasma concentrations, considered 
to be necessary for our experiments. In folate epilepsy animals were given 
0.5 ml (150 mg/kg), 0.7 ml (210 mg/kg), 1.0 ml (300 mg^kg) or 1.5 ml (450 
mg/kg) of this suspension. Two hours later the epilepsy inducing substance 
was injected. After 4 hours, at the end of the folate experiments blood from 
all animals was sampled and the plasma concentration of CBZ determined. 
Groups were composed on the basis of the plasma concentration ( <4, 4-6, 6-9 
mg/l) and on the basis of toxicity (motor incoordination), which showed a 
high correlation with the plasma concentration. Toxicity did not occur at 
doses below 1.0 ml and plasma concentrations below 4 mg/l. 
For penicillin no blood samples were taken and the groups were composed 
on the basis of observed toxicity. The doses were 1.0 and 1.5 ml sc. 
Due to the application of propyleneglycol we were forced to analyse the 
influence of this solvent f i r s t . In Table 45 the results for propyleneglycol on 
duration of epilepsy and number of jerks are given. 
fable 45: Propyleneg 
For legend see text 
PROPYLENEGLYCOL DUBATIOH 
DOSE N MEAD 
FOLATE - EPILEPSY 
contr .4 15 64 
0.7 15 64 
1.5 15 61 
PENICILLIN - EPILEPSY 
сопсг.2 18 65 
1.0 15 59 
SEM 
4 
2 
4 
2 
4 
to 
ycol : 
Table 
TOTAL NUMBER 
MEAN 
751 
807 
588 
893 
651 
SEM 
159 
143 
97 
137 
180 
durat ion of 
36. DOSE is 
LONG 
MEAN 
362 
384 
371 
609 
341 
INTERVAL 
SEM 
60 
52 
63 
96 
* 95 
epi lepsy and 
ml. 
MEDIUM 
MEAN 
151 
144 
98 
118 
125 
s c . 
INTERVAL 
SEM 
46 
26 
15 
22 
33 
Mm 
15 
11 
14 
16 
12 
numbe 
SHORT 
MEAN 
262 
516 
196 
385 
319 
r of j e r k s . 
INTERVAL 
SEM 
84 
134 
45 
84 
121 
Ns 
13 
10 
11 
10 
11 
DATE 
a p r 8 0 
j u n 8 0 
j u n 8 0 
n o v BO 
n o v 8 0 
An inhibition of the number of long interval jerks m penicillin induced 
epilepsy was the only result, found for propyleneglycol. One should bear in 
mind however, that the power of our test (see section 2.9) is insufficient to 
detect -reliably - reductions m the order of a factor 2-3, found in the folate 
groups. The - negative - effect of this solvent on the other variables is 
depicted in Table 46. 
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τ 
For legend see 
SEIZURES 1 
PROPYLENE-
GLYCOL 
DOSE Ν N 
FOLATE - EPILEPSY 
contr U 15 5 
0.7 15 5 
1.5 15 6 
PENICILLIN - EPILEPSY 
contr.2 18 9 
1.0 15 8 
able 
text 
46 
to 
SEIZURES 2 
N 
9 
9 
9 
6 
7 
Propylen 
Table 37. 
SPREAD TO FACE 
N 
7 
11 
11 
M 
8 
eglycol: other 
AXIAL TURNING 
N 
4 
4 
5 
8 
5 
»° 
N 
15 
13 
14 
17 
11 
variables. 
MODE 
8 1.3 
N 
8 
8 
10 
10 
5 
( s e c . ) 
<o.e 
N 
10 
8 
6 
8 
10 
HO 
N 
0 
2 
0 
0 
1 
SIDE-EF. 
N 
0 
0 
0 
0 
1 
DATE 
jUD 8 0 
j u n 8 0 
J un 8 0 
n o v 8 0 
j u n 8 0 
Propylenegicol did not alter the variables, listed in Table 46. The adjustment 
for the Jl-mode is shown m Table 47. 
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Table 47: Propyleneglycol 
PROPYLENE SEIZURES 
GLYCOL 
DOSE N expec ted 
FOLATE-EPILEPSY 
contr.4 15 9 
0.7 15 9 
1.5 15 10 
PENICILLIN-EPILEPSY 
contr.2 18 9 
1.0 15 6 
: adjustment for the 
2 
observed 
9 
9 
9 
6 
7 
SPREAD TO 
expected 
9 
8 
10 
14 
11 
J l -mode . 
FACE 
observed 
8 
11 
11 
14 
8 
Corresponding with the often recognized minor anticonvulsant effect of 
propyleneglycol on seizures, we found, that propyleneglycol antagonized the 
long interval jerks to a considerable degree in penicillin epilepsy. This was 
only seen after a high dosage. The influence of CBZ on this parameter there-
fore may not be reliable, when found at a high dosage. For the potentiation 
between propyleneglycol and CBZ no correction could be made. 
In Table 48 the results of carbamazepme on duration of epilepsy and 
number of jerks are shown. 
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Table 48: Ca 
For legend see 
given as mg/l, 
rbamazepme. duration of 
text to Table 36. 
4 
s c ) , TOXICITY 
hours afte 
-efers to 
or without toxicity (in folic 
contains also PG. 
from each other) . 
CABSAMAZEPIRE DUHATIOM 
PLASMA N MEAD 
F O U T E - EPILEPSY 
P G . 0 . 7 15 64 
P G . 1 . 5 15 6 1 
< 4 26 65 
4 - 6 19 66 
6 - » 17 69 * * 
TOXICITY 
NO 52 67 
YES 10 6 6 
P E N I C I L L I N - EPILEPSY 
F G . l 0 15 59 
NO 17 52 
YES 14 6 1 
SEM 
2 
4 
3 
2 
1 
2 
1 
4 
4 
2 
0.5 ml. an 
TOTAL NUMBER 
MEAN SEM 
807 143 
5ββ 97 
6 6 1 100 
4 1 2 ( * ) 82 
847 183 
6 2 6 73 
4 0 4 ( * ) 107 
6 5 1 180 
227 58 
2 8 1 68 
г sc. 
epilepsy and number of 
PLASMA is t h e 
injection, PG. = 
the compos it 
acid 
d 0.7 
LONG 
MEAN 
3 8 4 
3 7 1 
4 7 3 
315 
715 
4 6 9 
358 
3 4 1 
192 
2 3 1 
ion of 
induced epil 
ml. so both 
INTEKVAL 
SEM 
52 
6 3 
7 1 
62 
154 
55 
9 8 
* »5 
52 
60 
MEDIUM 
MEAN 
144 
9 8 
135 
99 
259 
140 
50 
125 
38 
53 
jerks. 
plasma concentration, 
- propyleneglyco 
groups 
epsy th 
non 
into 
e non 
(ml. 
animals with 
-toxic 
-toxic groups 
INTEEVAL 
SEM 
26 
15 
19 
22 
57 
ί * ) 1 7 
8 
33 
14 
12 
Nm 
11 
14 
24 
14 
10 
39 
7 
12 
12 
8 
SHORT 
MEAN 
516 
196 
group 
differed 
INTERVAL 
SEM 
134 
4 5 
135 ( * ) 29 
9 6 
7 
127 
? 
3 1 9 
3 1 
4 9 
32 
7 
2 1 
? 
121 
9 
19 
Ns 
10 
11 
18 
5 
3 
18 
1 
11 
5 
5 
DATE 
J un 80 
j u n 8 0 
j u n 80 
j u n 80 
j u n 80 
j u n 80 
j u n 80 
nov 80 
nov 80 
nov 80 
1 
From Table 48 one can see that not all CBZ effects were of an antiepi-
leptic nature. Duration of epilepsy was sl ightly prolonged at high doses. In 
the folate and penicillin groups the short interval jerks were reduced. The 
effect of CBZ on the other variables is shown m Table 49. 
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For legend see 
SEIZURES 1 
CARBAHA-
ZIPINE 
DOSE Ν N 
FOLATE - EPILEPSY 
P G . 0 . 7 15 5 
P G . l 5 15 6 
< 4 26 9 
4-6 19 β 
6-9 17 3 
TOXICITY 
HO 5 2 1 8 
YES 10 2 
PENICILLIN - EPILEPSY 
P C . 1 . 0 15 β 
NO 17 3 ( * ) 
YES 14 2 ( * ) 
Table 49: 
text to Τ 
SEIZURES 2 
N 
9 
9 
» 
2 * * 
1 * * 
11 * 
1 * 
7 
1 * 
1 * 
Carbamazepme: 
able 37 
SPREAD TO FACE 
N 
11 
11 
13 
3 » 
1 * * * 
17 * 
0 * * 
β 
3 (*) 
3 
oth 
AXIAL TURNING 
N 
4 
5 
3 
0 * 
0 * 
3 * 
0 
5 
0 * 
I 
er 
>o 
N 
13 
14 
19 
14 
11 
37 
7 
11 
11 
12 
varia 
.8 
MODE 
1.3 
N 
β 
10 
15 
7 
6 
25 
3 
5 
4 
3 
bles . 
(•ее.) 
< 0 . 8 
R 
8 
6 
β 
3 
0 * 
11 
0 ( * ) 
10 
6 
2 * 
NO 
N 
2 
0 
3 
5 
6 * 
11 
3 
1 
1 
2 
SIDE-EF. 
N 
0 
0 
0 
3 
7 
0 
10 
1 
0 
14 
DATE 
J i m 8 0 
J i m 8 0 
jun 80 
jun 80 
jim 80 
jun 80 
jun 80 
jun 80 
nov 80 
DOV B0 
These results from Table 49 indicate, that m folate and penicillin epilep­
sy spread and type 2 seizures were effectively suppressed. In folate epilepsy 
a moderate influence of CBZ on the Jl-mode was seen, consisting of a reduc­
tion m the number of animals with a mode < 0.8 sec. and an increase of the 
number of animals without any mode at a high dose. In penicillin epilepsy 
only the f i rs t effect was present Spread and intensity were effectively inhib­
ited in both types of epilepsy. In Table 50 the adjustment for the Jl-mode is 
shown. 
From Table 50 one can see, that the expected number of animals with 
type 2 seizures m penicillin epilepsy became too small to be able to test the 
effect of CBZ reliably. This was due to the fact that the number of animals 
with a Jl-mode of 1.3 sec was small in the PG-control group. Since m peni­
cill in induced epilepsy the probabil ity of spread to the face is not so closely 
associated with the Jl-mode as m the folate induced form, (see Figure 18) the 
low number of animals with a 1.3 sec. Jl-mode m the control group did not 
obscure effects of CBZ on the spread of jerks to the face. Therefore we 
conclude, that CBZ suppressed spread m both types of epilepsy - m pemcil-
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Table 50: Carbamazep ne: a 
CAKBAMAZEPINE SEIZURES 2 
PLASMA N expected 
FOLATE-EPILEPSY 
PCO.7 15 
PC.1.5 15 
< 4 26 
4-6 19 
6-9 17 
TOXICITY 
NO 52 
YES 10 
PENICILLIN-
PG.1.0 15 
NO 17 
YES 14 
9 
10 
15 
8 (*) 
7 * 
25 ** 
4 
EPILEPSY 
6 
6 (*) 
5 
djustment for the 
observed 
9 
9 
9 
2 
1 
11 
1 
7 
1 
1 
SPREAD TO 
expected 
8 
10 
15 
8 
7 * 
26 
4 (*) 
11 
13 ** 
10 * 
Jl-mode. 
FACE 
observed 
11 
11 
13 
3 
1 
17 
0 
8 
3 
3 
Im epilepsy already at a not toxic level - , and type 2 seizures, with the 
restriction that no significant results for the latter could be obtained in peni-
cillin induced epilepsy. These effects were similar to those of PHT, although 
the inhibition of spread m folate induced epilepsy was not found there. Fur-
thermore, m CBZ toxic effects were found, in contrast with phenytom. 
In Figure 39 the effects of CBZ are summarized. 
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32 
plasma <4 
FOLATE 
seiz. 1 
selz. 2 
spread 
1.3 sec. 
no mode 
С 
Π 
с 
P E N I C I L L I N 
m 
4-6 no yes no yes 
toxicity toxicity 
Figure 39: Summary of the effects of carbamazepme. In penicillin epilepsy 
the animals were grouped, according to the presence or absence 
of behavioral toxicity (ataxia). For legend see text to Figure 35. 
? = No relative contribution of the three subclasses known. 
From Figure 39 one can see, that CBZ was not very effective in reducing the 
number of jerks. The effects of CBZ are comparable to those of PHT, but in 
folate induced epilepsy a greater number of animals without any Jl-mode was 
seen and a reduction of the number of animals with spread to the face. 
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6.3.5 CLONAZEPAM 
Due to the fact that clonazepam is only soluble m organic solvents, we 
used the commercially available Rivotril® ampuls, containing 1 mg of the drug 
m 1 ml propyleneglycol 400. All animals therefore received a volume of propy-
leneglycol varying from 0.04 to 0.17 ml. The propyleneglycol control groups 
from section 6.3.5 served as controls. 
The plasma concentrations of clonazepam after sc. injections are depicted 
m Figure 40. 
Ptaemaconcwitralion 
ISO CP(mg/l) 
Figure 40: Plasma concentration curves of clonazepam. = 1 08 mg 'kg , 
= 0.36 mg/kg, = 0 12 mg 'kg . All doses given sc. 10 
mm. before injection of folic acid. The uninterrupted line is the 
curve of 0.12 mg/l without folic acid injection. Mean and SEM of 
three animals are given. Peak levels were not linear with dose. 
jerks. 
In Table 51 the results are given for duration of epilepsy and number of 
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Table 51: 
f-or legend see 
Clona 
tex t 
CLONAZEPAM DURATION 
DOSE N MEAD 
FOLATE - EPILEPSY 
PC.0.7 15 M 
0.16 15 75 
0.3Э 15 64 
0.67 15 M 
SEM 
2 
7 
3 
* 3 
PENICILLIN - EPILEPSY 
PC.1.0 15 59 
0.33 15 «9 
0.67 15 51 
4 
( · ) 4 
3 
zepam: 
to 
durat ion 
Table 
TOTAL NUMBER 
MEAN 
807 
652 
268 
23 
651 
149 
172 
* 
*** 
*+ 
** 
SEM 
143 
142 
65 
4 
180 
48 
65 
36. PG 
of epi lepsy and number 
. = propyleneglycol 
LONG INTEKVAL 
MEAN 
384 
424 
176 * 
SEM 
52 
92 
43 
20 *** 4 
341 * 
126 * 
141 * 
95 
4Э 
53 
MEDIUM 
ЖАН 
144 
106 
49 
Τ 
125 
26 * 
61 
INTEBTAL 
SEM 
26 
17 
9 
Τ 
33 
7 
16 
Nm 
11 
11 
9 
1 
12 
4 
4 
(ml. 
SBORT 
MEAD 
516 
374 
158 
-
319 
48 
56 
of J 
sc. 
erk 
) . 
IHTE1VAL 
SEM 
134 
80 
17 
-
121 
11 
23 
N« 
10 
10 
6 
0 
11 
4 
4 
s. 
DATE 
juo 
•ep 
aep 
•ep 
no» 
nov 
nov 
80 
80 
80 
80 
80 
80 
80 
From Table 51 one can see, that clonazepam reduced the number of jerks 
most efficiently m folate induced epilepsy. In penicillin epilepsy a strong but 
less pronounced influence on all classes of jerks was present. Duration of 
epilepsy was slightly shortened. 
In Table 52 and Table 53 the influence of CP on the other variables is 
summarized. 
Table 52: 
For legend see text 
SEIZURES 1 
CL0NAZC-
PAH 
DDSL Ν N 
FOLATE - EPILEPSY 
PC 0 . 7 15 г 
0.16 I S в 
0 . J J 1» s 
0 . 6 7 15 0 « 
P E N I C I L L I N - EPILEPSY 
PG 1 . 0 15 β 
0 . J J 15 5 
0 él 15 2 * 
Clonazepam 
to Table 37. 
H I Z U H L S 2 
N 
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0 · · · 
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0 · » 
SPHEAD 10 IACE 
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Table 53: Clonazepam: 
CLONAZEPAM SEIZURES 
DOSE N expected ob 
FOLATE-EPILEPSY 
PG.0.7 15 9 
0.16 15 6 
0.33 15 5 
0.67 15 1 
PENICILLIN-EPILEPSY 
PG.1.0 15 6 
0.33 15 4 
0.67 15 4 
adjustment for t h e 
2 
served 
9 
6 
3 
0 
7 
Û 
0 
J l -mode . 
SPREAD TO FACE 
expected 
8 
6 
5 
0 
11 
10 * 
10 * 
observed 
11 
S 
4 
0 
8 
3 
3 
Combining the results from Table 52 and Table 53 it appears, that CP 
had a considerable effect on spread of long interval jerks and type 2 sei-
zures. However, correction for the Jl-mode caused these effects to disappear 
m folate induced epilepsy. They probably are secondary to the disturbance of 
the Jl-mode, which must be considered as the central effect of clonazepam. In 
penicillin induced epilepsy CP additionally blocked the spread of long interval 
jerks. 
Minor side-effects of this drug appeared m low doses and consisted of 
slight motor incoordination. 
The results obtained for CP are summarized m Figure 41 . 
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seizure 1 
seizure 2 
spread 
1.3 sec. 
no mode 
FOLATE 
с 
0.5 
R 1 
2 
4 
8 
16 
32 
dose 
plasma 
;т^5о_ 
®аШ!Штш& 
^ 
?
^ ^ \ 
0.16 
0.023 
0.33 
0.042 
0.67 
0.066 
seizure 1 
seizure 2 
Π 
spread 
1.3 sec. 
no mode 
0.33 0.67 
F i g u r e 4 1 : Summary of t h e ef fects of clonazepam. For legend see t e x t to 
F i g u r e 35. ? = No r e l a t i v e c o n t r i b u t i o n of t h e t h r e e subclasses 
k n o w n . 
From F i g u r e 41 one can see, t h a t CP was t h e most e f f e c t i v e d r u g of all six 
a n t i c o n v u l s a n t s , especia l ly w i t h r e g a r d t o t h e n u m b e r of j e r k s m folate 
i n d u c e d e p i l e p s y . T h i s can be expla ined b y t h e r e d u c t i o n of the number of 
animals w i t h a 1.3 sec. J l - m o d e t o z e r o . 
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6.3.6 ETHOSUXIMIDE 
The plasma concentrations of ESM are shown in Figure 42. 
ріавіласопселігаіюл 
500 ESM (mg^/l) 
200 
120 
timefminj 
10 30 60 
Figure 42: Plasma concentration curves of ethosuximide. 
= 450 mg/kg, 200 mg/kg, = 90 mg^kg. All 
doses given sc. 10 mm. before injection of folic acid. The unin­
terrupted line is the curve of 200 mg/l without folic acid injec­
t ion. Mean and SEM of three animals are given. ! = 2 animals. 
Peak levels were not linear with dose. 
In Table 54 the results for duration of epilepsy and number of jerks are 
given. 
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Table 
For lege 
ETHOSUXIMIDE 
DOSE N 
54: Ethosuximid 
nd see t e * 
DURATION 
WAN 
FOLATE - EPILEPSY 
contг .5 15 
40 15 
90 15 
200 15 
450 15 
PENICILLIN -
contг .2 18 
90 15 
200 15 
65 
66 
56 * 
55 * 
69 
EPILEPSY 
65 
74 
58 <« 
SEM 
3 
3 
3 
4 
3 
2 
5 
) 4 
t to 
e: с 
Table 
TOTAL NUMBER 
MEAN 
1013 
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221 
246 
105 
893 
1322 
716 
** 
** j 
SEM 
201 
221 
76 
89 
19 
137 
209 
122 
uration 
36. 
of 
LONG INTERVAL 
MEAN 
486 
449 
135 * 
184 * 
86 * 
609 
900 
506 
SEM 
106 
94 
42 
68 
16 
96 
149 
83 
epilepsy and 
MEDIUM 
MEAN 
197 
122 
42 * 
84 * 
Î 
118 
229 
no 
INTERVAL 
SEM 
35 
20 
10 
22 
Í 
22 
37 
23 
Na 
13 
12 
9 
7 
1 
16 
13 
14 
number 
SNORT 
MEAN 
528 
573 
173 * 
78 * 
? 
385 
368 
174 
of jer 
INTERVAL 
SEM 
91 
174 
103 
28 
Î 
84 
60 
43 
N· 
12 
И 
4 
3 
2 
10 
13 
10 
ks. 
DATE 
«ug 
Mlg 
«ug 
•ug 
•ug 
пот 
•ер 
•ер 
80 
80 
80 
SO 
80 
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80 
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ESM was found to have a rather large influence on the number of jerks 
m folic acid induced epilepsy. All categories were suppressed. Duration of 
epilepsy was temporarily reduced m folate epilepsy. 
In Table 55 and Table 56 the influence of ESM on the other variables is 
shown. 
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For legend see 
SEIZDIES 1 
ETHOSUX­
IMIDE 
DOSE Ν H 
FOLATE - EPILEPSY 
contr.5 15 7 
40 15 9 
90 15 7 
200 15 5 
450 15 0 ** 
PENICILLIN - EPILEPSY 
conCr.2 18 9 
90 15 8 
200 15 6 
Table 55: 
text to 
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Table 37. 
SPIKAD TO FACE 
я 
11 
8 
3 * * 
14 
14 
10 
AXIAL TDINING 
N 
11 
7 
2 * 
1 ** 
0 * * 
8 
7 
3 
er vana 
> ο . β 
Ν 
12 
10 
9 
5 * 
2 **· 
17 
14 
14 
MODE 
1 . 3 
Я 
10 
Ы e s . 
( s e c . ) 
< 0 . 8 
7 
6 
2 * * 
0 * * * 
10 
8 
11 
Я 
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7 
НО 
я 
0 
SIDE-EF. 
N 
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Table 56· Ethosuximi de adjustment for the Jl-mode. 
ETHOSUXIMIDE SEIZURES 2 
DOSE N expected 
FOLATE-EPILEPSY 
contr.5 15 9 
40 15 7 
90 15 7 
200 15 3 
450 15 1 
PENICILLIN-EPILEPSY 
contr.2 18 9 
90 15 8 
200 15 9 
observed 
11 
8 
3 
5 
2 
6 
10 
7 
SPREAD TG 
expected 
10 
6 
6 
3 
1 
14 
12 
12 
FACE 
observed 
11 
3 
3 
2 
0 
14 
14 
10 
From Table 55 and Table 56 it becomes clear, that the action of ESM on 
folate epilepsy can be explained by its blockade of the 1.3 sec. Jl-mode. In 
penicillin epilepsy this was not found. 
In Figure 43 the findings for ESM are summarized. 
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FOLATE 
seizure 1 
seizure 2 
spread 
1.3 sec. 
no mode I [ I 
32 
dose 40 
plasma 
90 
113 
îlflo 
P E N I C I L L I N 
200 
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seiz. 2 
spread 
1.3 sec 
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Figure 43: 
Figure 
known. 
•у о 
35. 
2 0 0 
? = No relative contribution of the three subclasses 
450 
381 
In Figure 43 is i l lustrated, that disturbance of the 1 3 sec. Jl-mode, as 
shown by ESM in folate induced epilepsy, led to an important reduction of the 
number of jerks and to a chain of other events, such as reduction of type 2 
seizures. Since in penicillin induced epilepsy the antagonism of the 1.3 sec. 
Jl-mode was absent, the drug was ineffective here. 
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6.4 REVIEW 
In this review we shall discuss the findings for the six anticonvulsants 
tested m our model. In Table 57 the effect of all drugs on the intensity of 
the jerks is shown. 
Table 57 Influence of 
DRUG 
VALPROATE 
PHENYTOIN 
PHENOBARBITAL 
CARBAMAZEPINE 
CLONAZEPAM 
ETHOSUXIMIDE 
ant iconvulsants 
j e r k s . 
INTENSITY 
FOLIC ACID 
+ 
-
+ 
+ 
+ 
+ 
on INTENSITY of epileptic 
PENICILLIN 
_ 
+ 
+ 
+ 
+ 
-
In sections 3.4, 6.3.3 and we already indicated, that the intensity of 
jerks is a variable, which changes according to variations in the excitability 
of the internal and more external local circuits of neurons. Furthermore other 
excitatory and inhibitory influences to the spinal cord may also play a role. 
Besides, no good correction was possible for the influence of other epilepsy 
variables. Taken together, one can conclude, that changes found in the 
intensity of jerks should be interpreted very cautiously. In folate epilepsy 
the drug with least activity (PHT) did not inhibit the intensity of the jerks, 
while in penicillin the same was true for ESM (not active) and VPA (only 
active on spread). Therefore it is safe to assign only an aspecific value to 
this variable in the sense, that a change of intensity shows that at least mod-
erate activity against the focus itself is to be expected. 
A second variable indicating the global extent of antiepileptic action, 
without tell ing how this is reached is formed by the effective dose for reduc-
tion of the total number of jerks (ED), which is the dose at which the total 
number of jerks is reduced to 1/3 of the control value. This action was not 
found m PHT and CBZ (Table 58). 
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Table 58: Influence of anticonvulsants on THE 
leptic jerks. 
DRUG 
VALPROATE 
PHENYTOIN 
PHENOBARBITAL 
CARBAMAZEPINE 
CLONAZEPAM 
ETHOSUXIMIDE 
NUMBER OF 
FOLIC ACID 
+ 
-
• 
-
+ 
+ 
JERKS 
TOTAL NUMBER of epi-
PENICILLIN 
_ 
-
+ 
-
+ 
— 
These two drugs showed a preponderance for inhibition of seizures or 
SHI-jerks, which represent about 40 "о of the total number of jerks. There­
fore reduction to a level of 1/3 was not feasible. In penicillin epilepsy only 
two drugs (PB and CP) were effective suppressors of the number of jerks. 
A specific suppression of SMI jerks was only present m Phenytoin and 
carbamazepme. All other drugs were able to counteract the SHI jerks by a 
different mechanism (antagonism of Jl-mode > 0.8 sec). Different mechanisms 
too led to a reduction m the number of animals having seizures. We recall 
that type 1 seizures occured in the beginning of the development of epilepsy, 
were of medium interval frequency and arose gradually from isolated dis­
charges. Seizures type 2 on the other hand were afterdischarges. Their o r i ­
gin was sudden, on the wave of the spike-and-wave complex and their occur­
rence was associated with the underlying long interval discharge rhythm (see 
also section 2.4 and chapter 3 ) . Whether or not the seizures were sup 
pressed by drugs, is depicted m Table 59 and Table 60. 
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T a b l e 59 : I n f l u e n c e of a n t i c o n v u l s a n t s 
T Y P E 1 S E I Z U R E S . 
DRUG 
VALPROATE 
PHENYTOIN 
PHENOBARBITAL 
CARBAMAZEPINE 
CLONAZEPAM 
ETHOSUXIMIDE 
on t h e 
TYPE 1 SEIZURES 
FOLIC ACID 
+ 
+ 
+ 
+ 
n u m b e r of animals 
PENICILLIN 
+ 
+ 
with 
T a b l e 60 : I n f l u e n c e of a n t i c o n v u l s a n t s on t h e 
T Y P E 2 S E I Z U R E S . 
DRUG 
VALPROATE 
PHENYTOIN 
PHENOBARBITAL 
CARBAMAZEPINE 
CLONAZEPAM 
ETHOSUXIMIDE 
TYPE 2 SEIZURES 
FOLIC ACID 
+ 
-
-
+ 
-
~ 
n u m b e r of an imals 
PENICILLIN 
_ 
+ 
+ 
+ 
-
— 
with 
From Table 59 one can see, that in folate induced epilepsy four drugs 
antagonized type 1 seizures, the same substances that changed the JI-modes 
above 0.8 sec (see Table 62). The onset of this action always was late and 
lagged behind a suppression of the Jl-mode above 0.8 sec by the same drugs. 
This indicates, that inhibition of the LOI Jl-mode and type 1 seizures are 
similar actions in folate induced epilepsy. This was supported by the fact, 
that type 1 seizures developed and looked like a compression of the isolated 
long interval discharges (see section 2.4 and chapter 3 ) . In penicillin epilep-
sy, however, CP, PHT and possibly CBZ (see Table 49) were the drugs, that 
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antagonized type 1 seizures. To what extent the lack of "LOI-effect" 
contributes to this difference with folate induced epilepsy, is unknown. 
Type 2 seizures were inhibited by a different class of drugs, see 
Table 60. In folic acid CBZ - and VPA at a high dose - were found to have 
a substantial influence on this type of seizures. PHT reduced the number of 
seizures per animal (from a median value of 5-6 in controls to 1), by which 
the Jl-mode < 0.8 gradually disappeared, but no definite effect on seizure 
threshold could be found. In penicillin induced epilepsy PB, PHT and CBZ 
effectively controlled type 2 seizures. In this type of epilepsy PB was devoid 
of its effect on the long interval Jl-mode, so inhibition of type 2 seizures 
must be considered as an action of the drug apart from its abil ity to interfere 
with the 1.3 sec. Jl-mode. 
The two types of seizures therefore had a different susceptibility to 
drugs. 
In Table 61 the action of the drugs on the spread of the LOI-jerks is 
summarized. 
Table 61: Influence of anticonvulsants on the SPREAD of LOI-jerks. 
SPREAD OF LOI-JERKS 
DRUG FOLIC ACID PENICILLIN 
VALPROATE - + 
PHENYTOIN - + 
PHENOBARBITAL - + 
CARBAMAZEPINE + + 
CLONAZEPAM - + 
ETHOSUXIMIDE 
The spread of jerks in penicillin induced epilepsy was more easily sup-
pressed than the same phenomenon in the folate induced form. Only CBZ was 
shown to antagonize spread of jerks in folate induced epilepsy, but 
interaction with propyleneglycol could not be excluded for this d rug. 
As for the 1.3 sec. Jl-mode a remarkable difference was found (see 
Table 62) between folate and penicillin induced epilepsy. 
In folate induced epilepsy four drugs (VPA, PB, CBZ and ESM) sup-
pressed this rhythm and two (PHT and CBZ) did not. After induction of epi-
lepsy by injection of penicillin no drug was able to br ing about significant 
changes m this rhythm. Since a change in this rhythm is important for the 
141 
Table 62: Influence of anticonvulsants on the 1 3 SEC. JI-MODE. 
1.3 SEC. JI-MODE 
DRUG FOLIC ACID PENICILLIN 
VALPROATE 
PHENYTOIN 
PHENOBARBITAL 
CARBAMAZEPINE 
CLONAZEPAM 
ETHOSUXIMIDE 
+ 
-
+ 
-
+ 
+ 
probability of occurrence of type 2 seizures and spread of jerks to the face, 
the four drugs also effectively controlled these variables in folate epilepsy 
and were less potent m reducing type 2 seizures in penicillin induced epilep- 
sy. 
The influence of the drugs on the number of animals without any J l -
mode is shown in Table 63. 
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Table 63: Influence of 
NO JI-MODE 
Between [ ] temporary 
DRUG 
VALPROATE 
PHENYTOIN 
PHENOBARBITAL 
CARBAMAZEPINE 
CLONAZEPAM 
ETHOSUXIMIDE 
ant iconvulsants on the number 
effects a re shown. 
NO JI-MODE 
FOLIC ACID PENICILLIN 
[+1 
+ 
+ -
+ + 
+ 
of animals with 
The drug induced changes causing a rise m the number of animals wi th-
out any Jl-mode, correspond to those seen, m Table 62 with the exception of 
CP Cm penicillin induced epilepsy) and CBZ (in folate induced epilepsy). Pre-
sumably changes m the 1.3 sec. Jl-mode are not associated with a shift of 
the mode, but rather give rise to an absence of it. This is the reverse pro-
cess of the one, seen m Figure 21, where the development of the LOI dis-
charges was shown. 
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Chapter 7 
DISCUSSION 
In this chapter we discuss the results from our experiments. In chapters 
2-5 a number of procedures were described, which aimed to standardize and 
validate the method of heat lesion followed by chemical induction of epilepsy. 
Chapter 6 contained the results of the tests of six anticonvulsants, which m 
fact were an additional validation in the sense of gathering reference material. 
Throughout this thesis it was found, that type 2 seizures and spread of the 
discharges were counteracted by some drugs through an interaction with low 
frequent discharges. The following issues will be discussed: 
1. Validation of the method. 
2. Drug effects. 
3. Conclusion. 
7.1 VALIDATION OF THE METHOD 
Throughout a series of experiments the method of heat lesion, chemical 
induction of epilepsy and the observation and registration of epilepsy were 
re-evaluated and put into a new protocol \Ve will discuss these items in the 
following order: 
1. Properties of the heat lesion. 
2. Chemical induction of epilepsy. 
3. Registration of epilepsy. 
A. Useful variables. 
5. Partial motor epilepsy m patients. 
7.1.1 PROPERTIES OF THE HEAT LESION 
As was shown in sections 2.6 and 5.3, the anatomical features of the 
standard lesion did not bear any important relation to the functional parame­
ters of epilepsy. However, when a less intense Іеыоп was made by lowering 
the temperature of the probe, more jerks appeared and the variance 
increased. Larger lesions produced remarkably complex behavioral patterns 
without obvious signs of epilepsy (see section 2.2). Furthermore only one half 
of the animals, excluded due to lesions extending more than 2 mm. into the 
cortex, did not develop epilepsy. Therefore the current standard lesion size 
seemed the optimal one, having a low mortality rate and a high reproducibil i­
t y . 
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The induction of epilepsy with the help of anatomical lesions is not very 
popular (Purpura et al 1972), because of possible contaminating variables. 
Demonstrable anatomical damage in patients with partial epilepsy is shown 
more often as the methods of investigation become more sophisticated (Fngel 
1982 a,b and c ) . Hence the application of the technique of a lesion seems a 
sensible method, when care is taken to minimize its drawbacks. 
One of these disadvantages is the acute nature of most lesions. This 
gives rise to variable degrees of increased intracranial pressure, brain edema 
and blood-brain barrier breakdown. 
As evidenced m section 5.2, a moderate degree of increased intracranial 
pressure was supposed to be present in the heat lesion, giving rise to chang-
es m the vascular compartment, but not limiting the available energy supplies 
or drug transport into the focus m a critical way. 
The breakdown of the blood brain barrier provides the opportunity of 
chemical induction of epilepsy with agents, that normally have a very 
restricted entry into' the brain. This abnormal permeability within a heat 
lesion may also influence the local kinetics of anticonvulsants, whose entry 
into the brain normally is limited (valproate, ethosuximide and phénobarbital). 
This phenomenon was not studied here. However, the ED and TD50 of these 
drugs was found to correspond with other studies, mentioned m section 6 .1 . 
The boundaries of the lesion varied, according to the method of determi-
nation. Folic acid accumulated m the central region of the lesion adjacent to 
the area of necrotic tissue (see section 2.3), m approximately the same region 
as Evans Blue (see Figure 10). As shown m section 5.3, the boundary of the 
Evans Blue lesion coincided with the projection areas of hind- and forelimb, 
the organs, to which the primary spread is limited. The experiments from 
chapter 5, with "C-deoxyglucose and ^C-an t i pynne , disclosed more wide-
spread, at times inconstant, effects. They also showed, that the coupling of 
regional metabolism and blood flow is questionable under these pathological 
conditions. The slight hypoperfusion of the focus and its surroundings corre-
sponds to the diminished blood flow found m the focus of patients, presenting 
with severe partial epilepsy (Engel 1982a, b and c) . 
In conclusion the lesion itself caused more widespread changes than was 
suspected at the beginning of the experiments. This necessitates the search 
towards alternative methods, such as local injections, applicable in freely 
moving animals. 
7.1.2 CHEMICAL INDUCTION OF EPILEPSY 
A wide variety of agents is available for the provocation of epilepsy (Purpura et al 1972), possibly reflecting a similar number of chemical agents, 
able to provoke epilepsy m humans. One often wonders, why m several 
patients corresponding lesions do not result m an equal degree of epilepsy. 
Differences m the reactivity of damaged tissue, capability of neuronal organi-
zation and sensitivity to chemical tr iggers all play a role. The combination of 
a lesion with subsequent chemical induction of epilepsy mirrors such a si tu-
ation. This analogy does not imply, that the agents, which can induce epilep-
sy m this artif icial situation, will be a major pathogenic factor m man, 
although sometimes (like folic acid) this substance is normally found in the 
b ra ι η. 
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Penicillin already has been used for years and can be considered to be a 
safe agent. For folic acid the absence of demonstrable renal side effects 
(section 2.3.1) proved, that this substance could be used without fear for 
this intervening complication. 
An interesting subject is the disentanglement of the similarities and dif-
ferences between partial epilepsy, evoked by different agents from the same 
anatomical lesion. In the l i terature it has been shown, that an amount of pen-
icillin equal to the dose, given by us, causes generalized multifocal epilepsy, 
when no anatomic lesion is present (Fanello 1976, Gloor 1979). For folic acid 
to cause generalized epilepsy a toxic dose, 8 times as much as applied by us, 
is required (Obbens 1973). Therefore we expected, that the type of epilepsy 
provoked by penicillin would show a greater spread. This proved to be the 
case (see sections 2 5.5 and 3.3.2) . The anticonvulsants were more likely to 
counteract the spread resulting from epilepsy induced by penicillin than by 
folate (see section 6 3 and 6.4). The more localized secondary spread of epi-
lepsy by folic acid seemed rather refractory to the action of anticonvulsants, 
when these drugs did not alter the LOI-rhythm Of course a different chemi-
cal mechanism of folic acid and penicillin might play a role here. The consis-
tency of the f ind ing, that all anticonvulsants except ESM were more effective 
in antagonizing spread of jerks in penicillin induced epilepsy, can only be 
explained by a not specific origin and suggests, that the activation of di f fer-
ent neuronal aggregates by both epileptogenic substances is important, apart 
from their chemical mechanism of action 
In conclusion, irrespective of the mechanism behind i t , the folate 
induced form of partial epilepsy seems more appropriate to test the ability of 
drugs to interfere with a sequence of low frequent epileptic discharges, while 
the study of drug influence on spread better can be done with penicillin 
7.1.3 REGISTRATION OF EPILEPSY 
The value of the method of observation, compared to gathering evidence 
by means of electroencephalography, has been an important problem through-
out the fields of experimental epilepsy and clinical neurology. Direct meas-
urement (Feinstem 1971), by means of observation, seems at f i rst sight the 
optimal choice. However, because it is not known, which of both is function-
ally located 'nearer to the focus', f inding good correspondence between both 
methods guarantees the least controversial outcome. 
In sections 2.4 and chapter 4 both methods were compared, yielding a 
fair ly good degree of conformity. It was also shown, that for example the 
spread of the epileptic phenomena is easily observed, while the measurement 
of it m the ECoG requires an elaborate technique. Data regarding the inter-
vals between discharges and the description of the inhibitory components, 
double spikes etc. can be obtained more reliably with the help of the FCoG. 
The method of observation was not hampered by large mter-observer 
differences (see section 2.5.2) , or a major proportion of false findings (sec-
tions 2.4 and 4 .8) . Its ready-to-use character provided a base for handling a 
larger amount of data (from chapter 6) m a relatively short time. As a result 
of th is , a systematic study of the effects of anticonvulsants on several 
aspects of the partial epilepsy-complex was possible. 
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7.1.4 USEFUL VARIABLES 
As was mentioned m section 3.4, a number of variables was used, d iv id-
ed into two groups. In the f i rs t a quantitative description of the epileptic 
events was given (duration of epilepsy and number of jerks, total - LOI -
MEI - SHI), while in the second group each variable represented a more spe-
cial feature of epilepsy (.the two types of seizures, JI-mode, spread and 
intensity). 
We found, that the duration of epilepsy was very stable, an important 
decrease only being present, when the number of jerks was almost reduced to 
zero (see section 6.3.5, results of clonazepam). This means, that the critical 
period, during which epileptic discharges can appear, remains constant. 
With respect to the number of jerks a hierarchical order of suppression 
was found, the SHI-class being most liable to changes. This was true for all 
drugs. SHI jerks were suppressed by distinct mechanisms, directly (as by 
PHT, CBZ and sometimes PB) or indirectly through interference with the LOI-
jerks (VPA, PB, CP and ESM). The same effect on the number of SHI jerks, 
seen in VPA and PHT, therefore resulted from different mechanisms. This 
aspect emphasizes the need for fur ther systematic study of discharge-
intervals in partial epilepsies. 
With regard to the MEI-class of jerks we must realize, that they formed 
the major part of the - not very common - type 1 seizures, but their quanti-
tatively most important component was found during the course of type 2 sei-
zures. A decreased number of MEI jerks therefore mostly indicated a sup-
pression of seizures type 2. 
In the l i terature regarding partial epilepsy from the sensorimotor cortex 
the registration of discharge-intervals has been done more than once (Mares 
1981, Gartside 1978, Sherwin 1978), occasionally for the description of drugs 
effects, and for the analysis of mtenctal- ictal transit ion. A systematic study 
of more than two drugs m a dose dependent fdshion was not available. Our 
results indicate, that the six drugs had a different abil ity to interfere with 
the LOI-rhythms and that this ability m its turn depended on the way the 
partial epilepsy was init iated. Seizures developing according to an afterdisc-
harge pattern, and spread, were secondarily inhibited through this "LOI-
effect". By making adjustments for this "LOI-effect" we were able to segre-
gate regate primary and secondary drug actions on this form of partial 
epilepsy. In itself this clarification of drug effects was a strong indication, 
that intervening drug actions such as the "LOI-effect" really exist and are 
important mechanisms m the evolution of isolated discharges into partial sei-
zures. We assume, that the study of analogous primary and secondary drug 
effects m other parts of the brain will provide interesting data. 
During the experiments two seizure types were found, one consisting of 
a gradual increase of spike-waves (type 1), and the other arising during the 
wave of the spike-and-wave complex, showing the aspect of an afterdischarge (type 2) . A similar distinction was seen by Mares (1981), studying electrical 
afterdischarges in the sensorimotor cortex and finding even 5 different sei-
zure types, and by some others (Walker 1950, Ralston 1958, Angelen 1972 
and Sherwin 1978). Generally type 2 seizures dominate throughout the litera-
tu re . Our results indicate, that this type was directly blocked by some 
drugs (PHT, CBZ and PB) and predominantly indirectly by others (VPA, PB, 
CP and ESM). The f i rs t type of seizures however was only blocked by the 
four latter drugs, after the "LOI-effect" had been seen m folic acid induced 
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epilepsy. The suppression of type 1 seizures therefore followed the 
alterations, found in the sequence of spike-waves at a lower frequency. This 
was not t rue for penicillin induced type 1 seizures, where a separate mecha­
nism must have been operating. 
The spread of the jerks appeared to be composed of two parts, called 
primary and secondary (chapter 3 ) , the secondary one being useful to evalu­
ate drug effects. Here too indirect drug actions due to the "LOI-effect" were 
found. Direct drug-induced inhibition of spread was only seen after induc­
tion of epilepsy by penicil l in. All drugs except ESM were able to limit the 
spread of jerks in this form of epilepsy. 
Finally the intensity of jerks was monitored. The complex background of 
this phenomenon made us doubt, whether this variable would turn out to be 
valuable. We found, that limitation of intensity preceded most other drug 
induced changes within the focus. Therefore this variable was thought to 
have only an aspecific value. 
In conclusion, all variables except the number of MEI-jerks and intensity 
of jerks provided valuable information on different aspects of partial epilepsy. 
7.1.5 PARTIAL MOTOR EPILEPSY IN PATIENTS 
The transfer of results for this type of epilepsy to other mammals, including 
man, and to different parts of the brain is at the same time the major goal 
and problem of experiments like these. In general we are supported by the 
fact, that testing anticonvulsants in rodents, especially rats, has been a 
f r u i t f u l approach for the treatment epilepsy m patients. 
In order to obtain more insight in this transfer problem, we compared 
epilepsia partialis continua (or syndrome of Kojewmkow) m patients with the 
partial epilepsy found m the rats seen by us. Bancaud (1967), Bancaud et al (1982 and 1970) and Buser et al (1971) published results of a thorough analy­
sis of this form of epilepsy m humans Within their patients they identified 
two groups, one of which had limited spread of discharges and a benign 
course of the disease, the other showing more widespread changes and pro­
gressive worsening. They did not give a detailed account of the pattern of 
discharge intervals, but according to their data a less organized (ι e. less 
rhythmic) form of epilepsy was seen in their patients 1 he grapho-elements of 
the discharges m the EEG (Bancaud et al 1970) contained similar frequencies 
and a clear distinction was seen between spike-waves and spikes during sei­
zures of the afterdischarge type. 
The sensitivity of human epilepsia partialis continua towards anticonvul­
sants is limited, the f i rs t group of Bancaud et al showing a more favourable 
response, while the second one, presenting with more widespread epilepsy 
and pathological changes, was very diff icult to treat. A similar distinction was 
found in the epilepsy seen during our study, the penicillin induced form 
being more resistant to pharmacological therapy than its folate induced count 
erpart . 
The similarity between man and rats with respect to partial motor epilep­
sy is somewhat unexpected, because we know that the lissencephalic rat brain 
has less sophisticated cortical pyramidal connections. It is therefore l ikely, 
that the origin of certain epileptic (pseudo) rhythms and EEG-grapho-elements 
of epilepsy must be sought m common basic mechanisms within the mammalian 
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brain, which are separate from several other aspects, developing through 
advanced neocortical evolution. The common phenomenology of other forms of 
epilepsy (for example tonic clonic convulsions. Toman et al 1946 and 1947) 
contributes to this hypothesis too, as well as the ubiquitous f inding of certain 
neurophysiological mechanisms like the PDS (Prmce 1978). 
Because we don't know yet, to what extent the far more frequent partial 
epilepsies from other regions of the brain will show a similar "LOI-effect", 
generalization of our f indings toward all partial epilepsies remains speculative. 
However is fair to assume, that such-types of interactions do exist. 
7.2 DRUG EFFECTS 
According to Meldrum (1983) anticonvulsant drugs fall into three categories: 
1. Drugs selective for primary generalized seizures of the absence type 
(e .g . succi mm ides). 
2. Drugs selectively active against partial seizures, either simple or com-
plex (e .g . hydantoms and carbamazepme). 
3. Drugs with limited selectivity, acting against both and also against p r i -
mary generalized tome clonic seizures (e .g . benzodiazepines, branched 
fatty acids like valproate and phénobarbital). 
Two commonly used animal screening models, the maximal electroshock seizure 
test and the threshold pentylenetetrazol seizure test, are used m order to 
obtain information about the selectivity of drugs with these respects (see 
Purpura et al 1972, Woodbury et al 1982a). Some biochemical mechanisms 
have been shown to correlate with activity m these models. Benzodiazepines 
enhance the post-synaptic inhibitory effect of GABA at a site related, but not 
identical to the GABA receptor, causing an increased frequency of the open-
ing of the CL- channels by GABA (Study & Barker 1981, MacDonald 19/9, 
Barker Б Ransom 1978). This phenomenon correlates with the relative potency 
of benzodiazepines m the threshold pentylenetetrazol seizure test (Meldrum 
1983). A second mechanism, inhibition of the phosphorylation of certain mem­
brane proteins, was found for benzodiazepines, carbamazepme and the hydan­
toms, m anticonvulsant concentrations (DeLorenzo 1980). This phenomenon 
correlates with the relative potency of a series of benzodiazepines m the max­
imal electroshock seizure test (DeLorenzo et al 1981). Barbiturates are sup­
posed to have a different and mixed chemical mode of action. They prolong 
the opening time of the CI- channels, opened by GABA, and cause a direct 
opening of them (Meldrum 1983). If we t r y to explain the different drug 
effects of the six anticonvulsants by referr ing to their chemical mode of 
action, we can see a clear distinction between the seizure suppression, exert­
ed by PHT and CBZ (and PB), and the antagonism of the 1.3 sec. Jl-mode, a 
preferential action of CP. It is tempting to ascribe the abil ity to suppress the 
1.3 sec. Jl-mode to a GABA related mechanism. However for the other three 
drugs, found to share the inhibition of the 1.3 sec. Jl-mode, ESM, VPA and 
PB,a GABA related mechanism has not unequivocally been found (Woodbury et 
al 1982a, Glaser et al 1980). If this hypothesis is correct, one might be 
inclined to assign a GABA related chemical mode of action for folic acid too, 
because the suppression of the 1.3 sec. Jl-mode was only seen for this epi­
leptogenic agent. Penicillin is not a very strong GABA antagonist (Voskuyl 
1978). PB is the d r u g , that has both a mixed influence on seizures and iso-
149 
lated discharges, as well as a complex chemical mode of action and local 
kinetic behavior. 
Not all different anticonvulsant effects can be explained by a separate 
chemical mode of action as discussed above. The spread of jerks did not coin-
cide with either the suppression of type 2 seizures or the antagonism of the 
1.3 sec. Jl-mode. This variable was much easier suppressed m penicillin 
induced epilepsy (by all drugs except ESM) than m the folate induced count-
erpart. As was discussed m section 6.4 a distinct involvement of local neu-
ronal circuits might be the cause of this difference. In most epileptic patients 
partial seizures are caused by a lesion m the limbic system (psychomotor epi-
lepsy). Spread from a limbic focus is easy, because of its connections with 
other regions of the brain. PHT and CBZ are often used for this type of 
partial epilepsy. The potency of PTH to inhibit spread of seizures is assumed 
to contribute to its effectiveness (Woodbury et al 1982a). In the experiments 
from chapter 6 CBZ was found to be even more effective in inhibiting spread 
of jerks than PHT. This might explain, why CBZ generally is the preferred 
drug in psychomotor epilepsy, apart from its effectiveness in antagonizing 
hippocampal afterdischarges (Schmutz et al 1981). In addition to th is, the 
inhibition of spread, seen in rat partial motor epilepsy, is supposed to reflect 
an important variable, preferentially antagonized by CBZ PHT, VPA, PB and 
CP shared this property only in penicillin induced epilepsy. 
The preferential action of ESM, CP and VPA on the 1.3 sec. Jl-mode 
and the related type 1 seizures, corresponds to their selectivity for primary 
generalized seizures of the absence type (Woodbury 1982a, Swinyard 1982). 
Gloor (1979) showed, that cortical hyperexcitabil i ty is the most important fac-
tor m the generation of these attacks. As was argued in section 4.6, common 
mechanisms are supposed to underly the local cortical hyperexcitability in 
partial motor epilepsy and cortico-reticular epilepsy We assume, that the 
LOI Jl-mode represents a local epileptic phenomenon. Type 2 seizures and 
spread to the face appear to depend both on local as well as external circuits (for instance the thalamocortical excitability network). 
Finally, the overall effectivity of the six drugs, measured by their ED's, 
was low, except for clonazepam. The epilepsy generating neuronal circuit 
might show a state of excitabil i ty, too high to be counteracted. Alternatively, 
the generator network, initiating the epilepsy, might be relatively unaccessi-
ble for the anticonvulsants due to brain edema. 
7.3 CONCLUSION 
It will be clear from the findings m the l i terature and the experiments, pre-
sented m this thesis, that a rational combination of drugs m therapy resis-
tant patients includes substances with a complementary mechanism of suppres-
sion of seizures and spread. The results of the analysis of partial motor 
epilepsy can be used to separate the drugs according to the way they anta-
gonize type 2 seizures and spread of jerks. These results confirm the pattern 
of selectivity, summarized by Meldrum (1983), mentioned in section 7.2, and 
Porter (1984). We propose, that drugs interfering with the 1.3 sec. Jl-mode, 
should be combined with a drug able to suppress type 2 seizures and spread 
to the face. Thus ESM, CP and VPA, belonging to the f i rs t category might 
best be used together with CBZ or PTH from the second category. Since PB 
showed a mixed type of action, this drug is supposed not to be very useful, 
when given in conjunction with others. Combinations of drugs from the same 
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category is only advised, when a complementary action is deliberately needed, 
for example if one tries to use the potency of VPA to suppress type 2 sei-
zures and spread m addition to the limited action of ESM. Another example 
might be the preferential action of CBZ on spread of jerks and type 2 seizure 
threshold m conjunction with PHT. Whenever possible, however, a choice from 
the two different classes of drugs should be made f i r s t . This proposal needs 
confirmative evidence from future experimental results and controlled clinical 
tr ials. 
The value of the method, used for these experiments, is the last issue 
we will discuss. The choice of parameters for the assessment of anticonvulsant 
activity seems correct. It was demonstrated convincingly, that more than one 
mechanism can lead to prevention of partial seizures. However the choice of 
the method of lesionmg m order to evoke epilepsy, is questionable, because 
rather widespread changes in intracranial pressure and blood-brain barrier 
function, and indications for rather intensive local brain edema were found. 
In order to increase the general acceptance of the method, by which partial 
motor epilepsy is generated in the laboratory of experimental neurology, it 
will be necessary to look for ways of local administration of folic acid and 
penicillin with preservation of the current method of analysis of epilepsy. 
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TERMINOLOGY 
1. AFTERDISCHARGE: A sequence of high frequency electrical 
discharges occurring after electrical stimulation of part of the 
brain. More generally, this term is also used for a high f re­
quency electrical discharge, immediately following a relatively 
isolated epileptic event (such as a LOI-spike). The resulting 
behavioral pattern m the animal is a Cpartial) seizure. 
2. CENSORED OBSERVATION: The total duration of epilepsy is 
assumed to be greater than the observation period, when the 
animal has shown more than 10 jerks m the last period of 5 
minutes. In this case the total number of jerks and the LOI, 
MEI and SHI jerks are also considered to represent censored 
values (they get the suffix ' >'). 
3. DURATION OF EPILEPSY: Seconds (χ 100) from injection of 
epileptogenic substance until last jerk. In general the begin 
point of the period after which no more epilepsy has been 
observed, will be taken. In the case of censored observa­
tions, see above, the end point of the last period will be the 
value, of course preceded by the suffix ' >'. 
4. ECoG: electrocorticography, measurement of the electrical 
activity of the brain at the cortical surface. 
5. EEG: electroencephalography, a general term used for each 
measurement of gross electrical activity of the bra in, indepen­
dent of the site of measurement. 
6. EPSP: excitatory post synaptic potential. 
7. ICTAL: 'during sei7ures'. 
8. INTENSITY ΟΓ JERKS: Magnitude of movements, classified 
according to Table 7 m section 2 . 5 . 1 . 
9. INTERICTAL: 'between seizures'; in general isolated epileptic 
events are meant when using this term. There is however 
some disagreement in the clinical and neurophysiological use 
of this term (for example the one-per-second activity in our 
epilepsy model can neurophysiologically be considered to be 
mtenctal, from a clinical point of view however it is to be 
considered as being part of a seizure of the type "epilepsia 
partialis continua". 
10. IPSP: inhibitory post-synaptic potential. 
11. JERK: sudden flexion of a limb, not being part of another 
circumscribed pattern of movement and accompanied by a 
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spike m the ECoG. For the number of jerks, the total 
number, observed after six periods m each animal, is counted 
and for the group the mean is estimated according to section 
2 .9 .1 . The total number of jerks is divided in LOI, MEI and 
SHI groups (see below). When an animal has loss than 4 jerks 
dur ing all six periods together, he is considered, according 
to the findings in section 2.4, to have no epilepsy 
12. JERK INTERVAL: interval fseconds) to the foregoing jerk. 
13. JI-MODE: = ' jerk interval mode' e g most frequent jerk 
interval in the histogram of jerk intervals See Figure 11 and 
Figure 12 in section 3.1.1 for i l lustration. The jerk interval 
classes have class widths of 0.2 log sec. (from -1 to 2 6 (0 1 
- 300 s e c ) . A class is considered to be a mode, when 1 and 
2a or 2b are t rue: 1) it has an ordinate value of 10 or more; 
2a) for classes > - 0.1 log sec. (= 0.8 sec ) on abscis. when 
at its r ight side - stepwise - three successive or four out of 
f ive classes have lower or equal values and when also its left 
neighbouring class has a lower f igure; 2b) for classes < - 0.1 
log sec. on abscis: the class with the highest number out of 
all four is the Jl-mode, when its value is higher than in the 
class of - 0 1 (log sec). Despite the fact, that this definition 
is not exhaustive, almost all animals could be classified suff i -
ciently according to this definition The distinction between 
classes above and below - 0.1 log sec (= 0.8 sec.) is made, 
because below this value the classes encompass the jerks, 
observed during the seizures. When the Jl-mode falls within 
the area of the long interval, it's called a LOI Jl-mode etc. A 
small minority of animals with standard treatment has no 
mode. About one half of the animals shows two modes, one m 
the LOI and one most often in the SHI , but sometimes m the 
MEI range. 
14. LOI-jerk: = 'long interval jerk ' , e g. a jerk with a jerk inter-
val of more than 0.8 sec. 
15. MEI-jerk: = 'medium interval jerk ' , e g. a jerk with a jerk 
interval between 0.8 and 0 33 sec. 
16. SEIZURE: Ten or more jerks having estimated intervals of 
less than 0 80 sec. When the predominant interval of the f i rst 
ten jerks is less than 0.33 s e c , they are called type 2 sei-
zures; when the predominant interval of these jerks lies 
between 0 33 and 0.80 s e c , they are considered to be type 1 
seizures. 
17. SHI-JERK: = 'short interval jerk ' , e .g . a jerk with a jerk 
interval of less than 0 33 sec. 
18. SPIKE: the surface negative (downward) excitatory field 
potential registrated during epilepsy Its EEG definition 
includes a specification of duration (< 80 msec ), which does 
not f i t the duration range m our form of epilepsy For rea-
sons of clari ty we always use the term 'spike' because of its 
distinction with the subsequent inhibitory wave, although its 
duration exceeds often 80 msec, m which case the term 
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'sharp wave' has to be used. The spike coincides with the 
jerk seen at hindlimb and other body regions. Whenever in 
the definitions the word ' jerk' is encountered, replacement of 
it by 'spike' will yield the corresponding ECoG definition 
(e .g . spike interval, long interval spike e tc . ) . 
19. SPREAD OF JERKS: The visibi l i ty of muscular contractions 
over the body during LOI jerks, classified according to 
Table 6 m section 2.5.1 
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Appendix A 
EIGHT PROGRAMS TO ACCOMPLISH IMPULS AND PEAK 
DETECTION. 
J . Moleman, J . I . Кар 
Dept. of Clinical Neurophysiology 
Institute of Neurology 
Catholic University of Nijmegen. 
INTRODUCTION. 
Two separate sets of programs were developed for detection and display of 
registrations, recorded during epileptic seizures m the rat. 
One set is used for detection and display of impulses, recorded onto 
analogue tape. The second set of programs converts the recorded EEG of the 
rat to digital magtape, detects the epileptic peaks in this digitized EEG and 
displays derived histograms on a graphic terminal. 
MATERIALS. 
The impulses and EEG were recorded on a HP-3968A® instrumentation record­
er. The recordings were performed m FM mode with a tape speed of 15/16 
mch/s. Acquisition was done on a PDP 11/34 ©computer, supplied with three 
RK05J diskdrives®, a TU10® digital magtape unit, an ARU® 16 channel ana­
logue to-digital-converter and a DIFA® programmable f i l terset. The results 
were displayed on a Tektronix 4010® graphic terminal, copies were made on a 
Tektronix 4610® hard copy unit. 
PROGRAMS FOR DETECTION AND DISPLAY OF IMPULSES. 
This set consists of 2 programs: 
1. RAT IMP: input of impulses and generation of a file with timing parame­
ters. 
2. IMPDIS: display of curves and histograms and printout of data, derived 
from the timing parameters. 
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INPUT OF IMPULSES (RATIMP). 
Impulses, originating from 6 switches, are recorded on 6 channels of an ana-
logue recorder. The signals from these 6 channels are digitized m a double 
buffered mode. The impulses m each channel are searched for with a simple 
one threshold technique. The recording times, at which they arise are stored 
in a file on disk. 
DISPLAY OF IMPULSE TIMING PARAMETERS (IMPDIS). 
This program prints a list of detected impulses and displays curves and his-
tograms, derived from these timing parameters, shown in chapter 3. 
PROGRAMS FOR DETECTION OF EPILEPTIC PEAKS IN THE EEG. 
For the peak detection a set of 6 programs is available: 
1. CALIBR: a general purpose calibration program. 
2. RATMT: acquisition of the EEG on magtape. 
3. RATBS: calculation of baseline parameters (average and standard 
deviation of the base EEG) and generation of a parameter f i le. 
4. RATPK2: detection of epileptic peaks, storage of peaktimes and other 
relevant data in the parameter f i le. 
5. PK2DIS: display of the results of program RATPK2. 
6. RATDIS: display of the digitized EEG with indication of detected 
peaks. 
CALIBRATION (CALIBR). 
This program allows calibration of the acquisition system from the analogue 
tape recorder. Calibration is performed by acquiring a 10 Hz smewave with 
an amplitude of 1 mV. For each of the 6 channels the calibration factor (mV/ 
sample point) and the zero offset m sample points are calculated and stored 
in the calibration file CALIBR.DAT along with the date of calibration. 
ACQUISITION OF THE EEG (RATMT). 
At f i rs t the date of calibration and the calibration data are retrieved from the 
calibration file CALIBR DAT. The program stops if today's date does not 
match the date of calibration If this is the case, a calibration should be per-
formed f i rs t using program CALIBR Next some data are asked for: 
1. Time conversion factor: the factor by which the recorder is running 
faster than the recording speed. 
2. Time correction factor: the factor by which the recording speed devi-
ates from real time speed. 
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3. The name of the data file for storage of the digitized EEG. 
4. The total acquisition time (real time). 
Finally the program asks to GO? 
After pressing the <RETURN> key the acquisition is performed. 
The real time sample frequency is 100 Hz (10 ms sample interval). The 
recorded length in the acquisition buffer is 1536 samples per channel, 6144 
sample points in total, his has been proven to be the optimal buffer length 
for magtape acquisition It is possible to perform the acquisition 16 times 
faster than real time speed. Thus recording a 2 hour EEG takes only 7.5 
minutes. 
The generated data fi le consists of one header record (256 words) con-
taining the necessary parameters and about 450 data records of 1536 words'' 
channel (15.36 seconds real time length) for a 2 hour recording. 
BASELINE PARAMETERS (RATBS) 
The baseline parameters are the average and standard deviation of a specified 
number of records of the base EEG, which is recorded prior to activation of 
the rat. A parameter file is generated by the progrdm and the baseline 
parameters are stored in this f i le. 
DETECTION OF EPILEPTIC PEAKS (RATPK2) 
This is the most elaborate program of the set. The purpose is to detect epi-
leptic peaks m a digitized EEG and store the times at which they occur m the 
parameter file along with some data on peak forms and averages. 
In order to properly detect the peaks, a number of parameters are 
passed to the program: 
1. IWIDTH: estimated width m sample points of the peaks. 
2. PERC: the peakbase as a percentage of the peakheight. 
3. IDEL12: maximum delay between peaks in channel 1 and 2. 
4. IPUL(1, and 3 ) : maximal and minimal permitted width of the peaks m 
channel 1 and 3. Values for channels 2 and 4 are copied from channel 
1 and 3 resp. 
5. TRESH(1,2,3 and 4) : Detection thresholds for each channel in number 
of baseline standard deviations from the baseline average. Positive val-
ue: peak is positive (up) Negative value: peak is negative (down). 
These parameters are used to calculate criteria for detection (Figure 44). 
These are worked out as follows: 
1. The detection threshold is calculated for each channel: 
ITRESH(I)=AV(I)+TRESH(I)*SD(I) wi th: 
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Figure 44: Schematic representation of parameters for spike detection. For 
explanation see text. 
- ITRESH: detection threshold in sample points 
AV: average of the baseline EEG 
- SD: standard deviation of the baseline EEG 
- TRESH: threshold factor supplied by user 
- I: channel number 
2. The f i rs t point in channel 1 which exceeds this threshold is searched 
for . Suppose this point is found at sample with index ISAM. 
For each channel the following procedure is carried out: 
1. In an area with width IWIDTH, symmetrically around sample ISAM the 
extremes MIP (minimum) and MAP (maximum) along with their resp. 
indices Mil and MAI are calculated. 
If this maximum MAP (for positive peaks) or minimum MIP (for 
negative peaks) does not exceed the threshold ITRESH, no valid peak 
is detected for that particular channel The rest of the procedure is 
skipped. 
Let us consider positive peaks only as a matter of ease. 
2. The peakbase IUNDER is calculated: 
IUNDER(I)=AV(I)+PERC(I)*(MAP(I)-AV(I))*100 wi th: 
• IUNDER: peakbase in sample values 
• AV. average of the baseline EEG 
• PERC: user supplied percentage 
• MAP: value of the maximum of the peak 
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On both sides of the maximum MAP with index MAI the points IP1 and 
IP2, which are closest to the peakbase, are searched for . If one of 
these points is not detected within the area IWIDTH, than the peak is 
not valid (too wide) The rest of the procedure is skipped for this 
channel. 
3. The peakwidth IPW is calculated: 
IPW(0 = IP1(I)-IP2(I) 
If IPW exceeds the user supplied lower limit IPLL or the upper limit 
IPUL the peak is not valid either. 
4. The indices IP1, MAI and IP2 are stored for each channel. If no valid 
peak was detected, these values are all set to 0. 
The procedure for negative peaks is similar to the above, except that 
the variables MAP and MAI must be replaced by Ml Ρ and MM respectively. 
After the peaks m each channel have been detected, a validation proce­
dure is worked out: 
1. Are there any peaks detected in channel 1 and 2 ? 
2. Does the difference of the indices of the extremes of the peaks m 
channel 1 and 2 (MAI(1)- MAI(2) for positive peaks) not exceed IDEL12 
? 
If both of these conditions are met, a number of parameters are calculat­
ed and stored m the parameter f i le -
1. The time at which the top of the peak arises (the time of the peak in 
channel 1 determines the observation period). 
2. The average peakheight and peakwidth for each channel along with 
their standard deviations. 
3. The average peakform and the standard deviation of the peakform for 
peaks in channel 1 with an mterpeak latency between 0 1 and 1.0 sec­
onds. 
Now the index ISAM is shifted to the end IP2 of the detected peak and 
the above procedures are repeated until the end of the datafile is reached. 
DISPLAY OF THE RESULTS (PK2DIS). 
This program reads the parameters, generated by program RATPK2 from 
the parameter f i le. They are then printed and displayed as depicted m chap­
ter 4. 
DISPLAY OF THE DIGITIZED EEG (RATDIS). 
After the peak detection program RATPK2 is r u n , the user might feel the 
urge to check, whether all relevant peaks have been detected. A wrong 
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choice of the parameters in the latter program might have directed the 
program m the wrong direction and caused erroneous results. Program 
RATDIS offers the possibility to read pieces of the digitized EEG from the 
datatile. This EEG is displayed for a single channel or for all 4 channels, 
along with two lines indicating the average plus and minus the standard devi-
ation, both derived from the baseline parameters. In addition the user may 
instruct the program to show the locations of the detected peaks. In this way 
a wrong choice of the parameters can be clarified very easily. Mostly it is 
quite obvious, which parameter should be corrected. 
THE WAY TO GET THE RESULT. 
This chapter describes the best way to use the sets of programs. First the 
impuls detection programs are described, last the EEG- peak detection pro-
grams. 
DETECTION OF IMPULSES. 
The observed jerks are transmitted to the taperecorder. The recorded impul-
ses are digitized with program RAT IMP. Since the detection threshold is the 
only parameter which is of influence for the detection of the impulses, a 
wrong choice of this parameter will show up quite clear m the display of 
results by program IMPDIS. The only way to correct this is to run program 
RAI IMP again with a new value for the detection threshold. 
DETECTION OF PEAKS IN THE EEG. 
In this section the best sequence to run the set of programs is described 
(Figure 45). 
At f i rs t the program CALIBR is run on the recorded smewave to cali-
brate the system. Then program RATMT digitizes the baseline EEG and the 
activation FEG and creates datafiles on digital magtape. 
Now run program RATBS with the baseline EEG as mputf i le. This 
results in a parameterfile containing the baseline paramaters. For each activa-
tion EEG this fi le should be copied to an mputfi le with a different name. 
After this has been done, run program RATPK2 with estimated parame-
ters, the above mentioned copy of the parameterfile and the datafile of the 
activation EEG as input. The results are stored m the parameterf ile. 
At this point it is wise to run program RATDIS to show the locations in 
the EEG where the peaks were detected In this way a manifold of combina-
tions of wrong chosen parameters m program RATPK2 may appear. Peaks may 
be missed due to a wrong choice of the detection threshold, the peakwidth 
may be chosen too small, so that broad peaks will not be detected, etc. 
If this is the case, run program RATPK2 again with a corrected set of 
parameters Run program RATDIS to check, whether the choice was the r ight 
one. 
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Figure 45: Procedure for detection of epileptic peaks 
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If this is finally accomplished, run program PK2DIS to display and pr int 
the results for the various EEGs. 
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1. De rhytmic i te i t van laag f requente epi lept ische ont ladingen (beneden 1 
Hz. ) is van belang voor het ontstaan van part ie le epileptische 
aanval len. Het tegengaan van deze rhy tmic i te i t leidt indi rect tot een 
verminder ing van deze aanval len. 
- Sherwin I., Electroenc. Clin. Neurophysiol. 45:525-34, 1978. 
- Dit proefschrift. 
2 Een pat iënt ger ichte kwant i tat ieve analyse van de stochastische 
eigenschappen van het mter ic ta le EEG kan nu t t i g zijn voor een ju is te 
diagnost iek en behandeling van slecht te onderd rukken epileptische 
aanval len. 
- Sherwin I'., Electroenc. Clin. Neurophysiol. 15:533. 1978. 
3. Gezien de wijze waarop de gebru ike l i j ke ant i -epi lept ica part iele 
motorische aanvallen onde rd rukken , is een indel ing m d i rec t en indirect 
werkende stoffen te overwegen, gebaseerd op al of met aanwezig zijn 
van effekten op laag f rekwente (beneden 1 Hz. ) epileptische 
ont lad ingen. Fenytome en carbamazepme zijn d i rec t , ethosuximide, 
clonazepam en valproaat overwegend ind i rect en phénobarbital gemengd 
werkzaam 
- Dit proefschrift. 
4. Partiele epileptische aanvallen kunnen, zelfs indien zij met 
overeenkomstige verschi jnselen gepaard gaan, verschi l lende 
ontstaanswijzen hebben. 
- Dit proefschrift. 
5. Zolang de kl inische waarde van combinaties van ant i-epi lept ica nog 
onvoldoende vaststaat, dienen experimentele gegevens mode als 
u i tgangspunt te worden genomen bij het samenstellen van combinaties 
voor pat iënten. 
6. Het verd ient aanbeveling de grens tussen mter ic ta le en letale 
verschi jnselen te def inieren aan de hand van de t i j dsduu r tussen twee 
opeenvolgende epileptische ont lad ingen. 
7. Het vuurgedrag van neuronen ver toont waarschi jn l i jk overeenkomst met 
het pr inc ipe van cel lulaire automata, zoals het 'game of l i fe ' , waarbij 
iedere cel reageert op grond van regels die een omschreven toestand 
van diens buren vereisen. Hierdoor worden patronen op grote schaal 
z ichtbaar, veroorzaakt door in wezen eenvoudige interacties op 
microniveau. Verander ing van de regels kan leiden tot het ontstaan van 
epi lepsie. 
- zie ook: B. Hayes, Scientific American 250:10-16, maart 1984. 
8 In de gezondheidszorg dient in format ieverwerk ing centraal te staan. Een 
afdel ing informatica is dan ook even onmisbaar als een kl inisch chemisch 
laboratorium 
9. Elke kl inische ervar ing dient te worden getoetst 
10. BIJ het verdedigen van een proefschr i f t zou het de promovendus moeten 
worden toegestaan andere dan alleen verbale middelen te geb ru i ken , 
var iërend van v ideo-presentat ie tot een ouderwets due l . 
11. Een arts komt t i jdens zijn opleiding to t specialist vaker m aanraking 
met problemen van bureaucrat ische dan van vaktechnische aard . 
12. Een v r i j gevest igd ar ts dient te worden betaald naar wat hij niet omzet. 
13. Een niet v r i j gevest igd arts dient te worden betaald naar wat hij omzet. 



